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Type  2  diabetes  is  a  metabolic  disease  marked  by  an  abnormally  high  level  of  glucose  (sugar)  in  
the  blood.  Type  2  diabetes  is  now  reaching  an  epidemic  level  with  more  than  30  million  adults  in  the  
United  States  afflicted  and  1.5  million  new  cases  documented  every  year.  Type  2  diabetes  is  linked  with  
obesity,  heart  disease,  hypertension,  and  liver  disease,  and  individuals  with  type  2  diabetes  are  at  an  
increased  risk  for  heart  failure,  stroke,  blindness,  kidney  failure,  and  amputation.  According  to  the  Centers  
for  Disease  Control  and  Prevention,  more  than  $245  billion  was  spent  in  the  United  States  in  2012  on  
medical  expenses  related  to  diabetes  and  despite  that,  nearly  a  quarter  of  a  million  Americans  are  losing  
their  lives  due  to  this  disease  each  year.  Indeed,  type  2  diabetes  is  one  of  the  leading  causes  of  death  in  
the  United  States  and  worldwide;;  its  prevalence  has  almost  doubled  in  the  last  35  years,  from  4.7%  of  the  
total  population  in  1980  to  8.5%  in  2014.  Consequently,  more  than  400  million  people  are  at  high  risk  for  
severe  health  problems  and  complications,  poor  quality  of  life,  and  early  death.    
Research  such  as  the  Diabetes  Prevention  Program  (DPP),  the  Finnish  Diabetes  Prevention  
Study  (DPS),  the  Vesterbotten  Intervention  Program  (VIP),  and  the  Diabetes  Prevention  Program  
Outcome  Study  (DPPOS)  suggests  that  type  2  diabetes  can  be  delayed,  and  even  prevented,  with  a  
lifestyle  behavioral  modification  program  that  includes  healthy  eating  and/or  exercise.  Therefore,  focus  
has  been  shifted  from  management  to  prevention.  An  early  manifestation  of  dysfunction  in  the  
progression  of  type  2  diabetes  is  insulin  resistance,  a  metabolic  impairment  associated  with  obesity.  
Indeed,  it  is  estimated  that  ~90%  of  people  with  type  2  diabetes  also  are  obese.  The  link  between  insulin  
resistance  and  obesity  is  well-­established;;  however,  the  mechanistic  basis(es)  underpinning  this  link  





theory  that  has  gained  traction  in  recent  years  suggests  that  type  2  diabetes,  and  the  insulin-­resistant  
state  that  predates  it,  are  rooted  in  dysfunctional  lipid  metabolism  (i.e.,  a  reduced  capacity  to  use  lipid  for  
energy  production  in  circumstances  where  lipid  would  be  preferred,  such  as  in  the  basal  fasting  condition,  
after  a  high-­fat  meal,  and  during  light-­  and  moderate-­intensity  exercise).  However,  there  are  conflicting  
findings  regarding  the  degree  to  which  the  ability  to  oxidize  lipid  during  these  circumstances  is  
compromised  for  individuals  with  the  overweight/obesity  that  is  associated  with  the  disease  progression.  
The  reason(s)  for  this  ambiguity  is/are  unclear  but  might  have  to  do  with  a  number  of  factors  that  were  
poorly  controlled  when  substrate  selectivity  (i.e.,  lipid  vs.  carbohydrate  oxidation  rates)  were  compared  
between  normal-­weight  individuals  and  those  with  the  overweight/obese  condition.  These  include:    
(a)  acute  energy  balance  and  macronutrient  composition  of  the  diet;;  (b)  the  intensity  and  duration  of  the  
exercise  bout;;  and  (c)  subject  characteristics  including  the  amount  of  muscle  tissue  they  possess,  their  
cardiorespiratory  fitness  level,  and,  perhaps  most  importantly,  their  insulin-­sensitivity  state.  The  purpose  
of  this  dissertational  work  is  to:  (a)  help  to  resolve  this  ambiguity  by  identifying  the  degree  to  which  
conflicting  results  that  have  been  reported  might  be  explained  by  factors  that  were  left  unaccounted  for  
and/or  inadequately  controlled  in  previous  research;;  and  (b)  compare  substrate  selectivity  in  normal-­
weight  individuals  and  those  with  the  overweight/obesity  condition  during  a  physiologically-­equivalent  
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CHAPTER  1  –  INTRODUCTION  
1.1  Purpose  
An  early  manifestation  of  dysfunction  in  the  progression  to  hyperglycemia  (i.e.,  elevated  blood  
glucose  levels)  and  type  2  diabetes  is  insulin  resistance.  Recent  studies  link  insulin  resistance  with  the  
accumulation  of  lipids  in  skeletal  muscle  and,  therefore,  type  2  diabetes  has  been  “redefined”  as  a  
disease  of  dysfunctional  lipid  metabolism  (i.e.,  lipid  storage  in  muscle  that  exceeds  lipid  oxidation  
resulting  in  lipid  accumulation).  Excess  body  fat  is  associated  with  an  increased  risk  of  developing  insulin  
resistance  and  the  chronic  positive  energy  balance  that  facilitates  weight  gain  results  in  excess  lipid  
accumulation  throughout  the  body.  Consequently,  insulin  resistance  and  an  impaired  capacity  for  lipid  
metabolism  have  been  suggested  to  form  the  basis  for  the  overweight/obese  condition.  The  link  between  
insulin  resistance  and  the  overweight/obese  condition  is  well  established,  and  overweight/obesity  
accounts  for  80-­85%  of  the  likelihood  of  developing  type  2  diabetes.  However,  it  is  interesting  to  note  that  
not  all  individuals  with  the  overweight/obese  condition  demonstrate  insulin  resistance  and,  heretofore,  
there  are  conflicting  findings  regarding  the  degree  to  which  the  ability  to  oxidize  lipid  during  functional  
circumstances  where  lipid  use  is  preferred  (e.g.,  during  fasting  and  in  response  to  a  high-­fat  diet/meal)  is  
compromised  for  individuals  with  overweight/obesity.  The  reason(s)  for  this  ambiguity  is/are  unclear  but  
might  have  to  do  with  measurement  bias  and/or  a  number  of  important  factors  that  were  not  well  
controlled  in  these  conditions  (e.g.,  low  metabolic  demand,  day-­to-­day  variability  in  energy  balance,  
weight  imbalance,  and  plasma  glucose  and  free-­fatty  acid  concentration).  Citing  these  concerns,  
scientists  are  now  recommending  assessing  substrate  selectivity  (i.e.,  rates  of  lipid  vs.  carbohydrate  
oxidation)  during  exercise  as  a  way  to  explore  the  link  between  impaired  lipid  metabolism  and  insulin  
resistance.  Unlike  the  resting  or  feeding  state,  metabolic  demand  is  significantly  higher  during  exercise  
and  therefore,  if  a  defect  exists,  it  is  more  likely  to  show.  However,  conflicting  findings  also  exist  regarding  
the  degree  to  which  excess  fat  and/or  insulin  resistance  are  associated  with  impaired  lipid  metabolism  
during  exercise.  Once  again,  the  ambiguity  is  likely  related  to  a  number  of  key  factors  that  were  poorly  
controlled  when  substrate  selectivity  was  compared  between  individuals  with  and  without  the  
overweight/obesity.  These  include:  (a)  acute  energy  balance  and  macronutrient  composition  of  the  diet;;  





muscle  tissue  they  possess,  their  cardiorespiratory  fitness  level,  and,  perhaps  most  importantly,  their  
insulin-­sensitivity.    
The  purpose  of  this  dissertational  work  is  to:  (a)  study  the  influence  of  the  overweight/obese  
condition  on  exercise  lipid  oxidation  from  the  existing  data;;  (c)  inform  future  research  by  determining  the  
degree  to  which  conflicting  results  that  have  been  reported  might  be  explained  by  factors  left  
unaccounted  for  and/or  inadequately  controlled  in  previous  research;;  and  (c)  resolve  this  ambiguity  by  
comparing  substrate  selectivity  in  individuals  with  and  without  overweight/obesity  during  both  fasting  and  
exercise  with  the  aforementioned  factors  rigidly  controlled.    
1.2  Background  and  Rationale  
1.2.1   Diabetes—Definition,  Prevalence,  and  Impact    
Diabetes  is  a  complex  disease  marked  by  a  high  level  of  glucose  (sugar)  in  the  blood  (e.g.,  
fasting  glucose,  >126mg∙dl-­1;;  2-­hr  post  75g  glucose  drink,  >200mg∙dl-­1;;  HbA1c,  >6.5%).  The  vast  majority  
(>90%)  of  individuals  with  diabetes  possess  type  2  diabetes,  a  condition  associated  with  insulin  
resistance  and  obesity.  Recent  reports  from  the  Centers  for  Disease  Control  and  Prevention  (CDC)  
suggest  that  diabetes  has  reached  an  epidemic  level  with  more  than  1.5  million  new  cases  documented  
every  year  and,  at  present,  nearly  30  million  people  in  the  United  States  have  diabetes.  Individuals  with  
diabetes  are  at  increased  risk  for  various  complications  and  co-­morbidities,  including  blindness,  heart  
disease,  stroke,  hypertension,  kidney  failure,  liver  disease,  obesity,  infertility,  and  amputation.  In  2012,  
the  economic  cost  of  diabetes  in  the  United  States  was  $245  billion  (a  41%  increase  from  2007),  which  
indicates  the  significant  burden  that  diabetes  has  on  our  society  (American  Diabetes  Association,  2013).  
In  addition,  individuals  with  diabetes  have  a  50%  greater  risk  for  premature  death  compared  with  
individuals  without  diabetes,  and  more  people  in  the  United  States  are  dying  from  diabetes  than  from  
AIDS  and  breast  cancer  combined.  In  2010,  diabetes  was  mentioned  as  a  cause  of  death  in  more  than  
234,000  cases,  and  together  with  heart  disease  and  stroke,  diabetes  is  among  the  seven  leading  causes  
of  death  in  the  United  States  (CDC,  2014).  Given  the  devastating  health  consequences  and  the  
substantial  economic  burden,  research  and  clinical  work  has  been  shifted,  to  some  degree,  from  diabetes  
management  to  diabetes  prevention.    





1.2.2   Obesity—Definition,  Prevalence,  and  Impact  
The  state  of  overweight/obesity  is  characterized  by  excess  body  fatness.  Typically,  overweight  
and/or  obesity  are  classified  using  the  body-­mass  index  (BMI)  scale,  which  is  a  mathematical  computation  
using  body  weight  (in  kilograms)  and  body  height  (in  meters  squared).  A  normal  BMI  is  between  18.5    
and  24.9  kg∙m-­2,  which  suggests  an  appropriate  level  of  body  fat  relative  to  body  weight  and  height.  
Conversely,  a  BMI  greater  than  25.0  kg∙m-­2  is  considered  abnormally  high  (“overweight”)  and,  at  present,  
more  than  70%  of  U.S.  adults  fall  in  to  this  category.  Moreover,  a  BMI  greater  than  30.0  kg∙m-­2  indicates  a  
state  of  excess  fat  accumulation  labeled  “obesity.”  The  prevalence  of  obesity  in  the  United  States  has  
increased  significantly  in  recent  years,  from  11.1%  in  1970  to  14%  in  1990  to  nearly  40%  in  2017,  with  
more  than  a  quarter  of  the  people  with  this  condition  falling  into  the  morbidly-­obese  (BMI  >35  kg∙m-­2)  and  
extremely-­obese  (BMI  >40  kg∙m-­2)  categories  (Flegal,  Carroll,  Ogden,  &  Curtin,  2010).  From  a  public  
health  perspective,  this  is  alarming  because  epidemiological  studies  have  demonstrated  that  a  BMI  
greater  than  30  kg∙m-­2  is  a  major  risk  factor  for  various  neurological,  psychological,  circulatory,  
physiological,  and  metabolic  disturbances,  including  heart  disease,  high  blood  pressure,  fatty  liver,  stroke,  
heart  failure,  sleep  apnea,  depression,  and  osteoporosis  (Mitchell,  Catenacci,  Wyatt,  &  Hill,  2011).  
Interestingly,  the  overweight/obese  state  exerts  its  greatest  wrath  via  metabolic  repercussion  with  44%  of  
the  burden  of  diabetes  attributable  to  this  condition  (Press,  2009).  It  is  therefore  not  surprising  that  
overweight/obesity  and  type  2  diabetes  are  linked  at  epidemic  level.  The  primary  cause(s)  for  the  rise  in  
the  prevalence  and  incidences  of  obesity  is/are  not  fully  understood;;  however,  experimental  and  
epidemiological  studies  suggest  that  the  root  cause  is  multifactorial  (e.g.,  poor  nutrition,  lack  of  physical  
activity,  socioeconomic  status,  genetics,  hormonal  dysfunction,  medication,  smoking,  education  level,  and  
other  medical  conditions)  (Herpertz,  2008).  One  specific  theory  posits  a  relationship  between  weight  gain  
and  dysfunctional  lipid  metabolism  based  on  the  notion  that  excess  accumulation  of  lipid  in  skeletal  
muscle  (i.e.,  muscle  fat)  becomes  toxic  (“lipotoxic”)  and  breeds  insulin  resistance  when  it  is  not  turned  
over  on  a  regular  basis  (McGarry,  1992;;  Moro,  Bajpeyi,  &  Smith,  2008).  In  support  of  this  view,  there  is  
evidence  to  suggest  that  individuals  with  obesity  demonstrate  an  impaired  ability  to  rely  on  lipid  oxidation  
for  the  production  of  energy  in  circumstances  where  lipid  would  be  the  preferred  fuel,  such  as  after  an  





evidence  also  exists  suggesting  the  contrary—specifically,  that  lipid  oxidation  is  not  impaired  and  might  
even  be  enhanced  with  obesity.  The  reason(s)  for  this  ambiguity  is/are  not  understood  but  might  reflect  a  
number  of  factors  that  are  typically  poorly  controlled  when  lipid  oxidation  is  compared  between  individuals  
with  normal  weight  and  overweight/obesity.  Specifically,  the  insulin-­resistant  status  of  the  participant  with  
the  obesity  condition  is  often  not  considered  and  it  stands  to  reason  that  substrate  shifts  associated  with  
insulin  desensitization  could  exert  an  effect  independent  of  body  fatness.  Therefore,  it  remains  unknown  if  
the  metabolic  change  is  due  to  the  excess  accumulation  of  fat  or  the  insulin-­resistant  state  that  often  
accompanies  it;;  heretofore,  no  research  has  compared  lipid  oxidation  at  rest  and  during  a  physiological-­
equivalent  exercise  challenge  in  individuals  with  normal  weight  and  overweigh/obesity,  with  insulin-­
resistant  status  well  controlled.  
1.2.3   Insulin  Resistance  and  Dysfunctional  Lipid  Oxidation  
Insulin  resistance  characterizes  a  metabolic  state  for  which  muscle  tissue,  adipose  tissue,  and  
the  liver  do  not  respond  in  the  appropriate  manner  to  the  hormone  insulin.  The  result  is  elevated  blood  
glucose  (Wilcox,  2005).  It  is  well  recognized  that  insulin  resistance  is  a  primary  defect  in  the  progression  
to  type  2  diabetes  that  shares  a  strong  association  with  obesity  (Kahn  &  Flier,  2000).  For  example,  more  
than  90%  of  people  with  type  2  diabetes  are  overweight  or  obese.  The  link  between  insulin  resistance  and  
the  overweight/obesity  state  is  well  documented  (Kahn  &  Flier,  2000);;  however,  the  mechanistic  basis(es)  
is/are  still  being  debated  with  multiple  candidates  potentially  involved.  One  theory,  proposed  by  Dennis  J.  
McGarry  in  1992,  suggests  that  type  2  diabetes  is  rooted  in  the  dysfunctional  metabolism  of  lipid  (fat),  not  
sugar.  In  support  of  this  postulation,  a  growing  body  of  evidence  suggests  that  insulin  resistance  is  
associated  with  excess  accumulation  of  lipid  in  skeletal  muscle  and  that  these  elevated  intramyocellular  
lipids  (i.e.,  fat  stored  in  droplets  in  muscle  cells)  become  “lipotoxic”  when  it  is  not  “turned  over”  on  a  
regular  basis.  Insulin-­stimulated  glucose  metabolism  occurs  predominantly  in  the  muscle;;  hence,  excess  
lipid  accumulation  interferes  with  normal  glucose  processing.  Within  that  schema,  chronic  hypercaloric  
intake  and  a  sedentary  lifestyle  would  provide  the  conditions  for  pathological  elevation  of  intramyocellular  
lipids  that  leads  to  insulin  resistance  and  the  diabetes  progression.    
A  number  of  studies  support  this  contention.  For  example,  Krssak  et  al.  (1999)  reported  an  





and  intramyocellular  triglyceride  content  (IMTG)  in  normal-­weight  non-­diabetic  adults.  A  similar  
relationship  was  also  found  in  non-­diabetic  Pima  Indian  men,  a  group  that  is  at  high  risk  for  obesity  and  
diabetes,  independent  of  body  fat  percentage  (Pan  et  al.,  1997).  It  is  interesting  to  note  that  endurance  
athletes  also  demonstrate  markedly  high  levels  of  intramyocellular  lipids;;  however,  they  also  demonstrate  
high  insulin-­sensitivity  levels  (Goodpaster,  He,  Watkins,  &  Kelley,  2001).  Moreover,  a  higher  content  of  
intramyocellular  lipids  has  been  reported  in  individuals  post  exercise  intervention  (Dubé  et  al.,  2008).  
These  findings  appear  to  suggest  that  lipid  accumulation  in  skeletal  muscle  per  se  is  not  pathological.  
Since  day-­to-­day  energy  metabolism  and  lipid  use  are  typically  greater  in  those  who  are  physically  active  
versus  sedentary,  one  possible  explanation  is  that  lipid  accumulation  in  muscle  becomes  toxic,  or  
pathological,  when  it  is  not  consistently  and  sufficiently  used.  An  important  point  in  this  regard  is  that  
energy  expenditure  should  be,  on  average,  lower  than  energy  intake  (i.e.,  a  negative  energy  balance  
should  be  in  effect)  for  this  protectivity.    
The  accumulation  of  lipid  in  skeletal  muscle  can  be  the  result  of  excess  FFA  uptake,  inadequate  
lipid  utilization,  or  both.  In  1999,  Kelley,  Goodpaster,  Wing,  and  Simoneau  et  al.  measured  glucose  and  
FFA  uptake  in  the  basal  state  together  with  indirect  calorimetry  across  the  leg  in  lean  and  obese  subjects.  
They  found  that  FFA  uptake  exceeded  FFA  oxidation  in  both  groups,  which  means  that  lipid  accumulation  
was  taking  place  in  the  muscle  regardless  of  body  weight.  Moreover,  the  rate  of  FFA  uptake  by  skeletal  
muscle  was  similar  between  the  two  groups.  However,  lipid  oxidation  was  significantly  lower  in  those  with  
obesity,  which  suggests  that  the  net  accumulation  of  lipid  in  muscle  was  greater.  It  also  implies  that  it  is  
the  ability  to  use  the  fat  stored  in  the  muscle  (i.e.,  intramyocellular  lipid  oxidation)  that  dictates  whether  
storage  is  benign  or  harmful  (Kelley  et  al.,  1999).    
If  the  line  of  reasoning  advanced  by  Kelley  et  al.  (1999)  is  correct,  individuals  with  insulin  
resistance  and/or  obesity  should  demonstrate  dysfunctional  lipid  metabolism.  Specifically,  this  should  
manifest  as  an  impaired  capacity  to  rely  on  lipids  as  the  main  fuel  source  in  circumstances  where  lipid  
would  be  the  preferred  fuel  for  energy  production  (e.g.,  fasting,  in  response  to  a  high-­fat  meal  and  during  
exercise  performed  at  or  below  the  lactate  threshold;;  i.e.,  moderate-­intensity  exercise).  With  regard  to  
exercise,  it  is  important  to  note  that  compared  to  untrained  subjects,  endurance-­trained  individuals  oxidize  





Saris,  &  Wagenmakers,  1999)  and  this  increase  in  total  lipid  oxidation  is  almost  completely  derived  from  
IMTG-­  and/or  very-­low-­density  lipoproteins  (Schrauwen  et  al.,  2002).  Furthermore,  the  increased  capacity  
for  IMTG  storage  and  breakdown  in  subjects  after  a  6-­week  endurance  training  regimen  (see  above)  is  
correlated  and  mediated  via  expression  of  perilipins  2  and  5  (Shepherd  et  al.,  2013).  Importantly,  these  
lipid-­droplet  proteins  attenuate  lipotoxic  damage  (Bosma  et  al.,  2012)  and,  indeed,  as  is  typically  the  case  
after  an  endurance-­training  intervention,  the  protocols  employed  in  that  study  improved  insulin  sensitivity  
despite  a  ~2-­fold  increase  in  resting  IMTG  content  (Shepherd  et  al.,  2013).  Collectively,  these  findings  
suggest  that  it  is  intramyocellular  lipid  oxidation  and  turnover,  as  opposed  to  FFA  uptake  and  
accumulation  per  se,  that  determine  their  influence  on  insulin’s  regulatory  prowess.  With  this  in  mind,  it  is  
important  to  clarify  existing  ambiguity  regarding  the  degree  to  which  lipid  oxidation  is  compromised  for    
individual  with  obesity  and/or  insulin  resistance  in  circumstances  where  lipid  oxidation  is  the  preferred  fuel  
(see  above).    
1.2.4   Assessing  Fuel  Metabolism  and  Dysfunctional  Lipid  Oxidation  During  Basal  Conditions  
It  is  well  established  that  during  the  basal  state  (e.g.,  immediately  after  a  12-­hr  overnight  fast),  
skeletal  muscle  of  a  normal-­weight  healthy  individual  relies  on  lipids  to  supply  the  majority  of  energy  
production  (Andres,  Cader,  &  Zierler,  1956;;  Baltzan,  Andres,  Cader,  &  Zierler,  1962).  The  ability  to  
predominantly  rely  on  lipids  during  basal  conditions  is  related  to  muscle-­fiber  type  (Kelley  et  al.,  1999;;  
Mogensen  et  al.,  2007);;  mitochondrial  content  and  function  (Kelley  et  al.,  1999);;  enzymatic  activity  (He,  
Watkins,  &  Kelley,  2001);;  hormonal  state  (Randle,  Kerbey,  &  Espinal,  1988);;  and  substrate  availability  
(Randle  et  al.,  1988).  Based  on  this  observation,  researchers  have  measured  energy  metabolism  and  fuel  
selectivity  (i.e.,  rates  of  lipid  versus  carbohydrate  oxidation)  in  the  basal  condition  as  a  way  to  determine  if  
impairment  is  present.  For  example,  in  a  seminal  study,  Kelly  et  al.  (1999)  confirmed  a  lower  rate  of  lipid  
oxidation  for  individuals  with  obesity  compared  with  normal-­weight  subjects  after  a  12-­hr  overnight  fast.  
This  suggests  that  individuals  with  obesity  may  indeed  have  an  impaired  capacity  to  oxidize  lipid  for  
energy.  Filzof  et  al.  (2000)  reported  a  lower  lipid-­oxidation  rate  in  post-­obese  subjects  compared  with  
age-­  and  BMI-­matched  never-­obese  controls,  despite  similar  rates  of  energy  production.  Solomon  et  al.  
(2008)  reported  a  greater  reliance  on  lipid  oxidation  during  sleep  following  a  weight-­loss  intervention  





reported  increased  lipid  oxidation  during  fasting  in  pre-­diabetic  obese  subjects  after  a  weight  loss  induced  
by  exercise  or  exercise  and  diet.  Collectively,  these  findings  support  the  notion  that  dysfunctional  lipid  
metabolism  in  the  basal  state  could  be  the  primary  defect  that  links  insulin  resistance  and  the  
overweight/obesity  conditions.  However,  other  studies  provide  contradictory  findings;;  specifically,  that  
lipid  oxidation  in  the  basal  state  is  not  reduced  in  the  overweight/obese  state  (Balcı,  2012;;  Blaak  et  al.,  
2006;;  Colberg  et  al.,  1996;;  Ekelund  et  al.,  2007;;  Ezell  et  al.,  1999;;  Guesbeck  et  al.,  2001;;  Helge,  Watt,  
Richter,  Rennie,  &  Kiens,  2001;;  Kanaley,  Weatherup-­Dentes,  Alvarado,  &  Whitehead,  2001;;  Perez-­Martin  
et  al.,  2001;;  Steffan,  Elliott,  Miller,  &  Fernhall,  1999),  and  might  even  be  enhanced  (Nicklas,  Rogus,  &  
Goldberg,  1997;;  Schutz,  Tremblay,  Weinsier,  &  Nelson,  1992;;  van  Aggel-­Leijssen,  Saris,  Hul,  &  van  
Baak,  2001).  The  reason(s)  for  the  ambiguity  is/are  not  fully  clear  but  might  be  related  to  the  fact  that  
during  basal  conditions,  metabolic  demand  is  low  and  absolute  lipid-­oxidation  rate  is  minimal.  Moreover,  
acute  energy  balance  and  dietary  macronutrient  composition  of  the  diet  in  the  days  prior  markedly  
influence  the  measurement.    
1.2.5   Assessing  Substrate  Selectivity  in  Response  to  Insulin-­simulation  
The  role  of  insulin  in  regulating  oxidative  and  non-­oxidative  pathways  related  to  energy  
metabolism,  substrate  utilization,  and  glucose  homeostasis  is  well  documented  (Felber  et  al.,  197;;  Saltiel  
&  Kahn,  2001).  In  a  healthy  person,  increasing  the  blood  insulin  level  either  via  insulin  stimulation  (e.g.,  
post  intake  of  an  oral  glucose  drink  or  high-­carbohydrate  meal)  and/or  insulin  infusion  (e.g.,  post  insulin  
clamp)  leads  to  up  regulation  of  glucose  uptake  and  oxidation  in  skeletal  muscle  and  down  regulation  of  
lipid  metabolism  and  oxidation.  Based  on  these  effects,  the  ability  to  switch  from  predominantly  lipid  
oxidation  in  the  basal  condition  to  predominantly  carbohydrate  oxidation  post  insulin  stimulation/infusion  
has  been  used  to  assess  skeletal  muscle  “metabolic  flexibility,”  which  is  defined  as  the  capacity  of  
skeletal  muscle  to  adjust  fuel  use  based  on  fuel  availability.  In  1999,  Kelley  et  al.  were  the  first  to  
demonstrate  impaired  substrate  switching  in  overweight/obese  subjects.  By  comparing  fuel  utilization  and  
substrate  selectivity  immediately  during  insulin  infusion  with  that  collected  during  basal  conditions,  they  
demonstrated  that  normal-­weight  subjects  have  a  robust  capacity  to  shift  fuel  use  from  predominant  lipid  
oxidation  in  the  basal  state  to  predominant  glucose  oxidation  post  infusion.  In  contrast,  obese  subjects  





oxidation  when  infused  with  insulin.  This  observation  suggested  that  individuals  with  obesity  lack  the  
metabolic  flexibility  that  characterized  healthy  function,  and  since  insulin  resistance  can  manifest  in  both  a  
lower  level  of  lipid  oxidation  in  the  basal  state  and  blunted  suppression  in  the  insulin-­induced  state,  the  
authors  reasoned  that  this  might  reflect  a  primary  defect  associated  with  obesity  that  links  it  with  insulin  
resistance.  However,  using  a  similar  protocol  (i.e.,  hyperinsulinemic  clamp),  Galgani,  Moro,  and  Ravussin  
(2008)  found  similar  metabolic  flexibility  in  individuals  with  obesity  and  type  2  diabetes  compared  with  
individuals  with  obesity  but  no  type  2  diabetes  after  adjusting  for  the  rate  of  glucose  disposal  which,  by  
nature,  is  reduced  when  insulin  resistance  is  present.  This  may  suggest  that  the  metabolic  inflexibility  to  
glucose  in  patients  with  type  2  diabetes  is  related  to  a  defect  in  glucose  transport  as  opposed  to  fuel  
selectivity  (i.e.,  carbohydrate  and/or  lipid  oxidation)  (Galgani,  Moro,  &  Ravussin,  2008).  In  addition,  the  
insulin-­infused  conditions,  which  have  been  employed  by  Kelley  el  al.  and  others  to  assess  metabolic  
flexibility  and  functional  fuel  switching,  have  raised  concerns  because  of  their  “supra-­physiological”  nature  
(Bergouignan  et  al.,  2012).  
1.2.6   Assessing  Substrate  Selectivity  in  Response  to  High-­fat  Meal  
The  capacity  to  increase  fuel  oxidation  based  on  substrate  availability  is  another  hallmark  of  
normal  metabolic  function  (Storlien,  Oakes,  &  Kelley,  2004).  In  normal-­weight  healthy  individuals,  
increasing  the  proportion  of  dietary  fat  increases  FFA  availability  and  oxidation,  whereas  a  high-­
carbohydrate  meal/drink  or  glucose  infusion  suppresses  fat  oxidation  and  promotes  carbohydrate  
oxidation.  Based  on  these  effects,  researchers  started  using  a  high-­fat  meal  (acute)  or  diet  (chronic)  as  a  
way  to  assess  metabolic  function/flexibility  based  on  the  capacity  to  up-­regulate  fat  oxidation  in  
accordance  with  substrate  availability.  For  example,  Heilbronn,  Gregersen,  Shirkhedkar,  Hu,  and  
Campbell  (2007)  found  a  significant  difference  in  metabolic  flexibility  toward  dietary  fat  in  individuals  with  
a  family  history  of  diabetes  compared  with  age-­  and  fatness-­matched  controls,  despite  similar  level  of  
insulin  sensitivity,  fasting  fat  oxidation,  and  postprandial  FFA  level  in  the  blood.  Importantly,  there  was  no  
difference  between  the  groups  in  metabolic  flexibility  toward  carbohydrate.  Kelley  et  al.  (1999)  found  an  
impaired  capacity  to  increase  reliance  on  lipid  oxidation  that  lasted  more  than  6  hours  after  eating  a  high-­
fat  meal  in  individuals  with  diabetes  compared  with  weight-­match  healthy  controls,  despite  similar  levels  





lower  rate  of  lipid  oxidation  after  7  days  of  a  high-­fat  (>50%  of  total  calories)  feeding  protocol  in  African  
American  women  (i.e.,  a  group  predisposed  to  insulin  resistance  and  type  2  diabetes)  compared  with  their  
Caucasians  counterparts,  despite  similar  age,  wait-­to-­hip  ratio,  BMI,  percent  body  fat  and  fat-­free  mass.  
Together,  these  observations  suggest  a  link  between  insulin  action  and  dysfunctional  lipid  metabolism,  
and  the  presence  of  metabolic  inflexibility  to  dietary  lipid  in  individuals  with  a  family  history  of  diabetes  
may  indicate  that  impaired  lipid  oxidation  may  precede  insulin  resistance.  However,  using  postprandial  
fuel  use  as  a  way  to  assess  impairments  related  to  lipid  metabolism  has  been  questioned  after  Blaak  et  
al.  (2006)  found  increased  fat  oxidation  in  a  large  cohort  of  individuals  with  obesity  and  insulin  resistance  
compared  with  normal-­weight  healthy  subjects  after  high-­fat  meals.  This  difference  remained  significant  
even  after  adjusting  for  fat  mass,  fasting  fat  oxidation,  sex,  and  physical  activity  (Blaak  et  al.,  2006).  One  
possible  factor  that  may  explain  the  discrepancy  is  the  relative  low  level  of  metabolic  challenge  that  exists  
in  the  basal  and/or  postprandial  state  (Galgani,  Moro,  &  Ravussin,  2008).  
1.2.7   Assessing  Substrate  Selectivity  in  Response  to  Exercise  Stimulation  
Citing  the  various  limitations  and  conflicting  findings  regarding  the  degree  to  which  dysfunctional  
lipid  metabolism  can  or  should  be  assessed  in  the  basal,  insulin-­stimulated,  and  postprandial  states,  
Galgani,  Moro,  and  Ravussin  (2008)  proposed  using  exercise  as  a  tool  to  explore  the  link  between  insulin  
resistance  and  dysfunctional  lipid  metabolism  and  the  role  it  may  play  in  obesity.  The  authors  based  this  
contention  on  the  fact  that  energy  expenditure  and  metabolic  demand  are  significantly  higher  during  
exercise  compared  to  basal  or  postprandial  conditions.  Therefore,  if  a  defect  exists,  it  is  more  likely  to  
manifest  during  an  activity  that  requires  highly  coordinated  regulation  between  fuel  supply  and  the  
oxidative  machinery.  It  is  well  established  that  fit  individuals  are  able  to  up  regulate  lipid  oxidation  in  
response  to  an  exercise  challenge,  in  part,  to  conserve  precious  sources  of  muscle  glycogen  (Storlien  et  
al.,  2004).  Indeed,  Nordby,  Saltin,  and  Helge  (2006)  found  that  lipid  oxidation  is  higher,  and  occurs  at  
higher  exercise  intensities,  in  fit  compared  to  unfit  individuals.  While  exercise  can,  in  theory,  provide  a  
consistent  medium  for  assessing  lipid  use,  conflicting  findings  exist  regarding  the  degree  to  which  
exercise  lipid  oxidation  is  impaired  in  individuals  with  overweight/obesity  with  evidence  to  suggest  greater  
(Goodpaster,  Wolfe,  &  Kelley,  2002;;  Horowitz  &  Klein,  2000;;  Kanaley  et  al.,  2001;;  Lanzi  et  al.,  2014),  





2001),  and  similar  (Balcı,  2012;;  Colberg  et  al.,  1996;;  Ezell  et  al.,  1999)  rates  of  lipid  oxidation  in  
individuals  with  obesity  and/or  insulin  resistance  compared  with  normal-­weight  healthy  subjects.  This  lack  
of  consistency  might  be  related  to  a  number  of  factors  that  were  poorly  controlled  when  substrate  
selectivity  (i.e.,  lipid  vs.  carbohydrate  oxidation  rates)  was  compared  between  overweight/obese  and  
normal  weight  subjects.  These  include:  (a)  acute  energy  balance  and  macronutrient  composition  of  the  
diet;;  (b)  the  intensity  and  duration  of  the  exercise  bout;;  and  (c)  subject  characteristics  including  the  
amount  of  muscle  mass  they  possess,  their  cardiorespiratory  fitness  level,  and,  perhaps  most  importantly,  
their  state  of  insulin  sensitivity.  The  research  study  proposed  for  this  dissertation  work  is  the  first  to  date  
to  assess  substrate  selectivity  in  normal-­weight  and  overweight  individuals  during  physiologically-­
equivalent  exercise  challenges,  while  rigidly  controlling  for  various  factors  that  could,  in  theory,  affect  the  
comparison.    
1.3  Statement  of  Research  Questions  
1.3.1   Systematic  Review  
1.3.1.1.  Do  individuals  with  the  overweight/obese  condition  rely  on  lipid  oxidation  to  a  greater,  
lesser  or  the  same  extent  during  exercise  compared  to  normal-­weight  subjects?      
1.3.2   Clinical  Trial    
1.3.2.1   Do  individuals  with  the  overweight/obese  condition  rely  on  lipid  oxidation  to  a  greater,  
lesser  or  the  same  extent  during  a  physiologically-­equivalent  exercise  challenge  
compared  to  age-­,  gender-­,  and  fitness-­matched  normal-­weight  subjects?  
1.3.2.2   Hypothesis  #1:  Rates  of  lipid  oxidation  during  exercise,  adjusted  for  fat-­free  mass,  will  be  
lower  in  individuals  with  the  overweight/obese  conditions.  
1.3.2.3   Hypothesis  #2:  The  lower  rates  of  lipid  oxidation  will  be  related  to  changes  associated  
with  the  loss  of  metabolic  health  (e.g.,  insulin  resistance)  rather  than  the  
overweight/obese  state  per  se.  
1.4  Significance  and  Implications  
The  overlying  objective  of  this  dissertation  work  was  to  resolve  ambiguity  regarding  the  capacity  
for  lipid  oxidation  in  individuals  with  the  overweight/obese  condition.  This  is  important  because  the  degree  





important  factors  to  consider  when  designing  an  exercise  intervention  to  “treat”  this  disease.  For  example,  
if  lipid  use  is  impaired  in  individuals  with  the  overweight/obese  condition,  it  supports  the  contention  that  a  
mitochondrial  defect  exists;;  hence,  exercise  that  is  specific  for  improving  mitochondrial  capacity  (e.g.,  
high-­intensity  interval  training)  would  be  warranted.  Conversely,  if  the  capacity  for  lipid  use  is  similar,  or  
enhanced,  with  the  overweight/obese  condition,  mitochondrial  function  would,  apparently,  be  sufficient;;  
hence,  a  training  work  rate  situated  closer  to  the  one  at  which  lipid  use  is  maximized  might  be  preferred  
as  a  way  to  perturb  the  intramyocellular  lipid  pool  and  reduce  its  pathogenic  influence.  
1.5  Scope  and  Delimitation  
This  clinical  research  is  a  cross-­sectional  comparison  between  four  groups  designed  to  determine  
whether  dysfunctional  lipid  oxidation  is  related  to  the  overweight/obese  condition  (e.g.,  due  to  excessive  
fat  accumulation  throughout  the  body  and,  specifically,  in  areas  other  than  adipose  tissue;;  i.e.,  “ectopic  fat  
deposition”)  or  loss  of  metabolic  health  (e.g.,  insulin  desensitization).  Due  to  the  nature  of  the  design,  the  
application  is  not  equipped  to  establish  a  causality  relationship  (e.g.,  dysfunctional  lipid  oxidation  leads  to  
insulin  resistance  or  vice  versa)  but  may  be  able  to  establish  an  associative  relationship  (e.g.,  
dysfunctional  lipid  oxidation  is  associated  with  insulin  resistance,  but  not  to  ectopic  fat  accumulation).    
1.6  Definitions  of  Terms  
Type  2  diabetes  (T2D):  A  metabolic  disorder  associated  with  insulin  resistance  and/or  insulin  
production  characterized  by  an  abnormal  level  of  blood  sugar.  
Metabolic  flexibility:  The  ability  to  shift  between  carbohydrate  and  fat  as  the  predominant  fuel  
based  on  physiological  needs  and  circumstances.  The  lack  thereof  is  known  as  metabolic  inflexibility.    
Metabolic  syndrome:  A  cluster  of  conditions,  including  elevated  blood  pressure,  high  blood  
sugar,  excess  abdominal  fat,  and  suboptimal  blood  lipids,  that  occur  together  and  increase  risk  of  heart  
disease,  diabetes,  stroke,  and  other  illnesses.    
Family  history  of  diabetes:  The  presence  of  an  affected  first-­degree  relative.  
High-­intensity  interval  training:  Repeated  bouts  of  high-­intensity  effort  separated  by  recovery  
intervals.  
Endurance  training:  Exercise  that  is  rhythmic,  continuous,  sustainable,  and  performed  using  





V̇O2max:  The  highest  rate  of  oxygen  consumption  that  can  be  achieved  by  the  individual.  
Gas  exchange  threshold  (GET):  A  breakpoint  in  the  production  of  carbon  dioxide  (V̇CO2)  
compared  to  the  consumption  of  oxygen  (V̇O2)  obtain  during  a  progressive  exercise  test.    
Constant-­work-­rate  exercise:  An  exercise  bout  where  the  external  power  output  does  not  
change.    
High-­fat  diet:  A  diet  pattern  characterized  by  dietary  fat  as  the  greatest  contributor  to  total  energy  
consumption  relative  to  carbohydrate  or  protein;;  for  example,  a  dietary  pattern  with  50%  of  the  daily  
caloric  intake  as  dietary  fat.    
Heart-­healthy  diet:  As  per  the  American  Heart  Association  and  the  USDA,  a  heart-­healthy  diet  is  






CHAPTER  2  –  REVIEW  OF  THE  LITERATURE  
2.1  Insulin  Resistance  and  Dysfunctional  Lipid  Metabolism  
According  to  the  World  Health  Organization  (WHO,  2018),  over  1.9  billion  adults  worldwide  were  
classified  as  “overweight”  in  2014  with  more  than  600  million  considered  “obese.”  This  “obesity  epidemic”  
conveys  a  considerable  health  risk;;  for  example,  a  raised  BMI  is  a  major  risk  factor  for  heart  disease,  
stroke,  musculoskeletal  disorders,  and  some  cancers  (WHO,  2018).  However,  overweight/obesity  exerts  
its  greatest  wrath  via  metabolic  repercussion,  with  44%  of  the  burden  of  diabetes  attributable  to  this  
condition  (Press,  2009).  It  is,  therefore,  not  surprising  that  a  “diabetic  epidemic”  (Zimmet,  Alberti,  &  Shaw,  
2001)  is  also  in  full  swing  with  23  million  U.S.  citizens  diagnosed  and  another  7.2  million  undiagnosed,  but  
afflicted  (CDC,  2014).  The  vast  majority  possess  type  2  diabetes,  which  is  a  disorder  associated  with  
insulin  resistance  that  is  often  a  characteristic  of  overweight/obesity  (Ludvik,  Nolan,  Baloga,  Sacks,  &  
Olefsky,  1995).  The  link  between  insulin  resistance  and  the  overweight/obese  state  is  well  established;;  
however,  mechanistic  basis(es)  is/are  still  debated  with  multiple  candidate  molecules,  systems,  and  
pathways  potentially  involved  (Qatanani  &  Lazar,  2007).    
In  the  late  19th  century,  Dr.  Oskar  Minkowski,  who  was  a  professor  of  medicine  at  the  University  
of  Breslau  (Germany)  and  a  pioneer  in  the  area  of  diabetes  and  endocrinology  research,  was  questioning  
the  assertion  that  pancreatic  enzymes  were  needed  to  break  down  fatty  acids  in  the  gut.  A  complete  
removal  of  the  pancreas  was  required  to  test  his  concerns;;  therefore,  it  was  impossible  to  assess  for  a  
human  subject.  Consequently,  Dr.  Minkowski  proceeded  with  his  experiment  using  his  dog.  After  a  
complete  removal  of  the  pancreas,  Dr.  Minkowski  noticed  that  the  urine  from  his  pancreactomized  dog  
attracted  an  unusually  high  number  of  flies.  Curious,  he  decided  to  taste  the  urine  and  was  struck  by  its  
sweetness.  Based  on  this  observation,  he  concluded  that  the  pancreas  produces  some  entity  essential  for  
controlling  blood-­sugar  level  which,  when  absent,  resulted  in  an  abnormally-­high  level  of  sugar  in  the  
blood  and  urine.  Thirty  years  later,  when  Fredrick  Benting  discovered  insulin,  the  concept  of  an  insulin-­
glucose  relationship  as  a  central  component  of  fuel  metabolism  came  into  being,  and  diabetes  has,  
therefore,  been  viewed  as  a  disorder  primarily  associated  with  abnormal  glucose  metabolism.  Indeed,  
diabetes,  or  impaired  glucose  tolerance  (i.e.  “pre-­diabetes”),  which  is  an  early  state  in  the  progression  to  





tests  that  identify  elevated  plasma  glucose  levels.  However,  for  diagnostic  and  treatment  purposes,  it  
might  be  short-­sighted  to  consider  diabetes  as  a  disease  of  glucose  metabolism  alone  because  the  other  
primary  fuel  source,  lipids,  might  also  play  a  role  (McGarry,  1992).  In  support  of  this  view  is  the  work  of  
Reaven  and  colleagues  in  the  late  1980s  which  confirmed  a  significantly  higher  plasma  FFA  
concentration  at  hourly  intervals  for  24  hours  in  patients  with  diabetes  compared  to  non-­diabetic  
counterparts,  despite  similar  levels  of  insulin  (Reaven,  Hollenbeck,  Jeng,  Wu,  &  Chen,  1988).  Based  on  
the  principles  of  the  Randle  glucose-­fatty  acid  cycle  (DeFronzo,  Bonadonna,  &  Ferrannini,  1992),  
abnormally-­high  levels  of  plasma  FFA  will  drive  the  conversion  of  pyruvate  (i.e.,  the  end  product  of  
glycolysis)  toward  lactate  (reduction),  as  opposed  to  acetyl  CoA  (oxidation),  which  will  further  enhance  
the  rate  of  glucose  production  and  resultant  hyperglycemia.  In  this  study,  both  FFA  and  lactate  were  
significantly  and  chronically  higher  in  the  diabetes  group  which  further  supports  this  contention  (Reaven  
et  al.,  1988).  In  the  same  cohort,  when  plasma  FFA  levels  were  compared  during  a  5-­hour  hyperglycemic  
clamp  at  low  (10  mU∙ml-­1,  0–150  min)  and  high  (60  mU∙ml-­1,  150–300  min)  insulin-­infusion  rates,  the  
afflicted  subjects  had  significantly  higher  plasma  FFA  levels  at  baseline  that  remained  high  despite  
infusion  of  insulin  at  either  rate  (Chen,  Golay,  Swislocki,  &  Reaven,  1987).  Furthermore,  in  both  animal  
and  human  models,  treatment  with  an  antilipolytic  agent  (e.g.,  nicotinc  acid)  results  in  a  rapid  decrease  in  
blood-­glucose  concentration  in  afflicted  subjects  (Reaven  et  al.,  1988;;  Saloranta,  Franssila-­Kallunki,  
Ekstrand,  Taskinen,  &  Groop,  1991).  Collectively,  these  findings  suggest  that  the  insulin-­resistant  state,  
which  is  central  to  type  2  diabetes,  is  characterized  by  the  inability  of  insulin  (stimulated  or  infused)  to  
affect  the  liver  (i.e.,  suppress  liver  gluconeogenesis  and  glucose  output),  skeletal  muscles  (i.e.,  increase  
glucose  uptake),  and  fat  cells  (i.e.,  suppress  adipose  tissue  lipolysis  and  the  release  of  FFA).    
In  1992,  citing  some  of  the  observations  mentioned  above,  Dr.  Denis  McGarry,  who  was  a  
professor  of  internal  medicine  at  the  University  of  Texas  Southwestern  Medical  Center  and  a  world-­
leading  expert  on  metabolism  and  biochemistry,  wrote  an  interesting  essay  entitled  “What  If  Minkowsky  
Had  Been  Ageusic?  An  Alternative  Angle  on  Diabetes.”  McGarry  explored  the  possibility  that  traditional  
thinking  about  diabetes  as  a  disease  of  glucose  metabolism  might  carry  the  wrong  emphasis.  Instead,    
he  speculated  that  the  pathophysiological  mechanisms  of  insulin  resistance  (and  the  resultant  





sense  of  taste,  McGarry  postulated  that  instead  of  tasting  the  urine  and  appreciating  its  sweetness,  he  
would  have  smelled  the  acetone  (i.e.,  a  direct  byproduct  of  acetoacetic  acid).  In  his  opinion  piece,  
McGarry  outlined  a  series  of  events  based  on  Randle’s  substrate-­competition  model  (DeFronzo  et  al.,  
1992)  whereby  an  increase  in  lipid  oxidation  would  inhibit  glucose  use.  Within  this  schema,  the  
abnormally-­high  level  of  insulin  in  the  blood  that  results  from  insulin  resistance  (hyperinsulinemia)  and  
resultant  liver  lipogenesis  and  synthesis  of  very  low-­density  lipoproteins  (VLDL)  would  serve  to  increase  
the  flux  of  triglycerides  into  storage  sites  including  adipose  tissue  and  muscle  (intramyocellular  lipid;;  
IMCL),  thereby  interfering  with  normal  glucose  processing  (i.e.,  glycogen  synthesis  and  glucose  
oxidation).  The  end  result  would  be  an  elevation  of  plasma  glucose  that  completes  a  vicious  cycle  of  
aberrant  fuel  partitioning  (McGarry,  1992)  that  would  be  more  likely  to  lead  to  overweight/obesity  if  a  
positive  energy  balance  is  in  effect  because,  compared  to  carbohydrate  storage,  lipid  storage  is  a  more  
energetically-­efficient  way  to  increase  body  energy  stores.  
It  is  interesting  to  note  that  when  Dr.  McGarry  wrote  his  piece  25  years  ago,  diabetes  only  
affected  about  ~1-­6%  of  the  adult  population  in  the  United  States  with  type  2  diabetes  accounting  for    
~75%  of  the  cases.  Today,  diabetes  affects  ~10%  of  the  total  population,  with  type  2  diabetes  accounting  
for  more  than  90%.  It  is  interesting  to  speculate  that  our  current  obesogenic  environment,  which  is  
characterized  by  a  chronic  calorie  overconsumption  (and  consequent  excess  lipid  storage  throughout  the  
body)  and  a  sedentary  lifestyle,  plays  a  central  role.  Moreover,  the  intake  of  dietary  fat  in  the  United  
States  has  also  increased  in  the  past  few  decades  (Vadiveloo,  Scott,  Quatromoni,  Jacques,  &  Parekh,  
2014)  and,  while  speculative,  this  may  also  play  a  role.    
2.2  The  Role  of  Insulin  Resistance  and  b-­cell  Function  in  the  Progression  to  Type  2  Diabetes  
The  progression  from  a  healthy  state  to  full-­blown  diabetes  likely  occurs  on  a  continuum  that  has  
been  suggested  to  include  five  unique  stages.  Each  of  these  stages  is  characterized  by  distinguishable  
changes  in  pancreatic  b-­cell  mass  and/or  phenotype  and/or  function  (Weir  &  Bonner-­Weir,  2004).  In  the  
first  stage  (i.e.,  “compensation”),  b-­cells  increase  insulin  secretion  to  maintain  blood  glucose  within  a  
normal  range  (i.e.,  70-­99  mg∙dL-­1)  in  the  face  of  insulin  resistance.  The  cause  of  insulin  resistance  is  still  
unclear,  but  might  be  related  to  genetic  and/or  environmental  factors  including  obesity,  poor  diet,  





inflammation,  or  family  predisposition  (ATTVALL,  Fowelin,  Lager,  Schenck,  &  Smith,  1993;;  Turner  &  
Heilbronn,  2008;;  Weir  &  Bonner-­Weir,  2004).  Despite  the  insulin-­resistant  glucose  metabolic  state,  the  
ability  of  the  b-­cells  to  increase  insulin  production  results  in  seemingly  normal  clinical  presentation  (i.e.,  
glucose  tolerance)  (DeFronzo  et  al.,  1992).  The  second  stage  (i.e.,  “adaptation”)  is  characterized  by  the  
inability  of  the  b-­cells  to  continue  to  compensate  for  the  loss  of  insulin  sensitivity  by  producing  more  
insulin  to  keep  blood  glucose  in  the  normal  range.  However,  b-­cells  are  still  able  to  produce  enough  to  
keep  blood  glucose  level  from  reaching  a  state  of  diabetes  (>125  mg∙dL-­1).  Individuals  with  impaired  
glucose  tolerance  (“pre-­diabetes”)  evidenced  by  fasting  blood  sugar  of  100–125  mg∙dL-­1  and/or  HbA1c  
5.7–6.4%  and/or  OGTT  140–199  mg∙dL-­1  are  said  to  be  at  that  stage  in  terms  of  insulin  resistance  and    
b-­cell  function.  Despite  being  a  significant  risk  factor,  not  all  individuals  with  impaired  glucose  tolerance  
(stage  2)  will  progress  to  stage  3  (“unstable  early  decompensation”)  and/or  frank  diabetes.  Individual  
variability  depends  on  genetics,  b-­cell  function  and  resilience,  environment,  eating  habits,  physical  
activity,  and  other  factors  (Weir  &  Bonner-­Weir,  2004).  However,  it  is  now  clear  that  overt  diabetes  
develops  in  those  whose  pancreatic  b-­cells  cannot  continue  to  compensate.  One  of  the  prominent  
changes  in  b-­cell  phenotype  and  function  that  is  often  a  prominent  feature  of  this  stage  is  loss  of  the  acute  
phase  of  insulin  secretion  that  occurs  3–10  min  after  glucose  infusion  (glucose-­stimulated  insulin  
secretion;;  GSIS)  or  early  insulin  release,  which  is  completely  absent  when  blood  glucose  reaches  levels  
characteristic  of  the  diabetic  state  (Weir  &  Bonner-­Weir,  2004).  The  exact  cause  of  GSIS  is  not  fully  
understood,  but  might  be  related  in  full  or  part  to  elevated  plasma  FFA  and  lipotoxicity  (Weir  &  Bonner-­
Weir,  2004).  Stage  3  of  the  progression  of  insulin  resistance  is  characterized  by  a  relatively  rapid  and  
transient  increase  in  blood  glucose  from  a  stable  adaptation  at  ~100–125  mg∙dL-­1  (stage  2)  to  ~250–350  
mg∙dL-­1  (stage  4).  This  pathologic  progression  signifies  the  point  at  which  b-­cell  mass  and  function  
become  inadequate  to  compensate  for  the  insulin-­resistant  state  and,  at  this  point,  the  progression  to  
frank  diabetes  is  inevitable.  The  transition  from  a  stable  stage  2  to  a  stable  stage  4  via  the  relatively  short  
but  rapid  unstable  stage  3  may  or  may  not  be  coupled  with  classic  symptoms  associated  with  diabetes,  
such  as  weight  loss,  frequent  urination,  extreme  fatigue,  hunger,  thirst,  and  dry  mouth  and  skin.  Stage  4  
(“stable  decompensation”)  is  marked  by  a  number  of  significant  changes  in  b-­cell  mass  and  function,  





Weir,  2004).  Despite  markedly-­high  glucose  in  the  blood  (e.g.,  250–350  mg∙dL-­1),  individuals  in  stage  4  
still  produce  enough  insulin  to  keep  blood  sugar  “abnormally”  stable  and  to  avoid  progression  to  
ketoacidosis.  Individuals  with  diabetes  might  stay  in  stage  4  for  a  lifetime;;  however,  once  the  reduction  in  
b-­cell  mass  and  function  is  severe  enough  (stage  5;;  “severe  reduction”),  a  pathological  increase  in  the  
production  of  ketone  bodies  is  present  (severe  ketoacidosis)  as  is  severe  hyperglycemia,  and  the  result  is  
that  they  must  inject  insulin  to  live  their  next  day.  
2.3  Quantifying  Insulin  Action  and  Fuel  Metabolism  Using  Glucose  Clamp  Technique  
In  1979,  De  Fronzo  and  co-­workers  developed  and  validated  a  technique  for  assessing  insulin  
resistance  by  measuring  whole-­body  tissue  sensitivity  to  insulin.  The  procedure  is  called  the  euglycemic-­
hyperinsulinemic  clamp  (DeFronzo,  Tobin,  &  Andres,  1979).  For  this  method,  plasma  insulin  
concentration  is  acutely  raised  to  a  higher  plateau  to  induce  physiological  hyperinsulinemia  (e.g.,  100  
mU∙mL-­1  above  baseline),  which  is  maintained  for  the  entire  procedure  via  constant  insulin  infusion.  This  
level  of  circulating  insulin  would  rapidly  induce  a  very  low  blood-­glucose  concentration  characteristic  of  
severe  hypoglycemia  if  glucose  was  not  kept  at  its  basal  euglycemic  levels  (e.g.  70–100  ml∙dL-­1).  
Therefore,  the  technique  involves  the  simultaneous  constant  infusion  of  a  predetermined  fixed  dose  of  
insulin  (e.g.  40  mU∙mL-­1∙min-­1)  to  achieve  hyperinsulinemia  in  conjunction  with  a  variable  rate  of  glucose  
infusion  to  maintain  basal  arterial  plasma  glucose.  When  a  steady  state  is  achieved,  glucose-­infusion  rate  
must  equal  glucose  uptake  by  all  tissues  in  the  body.  Of  particular  note  in  this  regard  is  skeletal  muscle,  
which  is  a  major  site  for  insulin-­stimulated  glucose  disposal  and,  therefore,  an  important  determinant  of  
whole-­body-­tissue  insulin  sensitivity  (DeFronzo  et  al.,  1979).  
The  euglycemic-­hyperinsulinemic  clamp  was  used  to  establish  the  link  between  insulin  
sensitivity/resistance  and  dysfunctional  lipid  metabolism  in  1999,  when  Kelley  et  al.  (1999)  described  the  
impaired  substrate  switching  that  is  present  with  obesity.  These  researchers  compared  leg  respiratory  
quotient  (RQ;;  i.e.,  rate  of  carbon  dioxide  production  divided  by  rate  of  oxygen  consumption  with  values  
ranging  from  0.7  to  1.0  reflecting  exclusive  lipid  and  carbohydrate  oxidation,  respectively)  during  a  
euglycemic-­hyperinsulinemic  clamp  with  fasting  values  and  found  that  for  lean  subjects,  RQ  increased  
significantly  from  the  fasting  to  insulin-­stimulated  condition,  whereas  for  obese  subjects,  it  did  not  (Kelley  





the  fasting  value  for  lean  subjects  and  less  than  the  insulin-­stimulated  one  (Kelley  et  al.,  1999).  This  
impaired  capacity  to  match  fuel  oxidation  to  fuel  availability  (i.e.,  predominantly  lipid  oxidation  during  
fasting  and  a  high  rate  of  glucose  oxidation  during  insulin  stimulation)  suggests  that  obese  individuals  
lack  the  “metabolic  flexibility”  that  characterizes  healthy  function.  In  accordance  with  these  findings,  
researchers  began  using  the  difference  in  RQ  across  the  extremes  established  during  the  clamp  
procedure  (ΔRQclamp-­fast  or  ΔNPRERclamp-­fast  when  non-­protein  respiratory  exchange  ratio  measured  at  the  
mouth  is  used  for  the  measurement)  as  a  way  to  assess  metabolic  health  and/or  explore  the  link  between  
impaired  insulin  action  and  the  overweight/obese  state  (Adamska  et  al.,  2013,  2014;;  van  de  Weijer  et  al.,  
2013;;  Wohl,  Wohl,  Girman,  &  Pelikánová,  2004).    
2.4  Substrate  Switching  in  Response  to  Insulin  Infusion  
Insulin  resistance  can  manifest  in  both  an  elevated  fasting  RQ/NPRER  (RQ/NPRERfast)  and  a  
blunted  elevation  in  insulin-­stimulated  RQ/NPRER  (RQ/NPRERclamp),  which  is  why  ΔRQ/NPRERclamp-­fast  
can  be  markedly  reduced  when  overweight/obesity  is  present.  Indeed,  it  has  been  suggested  that  the  
reduction  in  ΔRQ/NPRERclamp-­fast  that  has  been  reported  for  obese  subjects  could  reflect  a  “primary  
defect”  associated  with  obesity  (Kelley  et  al.,  1999).  However,  Galgani  et  al.  report  that  the  reduced  
ΔRQ/NPRERclamp-­fast  they  observed  in  individuals  with  type  2  diabetes,  compared  to  non-­afflicted  subjects  
matched  for  obesity,  was  abolished  after  adjusting  for  glucose  disposal  rate  which  would,  by  nature,  be  
reduced  when  insulin  resistance  is  present  (Galgani,  Heilbronn,  et  al.,  2008).  This  suggests  that  the  
decreased  RQ/NPRERclamp  observed  with  obesity  reflects  the  insulin  resistance-­related  inability  for  
glucose  transport  as  opposed  to  an  inherent  inability  to  oxidize  glucose  per  se  (Galgani,  Heilbronn,  et  al.,  
2008).  The  insulin-­infused  condition  that  establishes  the  “ceiling”  of  the  range  has  also  raised  concerns  
because  of  its  “supra-­physiological”  nature  (Bergouignan  et  al.,  2012).    
2.5  Substrate  Switching  to  Lipid  During  Fasting  
Unlike  the  insulin-­stimulated  state,  the  inability  to  up  regulate  lipid  oxidation  adequately  during  
fasting,  which  elevates  the  “floor”  by  increasing  RQ/NPRERfast,  is  not  affected  by  type  2  diabetes  
(Galgani,  Heilbronn,  et  al.,  2008)  and  could,  therefore,  reflect  an  inherent  defect  that  links  insulin  
resistance  with  the  overweight/obese  state  (Kelley  et  al.,  1999).  A  number  of  findings  support  this  





Indian  men  (a  group  that  is  predisposed  to  obesity  and  type  2  diabetes)  with  a  higher  24-­hour  RQ  were  at  
2.5-­times  higher  risk  of  gaining  weight,  compared  to  counterparts  with  lower  24-­hour  RQ  (90th  and  10th  
percentile,  respectively)  (Zurlo  et  al.,  1990).  Post-­obese  subjects  also  demonstrate  a  higher  fasting  RQ  
despite  a  similar  resting  metabolic  rate,  compared  to  age-­  and  BMI-­matched  never-­obese  controls  (Filozof  
et  al.,  2000).  These  findings  cohere  with  reports  of  decreased  sleep  RQ  following  a  weight-­loss  
intervention  (severe  caloric  restriction  induced  by  diet  alone  or  diet  plus  exercise)  for  healthy  obese  
women  (Kempen,  Saris,  &  Westerterp,  1995)  and  increased  fasting  lipid  oxidation  for  obese  subjects  with  
impaired  glucose  tolerance  after  weight  loss  due  to  exercise  or  exercise  with  caloric  restriction  (Solomon  
et  al.,  2008).  Finally,  for  nondiabetic  subjects  with  obesity,  the  enhanced  rate  of  fasting  lipid  oxidation  that  
occurred  due  to  weight  loss  following  16  weeks  of  exercise  training  with  caloric  restriction  was  the  
strongest  predictor  of  the  improvement  in  insulin  sensitivity  that  was  also  observed  (Goodpaster  et  al.,  
2003).  Collectively,  these  observations  support  the  notion  that  impaired  substrate  switching  to  lipid,    
which  manifests  in  the  fasted  state,  could  be  a  “primary  defect”  that  links  insulin  resistance  with  the  
overweight/obese  condition.  However,  other  findings  suggest  that  fasting  lipid  oxidation  is  not  reduced  in  
overweight/obese  subjects  and  might  even  be  enhanced.  For  example,  in  a  cross-­sectional  analysis,  
Blaak  et  al.  (2006)  found  that  fasting  RQ  does  not  increase  with  increasing  BMI  (it  decreased  or  was  
unaffected  when  the  value  was  stated  in  absolute  terms  or  relative  to  fat  mass,  respectively),  and  there  
are  numerous  reports  of  a  similar  fasting  NPRER/rate  of  lipid  oxidation  for  obese  compared  to  normal-­
weight  subjects  (Balcı,  2012;;  Colberg  et  al.,  1996;;  Ekelund  et  al.,  2007;;  Ezell  et  al.,  1999;;  Guesbeck  et  
al.,  2001;;  Kanaley  et  al.,  2001,  Perez-­Martin  et  al.,  2001;;  Steffan  et  al.,  1999).  Furthermore,  no  correlation  
was  found  between  percent  body  fat  and  substrate  oxidation  in  the  fasted  state  for  untrained  healthy  
males  (Helge  et  al.,  1999)  and  longitudinal  analyses  indicate  that  fasting  lipid  oxidation  for  obese  subjects  
is  unaffected  (Goodpaster  et  al.,  2003)  or,  in  some  cases,  reduced  (Nicklas  et  al.,  1997;;  Schutz  et  al.,  
1992;;  van  Aggel-­Leijssen  et  al.,  2001)  by  weight  loss  if  exercise  is  not  part  of  the  intervention  
(Goodpaster  et  al.,  2003;;  Nicklas  et  al.,  1997;;  van  Aggel-­Leijssen  et  al.,  2001).  Consistent  with  the  latter  
observation,  Schutz  et  al.  (1992)  combined  the  results  from  cross-­sectional  and  longitudinal  analyses  of  
women  with  obesity  to  conclude  that  for  each  10-­kg  increase  in  fat  mass  that  occurs,  fasting  lipid  





fasting  state  for  subjects  with  obesity  regardless  of  metabolic  health  (i.e.,  normal  glucose  tolerance,  
impaired  glucose  tolerance  or  diabetic),  compared  to  healthy  subjects  without  obesity.  Finally,  Poynten  et  
al.  (2003)  found  that  compared  to  pre-­diet  level,  fasting  lipid  oxidation  was  reduced  for  subjects  with  the  
overweight/obese  condition  with  both  type  2  diabetes  and  normal  glucose  tolerance  5  years  after  
losing/regaining  ~5%  of  body  weight.  Importantly,  in  both  groups,  progressive  increases  in  adiposity  and  
hyperinsulinemia  also  occurred  during  the  5-­year  period,  which  suggests  that  even  if  fasting  lipid  
oxidation  is  impaired  in  subjects  with  the  overweight/obese  condition,  it  is  an  acquired  defect  that  
develops  longitudinally  in  concert  with  obesity-­related  metabolic  decline  (Poynten  et  al.,  2003).  
As  illustrated  above,  conflicting  findings  exist  regarding  the  degree  to  which  individuals  with  the  
overweight/obesity  condition  demonstrate  impaired  substrate  selectivity  towards  lipid  in  circumstances  
where  lipid  is  the  preferred  fuel  (e.g.,  after  an  overnight  fast).  This  ambiguity  may  reflect  day-­to-­day  
variability  in  energy  balance,  macronutrients  composition  of  the  diet,  body  weight  and  plasma  glucose  
and  free-­fatty  acids  if  these  factors  are  not  controlled.  Support  for  this  comes  from  a  number  of  studies  
demonstrating  that  day-­to-­day  variations  in  energy  balance  can  profoundly  affect  fasting  RQ/RER  levels  
(Schutz  et  al.,  1992;;  Weyer,  Vozarova,  Ravussin,  &  Tataranni,  2001).  For  example,  Schutz  and  co-­
workers  demonstrated  that  1-­day  increases  in  energy  intake  followed  by  1-­day  decreases  produced  
significantly  different  RQ  values.  Furthermore,  Hill  and  colleagues  (1991)  showed  that  a  consumption  of  a  
eucaloric  diet  with  fat  or  carbohydrate  being  the  major  fuel  source  modified  the  fasting  RQ  value  
according  to  the  diet  FQ  (food  quotient)  value.  Evidence  also  exists  to  suggest  that  under  energy  balance,  
24-­hour  RQ/RER  will,  eventually,  equal  24-­hour  FQ  in  both  normal-­weight  and  obese  subjects  (Davy,  
Horton,  Davy,  Bessessen,  &  Hill,  2001;;  Hill  et  al.,  1991;;  Kim,  Hickner,  Cortright,  Dohm,  &  Houmard,  2000;;  
Prentice,  2005;;  Weyer  et  al.,  2001),  although  the  time  it  takes  for  this  alignment  may  vary  depending  on  
weight,  health  status,  physical  activity  level,  and  other  factors  (Galgani,  Heilbronn,  et  al.,  2008).  
Regardless  of  this  distinction,  however,  increasing  availability  of  carbohydrate  in  the  diet  will  result  in  a  
greater  propensity  for  glucose  oxidation  (RER  >0.86),  whereas  increasing  fat  availability  in  the  diet  will  
drive  metabolism  toward  lipid  (RER  <0.82).  While  the  speed  of  adaptation  may  vary  between  individuals,  
evidence  suggests  that  adaptation  to  a  higher  carbohydrate  or  fat  diet  occurs  within  2–3  for  a  high-­





In  addition  to  energy  balance  and  macronutrient  composition  of  the  diet,  rate  of  carbohydrate  and  
lipid  oxidation  is  also  greatly  influenced  by  the  availability  and  concentration  of  plasma  glucose  and  FFA.  
The  chronic  elevated  blood-­glucose  concentration  characteristic  of  hyperglycemia  may  lead  to  substrate-­
level  regulation  and  a  propensity  toward  glucose  oxidation.  Similarly,  elevated  blood  FFA  can  lead  to  
increased  lipid  oxidation  (Galgani,  Heilbronn,  et  al.,  2008).  Finally,  the  relatively  low  metabolic  demand  
during  the  fasting/resting  condition  calls  assessment  of  substrate  selectivity  during  “challenges”  like  these  
into  question  (Galgani,  Heilbronn,  et  al.,  2008).  In  addition,  absolute  lipid-­oxidation  rate  in  the  
fasting/resting  state  is  minimal  compared  with  other  circumstances.  Given  the  extensive  capacity  of  
skeletal  muscle  to  increase  metabolic  rate  and  energy  production  in  circumstances  where  a  rapid  and  
large  energy  supply  is  required  during  physical  activity,  it  has  been  suggested  that  it  is  exercise  and  not  
the  resting  state  that  provides  the  appropriate  criterion  challenge  with  which  to  evaluate  the  capacity  for  
healthy  substrate  selectivity  (Galgani,  Heilbronn,  et  al.,  2008).      
Table  2.1  
Study  Comparison  Table:  Fasting  Lipid  Oxidation  in  Individual  With  Obesity  vs.  Normal  Weight    
First  Author   Year   Participants   Design   Results  
Kelley     1999   Normal  weight  (n  =  16)  vs.  
obesity  (n  =  40)  
Cross-­
sectional    
•   Significantly  higher  RQ  in  the  
group  with  obesity  during  fasting    
•   Significantly  higher  RQ  in  the  
normal-­weight  group  after  
insulin-­stimulation.  RQ  did  not  
change  in  the  group  with  obesity.    
•   Significantly  smaller  delta  RQ  
(fasting  vs.  insulin  stimulation)  in  
the  group  with  obesity    





•   After  adjusting  for  fat  and  fat-­free  
mass,  significantly  higher  RQ  in  
the  post-­obese  group    
Blaak     2006   Normal  weight  





•   After  adjusting  for  differences  in  
fat  and  fat-­free  mass,  fasting  
lipid  oxidation  rate  significantly  
higher  for  individuals  with  
obesity  
•   Lipid  oxidation  rate  increased  








Table  2.1  (continued)  
  
Schutz   1992   Sedentary  females  with  
obesity  but  otherwise  
healthy  (n  =  106)  
Cross-­
sectional    
•   Rate  of  lipid  oxidation  during  
basal  condition  increases  with  
the  degree  of  obesity  (20g∙d-­1  for  
every  additional  10  kg)  
Ekelund   2007   Normal-­weight  (n  =  15)  vs.  
obese  (n  =  13)      
Cross-­
sectional    
•   No  differences  in  resting  lipid  
oxidation  rate  and  RQ    
Galgani     2008   Sex-­  and  race-­matched  
obese  with  (n  =  59)  and  




•   No  significant  difference  in  
fasting  RQ    
•   Significantly  lower  RQ  in  the  
diabetes  group  after  insulin  
stimulation,  which  resulted  in  a  
significantly  smaller  delta  RQ  
(i.e.,  fasting  vs.  insulin-­
stimulated).  
•   Differences  in  insulin-­stimulated  
and  delta  RQ  were  completely  
abolished  after  adjusting  for  the  
rate  of  glucose  disposal,  which  




2001   Normal  weight  (n  =  26)  vs.  
overweight/obesity  (n  =  32)    
Cross-­
sectional    
•   No  significant  differences  in  
fasting  lipid  oxidation  rates    
Kanaley     2001   Non-­obese  (n  =  8)  vs.  
obese  (n  =  23)  
Cross-­
sectional    
•   No  significant  differences  in  
fasting  lipid  oxidation  rates  
Colbert     1996   Normal  weight  (n  =  7)  vs.  
obese  (n  =  7)  vs.  Type  2  
diabetes  (n  =  7)  
Cross-­
sectional    
•   Fasting  RER  and  lipid  oxidation  
rate  were  similar  in  all  three  
groups  
•   Lipid  oxidation  accounted  for  
more  than  66%  of  total  energy  
production  in  the  basal  fasting  
state  in  all  three  groups    
Ezell   1999   Never  obese  (n  =  5)  vs.  
obese  (n  =  5)  vs.  post-­
obese  (n  =  5)  
Cross-­  
sectional  
•   Similar  lipid  oxidation  rates  in  all  
three  groups  during  fasting  
conditions    
Steffan     1999   Normal  weight  (n  =  15)  vs.  




•   Similar  RER  during  fasting  in  
both  groups    
Goodpaster     2002   Normal  weight  (n  =  7)  vs.  
obese  (n  =  7)    
Cross-­
sectional    
•   No  difference  in  fasting  RER  
between  the  two  groups    
Weyer   2001   Normal  weight  (n  =  6)  vs.  
morbidly  obese  (n  =  8)  
Cross-­
sectional  
•   No  differences  in  fasting  RER  
and  lipid  oxidation  rates  between  
the  two  groups    
  





2.6  “Metabolic  Flexibility”  During  Exercise  
As  described  above,  ambiguous  findings  exist  regarding  the  degree  to  which  impaired  fasting  lipid  
oxidation  predates  and/or  accompanies  overweight/obesity,  and  the  use  of  the  fasting  state  to  assess  
substrate  selectivity  with  respect  to  lipid  has  been  questioned  because  of  the  low  metabolic  demand  
associated  with  the  condition  and  degree  to  which  the  value  is  influenced  by  acute  energy  balance  and  
dietary  macronutrient  consumption  (Galgani,  Heilbronn,  et  al.,  2008).  Citing  these  concerns,  Galgani,  
Heilbronn  et  al.  (2008)  recommended  assessing  fuel  selection  during  exercise  as  a  better  way  to  explore  
metabolic  flexibility  to  lipid  to  elucidate  the  link  between  dysfunctional  lipid  metabolism  and  the  insulin-­
resistant  state.  However,  it  is  not  clear  what  constitutes  “metabolic  flexibility”  in  response  to  an  exercise  
challenge.  For  example,  Prior,  Ryan,  Stevenson,  and  Goldberg  (2014)  assessed  subjects  with  the  
overweight/obesity  condition  and  found  that  during  10  minutes  of  treadmill  exercise  at  ~50%  and  ~60%  
V̇O2  reserve,  subjects  with  impaired  glucose  tolerance  had  a  significantly  lower  non-­protein  RER  (hence,  
propensity  toward  lipid  oxidation)  due  to  a  blunted  increase  in  non-­protein  RER  in  relation  to  the  pre-­test  
resting  condition.  The  authors  interpreted  this  as  an  inability  to  up  regulate  carbohydrate  oxidation  during  
exercise  and,  therefore,  a  metabolically-­inflexible  response  compared  to  a  glucose  tolerant  group,  and  
this  was  supported  by  the  lower  ΔNPRERclamp-­fast  that  they  reported  for  the  glucose-­intolerant  subjects  
(Prior  et  al.,  2014).  In  contrast,  Russell,  Kraemer,  and  Nelson  (2013)  believed  that  a  greater  increase  in  
carbohydrate  use  from  rest  to  peak  “exercise”  (passive  stretching)  for  subjects  with  type  2  diabetes  
compared  to  healthy  controls  indicated  a  metabolically-­inflexible  response  with  intermediate  values  for  
glucose-­tolerant  subjects  with  a  family  history  of  type  2  diabetes  (FH+),  which  is  suggested  to  have  
diagnostic  value  for  early  detection.  These  authors  found  a  lesser  increase  in  non-­protein  RER  following  
glucose  loading  in  FH+  and  type  2  diabetes  subjects  that  appears  to  support  their  interpretation  (Russell  
et  al.,  2013).  This  lack  of  congruence  exemplifies  the  danger  of  using  imprecise  terminology  (i.e.,  
“metabolic  flexibility”)  when  referring  to  substrate  selectivity  in  circumstances  where  different  responses  
are  “functional”  (e.g.,  a  transition  from  fasting  to  insulin  stimulation  where  a  complete  switch  is  optimal,  
compared  to  a  transition  from  lower  to  higher  exercise  intensity  where  the  ability  to  up  regulate  lipid  






2.7  Lipid  Oxidation  During  Exercise  
With  respect  to  substrate  selectivity  during  exercise,  it  has  long  been  known  that  the  ability  to  up  
regulate  lipid  use  in  response  to  an  exercise  challenge  is  a  hallmark  of  the  endurance-­trained  state  
(Holloszy  &  Coyle,  1984).  For  example,  in  a  cross-­sectional  analysis,  Nordby  et  al.  (2006)  found  that  the  
peak  rate  of  whole-­body  lipid  oxidation  during  a  graded  cycling  test  is  higher  and  occurs  at  a  higher  
relative  work  rate  in  endurance-­trained  compared  to  untrained  subjects.  Moreover,  Jansson  and  Kaijser  
(1987)  reported  that  when  cycling  at  65%  V̇O2max,  endurance-­trained  individuals  satisfied  ~53%  of  the  
energy  demands  with  lipid  oxidation  compared  to  ~33%  for  untrained  controls  and  this  difference  
appeared  exclusive  to  greater  utilization  of  non-­plasma  lipid  sources.  Collectively,  these  findings  suggest  
that  an  increased  reliance  on  lipids  during  exercise  might  explain  why  endurance-­trained  individuals  
possess  elevated  IMCL  without  pathological  repercussion  (i.e.,  the  so-­called  “athlete’s  paradox”)  (Amati  
et  al.,  2011;;  Goodpaster  et  al.,  2001)  and  how  endurance  training  can  increase  intramyocellular  lipids  
while  also  improving  insulin  sensitivity  in  overweight/obese  individuals  with  insulin  resistance  (Dubé  et  al.,  
2008).  Conversely,  if  Intramyocellular  lipid  accumulation  consequent  to  dysfunctional  lipid  metabolism  
underpins  the  link  between  insulin  resistance  and  the  overweight/obese  state,  overweight/obese  subjects  
would  be  expected  to  demonstrate  an  impaired  capacity  for  lipid  oxidation  during  exercise  compared  to  
their  normal-­weight  counterparts.  A  number  of  studies  support  this  contention.  For  example,  Wade,  
Marbut,  and  Round  (1990)  found  a  positive  correlation  between  percent  body  fat  and  NPRER  during  
cycling  at  100  W  for  a  group  of  predominantly-­sedentary  men  with  relatively  low  body-­fat  percentage  
(12.7  +/-­  7.3%),  and  subsequent  research  confirmed  lower  rates  of  lipid  oxidation  at  submaximal  work  
rates  in  healthy  sedentary  overweight/obese  adults  (Perez-­Martin  et  al.,  2001)  and  at  high-­  but  not  low-­
intensity  work  rates  (i.e.,  40-­60%  but  not  0-­30%  V̇O2peak)  in  obese  pubescent  children  (Zunquin,  
Theunynck,  Sesboüé,  Arhan,  &  Bouglé,  2009).  Similarly,  Lanzi  et  al.  (2014)  found  that  obese  subjects  
relied  less  on  lipid  oxidation  at  higher  exercise  intensities  (e.g.,  65-­85%  V̇O2peak)  compared  to  lean  
subjects  during  an  incremental  cycling  test  with  6-­minute  stages.  Collectively,  these  findings  suggest  that  
increased  body  fatness  is  associated  with  an  impaired  capacity  for  lipid  metabolism  during  exercise.  
Further  insight  comes  from  Geusbeck  et  al.  (2001),  who  found  that  subjects  who  were  previously  morbidly  





both  15  W  and  65%  V̇O2peak)  compared  to  weight-­matched  never-­obese  controls.  Interestingly,  lean  
children  with  a  severely-­obese  parent  also  exhibit  a  reduced  reliance  on  lipid  oxidation  during  10  minutes  
of  15-­W  cycling  compared  to  children  with  non-­obese  parents  (Eaves,  Colon,  DuBose,  Collier,  &  
Houmard,  2012).  Consequently,  these  findings  cohere  with  the  notion  that  an  impaired  capacity  for  lipid  
oxidation  during  exercise  is  a  function  of  an  inherent  defect  that  predisposes  obesity  as  opposed  to  the  
presence  of  obesity  per  se  (Guesbeck  et  al.,  2001).  Indeed,  impaired  mitochondrial  lipid  oxidation  has  
been  reported  in  vitro  for  myotubes  donated  by  obese  humans  (Boyle,  Zheng,  Anderson,  Neufer,  &  
Houmard,  2012).  However,  similar  studies  using  longer  exercise  bouts  (e.g.,  60  minutes)  found  no  
difference  in  substrate  oxidation  rates  between  formerly-­obese  subjects  and  similarly-­matched  controls  
(Ezell  et  al.,  1999;;  Ranneries  et  al.,  1998),  which  suggests  that  the  duration  of  the  criterion  bout  might  
play  a  role  (Kanaley,  Cryer,  &  Jensen,  1993).  Moreover,  despite  similar  elevation  in  fatty  Acyl-­CoA  (a  lipid  
intermediate)  in  muscle  strips  of  both  overweight/obese  and  extremely-­obese  individuals,  only  the  latter  
demonstrate  impaired  palmitate  oxidation,  which  suggests  that  degree  of  obesity  might  also  be  important  
to  consider  (Hulver  et  al.,  2003).  In-­vivo  measurements  also  suggest  that  exercise-­stimulated  whole-­body  
lipid  oxidation  is  not  impaired  by  a  decrease  in  mitochondrial  density  in  normal-­weight  healthy  men  
(Eaves  et  al.,  2012)  or  by  the  reduction  in  mitochondrial  content  (Boushel  et  al.,  2007;;  Larsen  et  al.,  2009)  
and/or  function  (Mogensen  et  al.,  2007;;  Phielix  et  al.,  2008)  that  is  present  in  subjects  with  type  2  
diabetes  (Blaak  et  al.,  2006;;  Boon  et  al.,  2007;;  Colberg  et  al.,  1996;;  Ghanassia,  Brun,  Fedou,  Raynaud,  &  
Mercier,  2006;;  Kang  et  al.,  1996;;  Larsen  et  al.,  2009).  Finally,  much  like  the  fasting  state,  decreased  lipid  
oxidation  during  exercise  for  overweight/obese  subjects  is  not  a  universal  finding,  with  the  preponderance  
of  evidence  suggesting  that  body  fatness  exerts  no  influence  (Balcı,  2012;;  Colberg  et  al.,  1996;;  Croci  et  
al.,  2014;;  Devries  et  al.,  2013;;  Ezell  et  al.,  1999;;  Geerling  et  al.,  1994;;  Helge  et  al.,  1999;;  Kanaley  et  al.,  
2001;;  Larsen  et  al.,  2009;;  Mittendorfer,  Fields,  &  Klein,  2004;;  Steffan  et  al.,  1999;;  Thyfault  et  al.,  2004;;  
Venables,  Achten,  &  Jeukendrup,  2005)  or  might  even  convey  an  enhancement  (Ara  et  al.,  2011;;  
Goodpaster  et  al.,  2002;;  Horowitz  &  Klein,  2000;;  Kanaley  et  al.,  2001;;  Lanzi  et  al.,  2014).  
2.8  Obesity  and  Enhanced  Lipid  Oxidation  During  Exercise  
In  the  aforementioned  study,  Lanzi  et  al.  (2014)  found  a  similar  capacity  for  lipid  oxidation  at  work  





demonstrating  higher  rates  from  20-­30%.  Similarly,  Ara  et  al.  (2011)  found  a  higher  peak  rate  of  lipid  
oxidation  for  obese  subjects  compared  to  age-­matched  controls  during  incremental  arm  and  leg  cycling,  
and  obese  subjects  had  higher  circulating  FFA  and  augmented  intramyocellular  lipid  concentrations  that  
might  have  contributed  to  the  enhancement.  However,  Numao  et  al.  (2006)  found  a  similar  NPRER  during  
60  minutes  of  cycling  at  50%   o2peak  for  subjects  with  visceral  compared  to  abdominal-­subcutaneous  
obesity  despite  ~59%  higher  plasma  concentration  of  FFA  for  the  former  group,  which  suggests  that  if  
exercise  lipid  oxidation  is,  indeed,  enhanced  due  to  increased  lipid  availability  in  obese  subjects  (Ara  et  
al.,  2011;;  Goodpaster  et  al.,  2002),  the  enhanced  capacity  is  finite  (i.e.,  a  plateau  exists).  Alternatively,  
the  enhancement  might  not  be  related  to  lipid  availability  per  se,  at  least  with  respect  to  plasma  sources  
(see  below).  Ara  et  al.  (2011)  also  found  that  post-­obese  subjects  that  were  BMI-­matched  to  the  control  
group  demonstrated  an  enhanced  capacity  for  lipid  use  during  exercise;;  however,  this  was  only  the  case  
for  leg  cycling.  This  means  that  regional  differences  can  play  a  role.  In  another  study,  Goodpaster  et  al.  
(2002)  compared  obese  men  with  lean  subjects  matched  for  age  and  V̇O2max  and  found  that  obese  
subjects  derived  a  greater  proportion  of  their  energy  from  fatty  acids  during  60  minutes  of  cycling  at  50%  
V̇O2max.  Specifically,  this  difference  reflected  a  ~50%  greater  oxidation  of  non-­plasma  fatty  acids  and  
~50%  lower  oxidation  of  muscle  glycogen  as  oxidation  of  plasma  fatty  acids  and  glucose  was  similar  
between  groups  (Goodpaster  et  al.,  2002).  Horowitz  et  al.  (2000)  also  found  greater  (~25%)  whole-­body  
fatty-­acid  oxidation  for  abdominally-­obese  compared  to  lean  women  during  prolonged  cycling  at  54%  
V̇O2max  despite  similar  rates  of  plasma  fatty  acid  appearance,  uptake,  and  oxidation.  Similarly,  Kanaly  et  
al.  (2001)  reported  that  compared  to  lean  women,  obese  women  oxidized  30%  more  lipid  while  expending  
a  similar  amount  of  energy  during  30  minutes  of  walking  at  70%  V̇O2peak  despite  no  difference  in  
circulating  FFA  between  groups.  Collectively,  these  findings  suggest  that  obese  subjects  might  use  lipid  
more  predominantly  during  exercise  in  particular  with  respect  to  non-­plasma  sources  (i.e.,  presumably,  
intramyocellular  lipids)  (Goodpaster  et  al.,  2002;;  Horowitz  &  Klein,  2000;;  Kanaley  et  al.,  2001).    
Interestingly,  Thyfault  et  al.  (2004)  found  that  compared  to  normal-­weight  women,  severely-­obese  
women  and  women  who  were  previously  severely  obese  (post  gastric  bypass  surgery)  demonstrated  a  
decreased  ability  to  oxidize  plasma  FFA  (assessed  using  tracer  methodology)  during  both  fasting  and  





calorimetry)  was  different  between  groups.  Similarly,  Mittendorfer  et  al.  (2004)  found  no  difference  in  total  
lipid  oxidation  during  the  final  30  minutes  of  a  90-­minute  cycling  bout  for  lean,  overweight  and  obese  
subjects;;  however,  lean  subjects  derived  ~50%  of  the  fatty  acids  from  non-­plasma  sources  with  that  
percentage  increasing  with  increasing  adiposity.  An  attractive  interpretation  of  these  findings  is  that  the  
ability  to  maintain  plasma  FFA  uptake/oxidation  in  the  presence  of  elevated  intramyocellular  lipid  
accumulation/oxidation  determines  the  "net  effect"  on  total  exercise  lipid  oxidation  (i.e.,  increase,  
decrease  or  unaltered)  consequent  to  the  overweight/obese  state.  Interestingly,  an  "offsetting”  
relationship  like  this  has  been  reported  for  obese  diabetic  subjects  who  demonstrate  similar  total  lipid  
oxidation  when  cycling  at  50%  V̇O2max  compared  to  obese  normoglycemic  controls  even  though  oxidation  
of  plasma-­derived  fatty  acids  is  markedly  reduced  (Blaak,  van  Aggel-­Leijssen,  Wagenmakers,  Saris,  &  
van  Baak,  2000).      
2.9  Methodological  Concerns  for  Assessing  the  Capacity  for  Lipid  Oxidation  During  Exercise  
In  addition  to  the  dynamic  balance  between  utilization  of  plasma  FFA  and  intramyocellular  lipids,  
discrepant  findings  in  the  literature  regarding  the  influence  of  body  fatness  on  exercise  lipid  oxidation  
might  be  related  to  characteristics  of  the  criterion  exercise  bout.  For  example,  in  the  aforementioned  
studies,  the  comparison  between  lean  and  obese  subjects  was  made  during  exercise  at  either  the  same  
absolute  work  rate  (Croci  et  al.,  2014;;  Geerling  et  al.,  1994;;  Guesbeck  et  al.,  2001;;  Horowitz  &  Klein,  
2000;;  Lanzi  et  al.,  2014;;  Wade  et  al.,  1990)  and/or  a  work  rate  calculated  relative  to  the  subject’s  
individual  V̇O2max  (Ara  et  al.,  2011;;  Colberg  et  al.,  1996;;  Croci  et  al.,  2014;;  Devries  et  al.,  2013;;  Ezell  et  
al.,  1999;;  Geerling  et  al.,  1994;;  Goodpaster  et  al.,  2002;;  Guesbeck  et  al.,  2001;;  Helge  et  al.,  1999;;  
Horowitz  &  Klein,  2000;;  Kanaley  et  al.,  1993;;  Lanzi  et  al.,  2014;;  Larsen  et  al.,  2009;;  Mittendorfer  et  al.,  
2004;;  Perez-­Martin  et  al.,  2001;;  Steffan  et  al.,  1999;;  Thyfault  et  al.,  2004;;  Zunquin  et  al.,  2009).  While  the  
latter  is  the  “traditional”  way  to  normalize  exercise  intensity  across  subjects,  it  is  now  well  established  that  
the  V̇O2  response  exhibits  non-­linear  characteristics,  such  that  subjects  working  at  the  same  percentage  
of  V̇O2max  will  encounter  considerable  intersubject  variability  with  respect  to  the  physiological  challenge  at  
hand  (DiMenna  &  Jones,  2009;;  Katch,  Weltman,  Sady,  &  Freedson,  1978;;  Lansley,  Dimenna,  Bailey,  &  
Jones,  2011).  Furthermore,  as  previously  mentioned,  the  duration  of  the  criterion  bout  might  also  play  a  





walking  for  obese  compared  to  normal-­weight  women  was  present,  despite  no  significant  difference  
between  groups  during  the  first  15  minutes.  Consequently,  a  minimum  duration  of  exercise  might  be  
required  to  unveil  overweight/obesity-­related  differences.  Finally,  in  addition  to  characteristics  of  the  
exercise  bout,  differences  in  subject  characteristics  might  also  explain  the  lack  of  consensus  regarding  
the  effect  of  overweight/obesity  on  the  capacity  for  exercise  lipid  oxidation.  Specifically,  age  and/or  
gender  might  play  a  role  (Balcı,  2012),  and  it  is  also  important  to  recognize  that  fat-­free  mass  exerts  a  
positive  impact  on  the  capacity  to  oxidize  lipids.  For  example,  Venables  et  al.  (2005)  reported  that  the  
positive  correlation  they  observed  between  the  maximal  rate  of  lipid  oxidation  and  fat  mass  in  a  large  
group  of  healthy  subjects  was  no  longer  present  when  lipid  oxidation  was  corrected  for  fat-­free  mass.  
Consequently,  it  is  important  to  match  fat-­free  mass  between  groups  and/or  express  lipid  oxidation  
relative  to  fat-­free  mass  instead  of  total  body  weight,  so  that  a  valid  comparison  between  lean  and  obese  
subjects  can  be  made  (Devries  et  al.,  2013).  Another  important  factor  to  consider  is  the  cardiorespiratory  
fitness  of  the  subjects  because  the  sedentary  lifestyle  that  is  associated  with  overweight/obesity  would  be  
predicted  to  lead  to  lower  cardiorespiratory  fitness  and,  therefore,  a  reduced  capacity  for  lipid  oxidation  
regardless  of  overweight/obesity  per  se.  Goodpaster  et  al.  (2002)  were  the  first  to  account  for  this  factor  
by  matching  groups  according  to  V̇O2max  and,  indeed,  this  important  aspect  of  control  might  explain  their  
unexpected  finding  (i.e.,  increased  capacity  for  lipid  oxidation  in  overweight/obese  subjects).  However,  
Croci  et  al.  (2014)  also  matched  overweight/obese  and  normal-­weight  subjects  by  V̇O2max  and  observed  
no  difference  between  groups  for  exercise  lipid  oxidation.  One  important  distinction  between  these  
studies  is  that  in  the  former,  no  mention  is  made  of  confirming  that  the  observed  V̇O2peak  was,  indeed,  the  
V̇O2max,  while  in  the  latter,  four  of  the  five  criteria  used  for  this  purpose  were  either  ineffective  (heart  rate,  
RER  and  blood  lactate  concentration)  or  often  not  present  (a  “V̇O2  plateau”)  (Poole,  Wilkerson,  &  Jones,  
2008).  This  is  important  because  if  some  subjects  had  stopped  their  test  prior  to  attainment  of  V̇O2max,  
their  cardiorespiratory  fitness  stratification  would  have  been  underpredicted.  It  is  now  well  established  that  
in  lieu  of  the  V̇O2  plateau  that  is  often  lacking  at  attainment  of  V̇O2max  during  incremental  exercise  (Day,  
Rossiter,  Coats,  Skasick,  &  Whipp,  2003),  a  “severe-­intensity”  constant-­work-­rate  bout  can  be  performed  
shortly  after  completion  of  the  V̇O2max  test  to  “create”  such  a  plateau  to  confirm  V̇O2max  or  reveal  a  further  





et  al.,  2008).  Interestingly,  a  “verification  bout”  of  this  nature  has  recently  been  established  for  sedentary  
adults  with  obesity  (Midgley  &  Carroll,  2009);;  hence,  heretofore,  it  is  reasonable  to  suggest  that  attempts  
to  match  cardiorespiratory  fitness  between  overweight/obese  subjects  should  include  this  critical  aspect  
of  control.  Other  important  differences  between  the  two  studies  that  might  explain  the  discrepancy  include  
the  duration  of  the  exercise  bout  (one  60-­minute  bout  for  the  former  vs.  multiple  4-­minute  bouts  for  the  
latter)  and  the  cardiorespiratory  fitness  of  the  subjects.  Specifically,  Croci  et  al.  (2014)  recruited  subjects  
who  were  “recreationally  trained,”  while  Goodpaster  et  al.  (2002)  assessed  “sedentary”  individuals  (i.e.,  
V̇O2max  of  ~50  compared  to  ~40  mL∙kgFFM-­1∙min-­1).  Unfortunately,  Croci  et  al.  did  not  determine  the  
metabolic  profile  of  their  subjects;;  hence,  they  could  only  speculate  that  they  possessed  greater  insulin  
sensitivity,  compared  to  that  which  would  be  present  for  the  average  overweight/obese  phenotype  
(CROC*2014).  If  this  was  true,  their  subjects’  “metabolic  health”  was  likely  much  different  (e.g.,  
“metabolically-­healthy  obese;;”  MHO),  compared  to  the  overweight/obese  individuals  assessed  by  
Goodpaster  et  al.  (2002),  who  possessed  10%  higher  fasting  blood  glucose  and  threefold  higher  
postabsorptive  insulin  levels  compared  to  the  normal-­weight  controls.  Although  exercise  lipid  oxidation  
was  not  associated  with  fasting  insulin  levels  in  that  study,  this  raises  the  interesting  possibility  that  the  
counterintuitive  finding  of  an  enhanced  capacity  for  lipid  oxidation  in  overweight/obese,  compared  to  
normal-­weight  subjects  matched  for  cardiorespiratory  fitness,  might  represent  a  “downstream”  influence  of  
the  insulin  resistance  associated  with  overweight/obesity,  as  opposed  to  the  effect  of  overweight/obesity  
per  se  (Braun,  Sharoff,  Chipkin,  &  Beaudoin,  2004;;  Goodpaster  et  al.,  2002).  
2.10  “Functional”  Insulin  Resistance  
On  the  surface,  the  suggestion  that  an  “unhealthy”  condition  like  insulin  resistance  might  facilitate  
what  would  be  considered  the  preferred  exercise  response  (i.e.,  increased  reliance  on  lipid  oxidation  and  
consequent  glucose/glycogen  sparing)  is  difficult  to  reconcile.  However,  insulin  resistance  has  recently  
been  “redefined”  based  on  the  observation  that  it  is  well  preserved  from  an  evolutionary  perspective  
(Soeters  &  Soeters,  2012).  Within  this  schema,  insulin  resistance  and  elevated  intermyocellular  lipids  are  
“functional”  responses  because  they  provide  a  “survival  advantage”  during  the  periods  of  prolonged  food  
deprivation  that  characterize  the  feast-­or-­famine  circumstances  of  a  hunting/gathering  lifestyle  (Stannard  





thereby  protecting  blood  stores  by  “opening  the  door”  for  increased  lipid  oxidation  from  easy-­to-­access  
intramuscular  sources  (Stannard  &  Johnson,  2004).  The  dramatic  change  in  insulin  sensitivity  that  
characterizes  the  circ-­annual  cycle  of  mammalian  hibernation  exemplifies  this  concept  (Martin,  2008).  
However,  once  prolonged  energetic  deficit  is  removed  from  the  equation  (e.g.,  due  to  the  advent  of  an  
agricultural  society  and/or  the  modern-­day  energetic  prosperity  that  begets  the  obesogenic  lifestyle),  the  
phenotype  becomes  dysfunctional  and,  ultimately,  pathogenic.  
2.11  Insulin  Resistance  and  Enhanced  Lipid  Oxidation  During  Exercise  
Recognizing  the  possible  influence  of  insulin  resistance  on  exercise  substrate  utilization  with  
respect  to  the  findings  of  Goodpaster  et  al.  (2002),  Braun  et  al.  (2004)  stress  that  in  addition  to  age,  
maximal  aerobic  capacity,  and  habitual  level  of  physical  activity,  the  insulin-­resistant  status  of  obese  and  
normal-­weight  subjects  should  be  controlled  to  conclude  that  a  shift  toward  less  carbohydrate/more  lipid  
use  during  exercise  is  attributable  to  body  fatness  per  se.  Accordingly,  these  authors  compared  exercise  
substrate  use  in  a  group  of  untrained,  overweight/obese  women  with  insulin  resistance  to  that  which  was  
present  for  insulin-­sensitive  women  of  similar  age,  weight,  body  composition,  habitual  physical  activity,  
and  maximal  aerobic  capacity.  Importantly,  Braun  et  al.  chose  insulin-­resistant  subjects  who  were  
normoglycemic  to  ensure  that  the  mass  action  effect  of  hyperglycemia  would  not  contribute  to  differences  
in  glucose  uptake/oxidation  they  observed  in  the  insulin-­resistant  group.  The  authors  found  that  during    
50  minutes  of  treadmill  walking  at  45%  V̇O2peak,  blood-­glucose  oxidation  was  similar  between  groups;;  
however,  total  carbohydrate  oxidation  and  the  estimated  proportion  of  energy  derived  from  muscle  
glycogen  were  less  for  the  subjects  with  insulin  resistance.  Importantly,  the  end  result  was  that  subjects  
with  insulin  resistance  satisfied  a  greater  proportion  of  the  energetic  cost  of  exercise  with  lipid  (~56%  vs.  
~44%  for  the  insulin  sensitive  controls).  Although  the  mechanism(s)  of  action  could  not  be  determined,  
the  authors  concluded  that  independent  of  body  fatness,  insulin  resistance  spares  muscle  glycogen  by  
shifting  substrate  oxidation  away  from  carbohydrate,  despite  similar  blood-­glucose  uptake  during  exercise  
(Braun  et  al.,  2004).    
2.12  The  Effect  of  Insulin  Resistance  on  Exercise  Lipid  Oxidation  Independent  of  Body  Fatness  
The  findings  of  Braun  et  al.  (2004)  might  help  to  explain  equivocal  reports  regarding  exercise  





status  was  not  controlled  in  those  investigations.  However,  a  number  of  limitations  to  their  findings  must  
be  considered.  Much  like  the  predominance  of  research  that  has  addressed  this  topic  (Ara  et  al.,  2011;;  
Colberg  et  al.,  1996;;  Crozi  et  al.,  2014;;  Devries  et  al.,  2013;;  Ezell  et  al.,  1999;;  Geerling  et  al.,  1994;;  
Goodpaster  et  al.,  2002;;  Guesbeck  et  al.,  2001;;  Helge  et  al.,  1999;;  Horowitz  &  Klein,  2000;;  Kanaley  et  al.,  
1993;;  Lanzi  et  al.,  2014;;  Larsen  et  al.,  2009;;  Mittendorfer  et  al.,  2004;;  Perez-­Martin  et  al.,  2001;;  Steffan  et  
al.,  1999;;  Thyfault  et  al.,  2004;;  Zunquin  et  al.,  2009),  exercise  intensity  was  prescribed  relative  to  V̇O2peak  
in  that  study  (Braun  et  al.,  2004).  This  means  that  subjects  were  likely  working  at  different  intensities  
relative  to  their  maximal  capacity  for  lipid  oxidation,  which  generally  occurs  at  or  slightly  below  the  
individual  lactate  threshold  (Achten  &  Jeukendrup,  2004;;  Rynders,  Angadi,  Weltman,  Gaesser,  &  
Weltman,  2011),  as  there  is  considerable  intersubject  variability  with  respect  to  where  lactate  threshold  is  
situated  relative  to  V̇O2peak  (Meyer,  Gabriel,  &  Kindermann,  1999;;  Weltman  et  al.,  1990).  Conversely,  a  
proper  comparison  of  exercise-­stimulated  substrate  selectivity  across  subjects  should  assess  lipid  
oxidation  at  a  given  percentage  of  lactate  threshold.  Moreover,  if  it  is  the  insulin-­resistant  status  of  the  
obese  individual  that  alters  exercise  substrate  selectivity  independent  of  obesity,  one  would  expect  
insulin-­resistant  individuals  who  were  not  overweight/obese  to  also  express  this  phenotype.  However,  
normal-­weight  insulin  resistant  and  insulin-­sensitive  subjects  were  not  included  in  that  study;;  hence,  that  
determination  could  not  be  made  (Braun  et  al.,  2004).  
2.13  Summary  
Equivocal  findings  exist  regarding  the  influence  of  overweight/obesity  on  substrate  selectivity,  
especially  towards  lipid,  in  the  fasting/resting  and  exercise-­stimulated  states.  This  likely  reflects  
methodological  differences  between  studies  and,  specifically,  a  lack  of  control  for  key  variables  that  can  
confound  a  comparison  between  overweight/obese  and  normal-­weight  subjects.  These  include:  (a)  acute  
energy  balance  and  macronutrient  composition  of  the  diet,  and  (b)  fat-­free  mass,  cardiorespiratory  fitness  
and  insulin-­resistant  status  of  the  subjects.  In  additional,  no  study  to  date  has  compared  lipid  oxidation  
during  a  physiological-­equivalent  exercise  challenge  in  individuals  with  normal  weight  and  
overweigh/obesity  with  these  factors  well  controlled.    
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Chapter  3  –  Systematic  Review  
3.1  The  Influence  of  Overweight/Obesity  on  Exercise  Lipid  Oxidation:  A  Systematic  Review  
3.1.1.  Introduction  
Obesity  (World  Health  Organization  [WHO],  2018)  and  diabetes  (Zimmet,  Alberti,  &  Shaw,  2001)  
epidemics  are  in  full  swing  and  a  link  between  the  insulin  resistance  (IR)  that  predates  type  2  diabetes  
(T2D)  and  the  overweight/obese  condition  is  well  established.  However,  the  mechanistic  basis(es)  
underpinning  this  link  is/are  still  debated  with  multiple  candidate  molecules,  systems,  and  pathways  
potentially  involved  (Qatanani  &  Lazar,  2007).  One  theory  posits  a  relationship  with  dysfunctional  lipid  
metabolism  based  on  the  notion  that  excess  accumulation  of  lipid  in  skeletal  muscle  (intramuscular  
triglyceride;;  IMTG)  becomes  “lipotoxic”  and  begets  IR  when  it  is  not  “turned  over”  on  a  regular  basis  
(McGarry,  1992;;  Moro,  Bajpeyi,  &  Smith,  2008;;  Pan  et  al.,  1997;;  Perseghin  et  al.,  1999).  In  support  of  this  
contention,  evidence  suggests  that  obese  individuals  demonstrate  an  impaired  capacity  to  up  regulate  
lipid  oxidation  during  fasting,  which  represents  a  condition  with  an  energetic  demand  that  should  be  
satisfied  predominantly  by  lipid  as  substrate  (Goodpaster,  Katsiaras,  &  Kelley,  2003;;Kelley,  Goodpaster,  
Wing,  &  Simoneau,  1999;;  Kim,  Hickner,  Cortright,  Dohm,  &  Houmard,  2000).  However,  use  of  the  fasting  
state  to  assess  the  capacity  to  oxidize  lipid  has  been  questioned  because  of  the  low  metabolic  demand  
and  degree  to  which  the  value  is  influenced  by  acute  energy  balance  and  dietary  macronutrient  
consumption  (Galgani,  Moro,  &  Ravussin,  2008).  A  better  alternative  might  be  to  investigate  the  capacity  
to  use  lipid  during  exercise  when  metabolic  demand  is  higher,  yet  lipid  can  still  contribute  significantly  
(Galgani,  Heilbronn,  et  al.,  2008).  In  this  regard,  obese  individuals  possess  reduced  mitochondrial  content  
(Kim  et  al.,  2000)  and  lower  oxidative  enzyme  capacity  (Simoneau,  Veerkamp,  Turcotte,  &  Kelley,  1999),  
which  are  “downstream”  factors  that  could  limit  the  ability  to  oxidize  available  lipid  during  exercise.    
Moreover,  “upstream”  limitations  in  lipid  availability  during  exercise  might  be  present  with  overweight/  
obesity  due  to  a  greater  cortisol  response  (Wong  &  Harber,  2006),  impaired  growth  hormone  (Wong  &  
Harber,  2006),  and  plasma  catecholamine  (Gustafson,  Farrell,  &  Kalkhoff,  1990;;  Salvadori,  Fanari,  
Mazza,  &  Baudo,  1993)  responses  and/or  reduced  lipolytic  effect  of  a  given  level  of  circulating  
catecholamines  (Connacher  et  al.,  1991;;  Mittendorfer,  Fields,  &  Klein,  2004).  There  is  also  evidence  of  a  





obese  condition  (Thyfault  et  al.,  2004).  Each  of  these  could  contribute  independently  or  in  concert  to  a  
reduced  capacity  for  exercise  lipid  reliance  for  overweight/obese  individuals.  
Despite  this  strong  theoretical  basis,  studies  carried  out  to  test  the  hypothesis  that  exercise  lipid  
use  is  reduced  with  obesity  have  returned  equivocal  findings  with  some  reporting  a  decrement  and  others  
finding  no  difference.  Interestingly,  there  is  even  evidence  of  enhanced  exercise  lipid  oxidation  with  
obesity,  which  might  reflect  an  increase  in  the  availability  of  stored  lipid  in  muscle  (Goodpaster,  Wolfe,  &  
Kelley,  2002;;  Horowitz  &  Klein,  2000)  and/or  substrate  selection  that  is  influenced  by  the  IR  that  often  
accompanies  the  overweight/obese  state  (Braun,  Sharoff,  Chipkin,  &  Beaudoin,  2004).  The  reason(s)  for  
these  conflicting  findings  is/are  unclear  but  might  reflect  methodological  differences  regarding  a  number  
of  important  factors  that  should  be  controlled  to  isolate  the  influence  of  overweight/obesity  on  lipid  use  
during  exercise.  For  example,  the  fat-­free  mass  (FFM)  and  cardiorespiratory  fitness  (CRF)  of  the  subject  
(Goodpaster  et  al.,  2002)  and  the  energy  balance  and  macronutrient  composition  of  the  subject’s  diet  
(Gregory  et  al.,  2011;;  Helge,  Watt,  Richter,  Rennie,  &  Kiens,  2001)  are  factors  that  can  affect  exercise  
lipid  use  irrespective  of  body-­fat  stores.  Furthermore,  the  ability  to  use  lipid  as  fuel  during  exercise  is  
profoundly  influenced  by  both  the  intensity  (Brooks  &  Mercier,  1994;;  Venables,  Achten,  &  Jeukendrup,  
2005)  and  duration  (van  de  Weijer  et  al.,  2013)  of  the  criterion  exercise  bout.  
Resolving  ambiguity  regarding  the  influence  of  overweight/obesity  on  the  capacity  to  oxidize  lipid  
is  important  because  understanding  this  influence  can  provide  insight  into  the  etiology  of  the  disease.  For  
example,  if  a  reduced  capacity  for  lipid  oxidation  is  present  in  overweight/obese  subjects,  it  is  consistent  
with  the  contention  that  an  inherent  defect  (e.g.,  compromised  lipolytic  activity  that  limits  lipid  availability  
and/or  a  mitochondrial  defect  that  restricts  oxidation  of  available  lipid)  predisposes  the  overweight/obese  
condition  (Guesbeck  et  al.,  2001;;  Thyfault  et  al.,  2004).  According  to  this  schema,  a  shift  in  substrate  
selectivity  away  from  lipid  in  favor  of  carbohydrate  metabolism  during  physical  activity  would  be  
accompanied  by  a  reciprocal  shift  toward  lipid  storage,  which  represents  the  more  energetically-­efficient  
way  to  increase  energy  stores  when  a  positive  energy  balance  is  present.  Consequently,  a  reduced  
capacity  to  oxidize  lipid  would  be  associated  with  a  greater  propensity  to  gain  body  fat  (Hickner,  Privette,  
McIver,  &  Barakat,  2001).  Moreover,  the  degree  to  which  overweight/obesity  affects  lipid  oxidation  and  





manage  and/or  treat  the  disease  (Goodpaster  et  al.,  2002).  For  example,  if  an  impaired  capacity  for  lipid  
utilization  predisposes  the  overweight/obese  state,  exercise  specific  for  improving  mitochondrial  function  
(e.g.,  high-­intensity  interval  training)  would  be  warranted  (Gibala,  Little,  MacDonald,  &  Hawley,  2012;;  
(Little  et  al.,  2011).  A  higher-­intensity  approach  (e.g.,  sustained  exercise  at  a  metabolic  rate  that  exceeds  
that  which  allows  for  the  maximal  rate  of  lipid  oxidation)  would  also  be  advantageous  for  overweight/  
obese  subjects  because  the  “target  energy  expenditure”  to  ensure  adequate  rate  of  weight  loss  (e.g.,  300  
kcals  per  session)  can  be  achieved  with  reduced  time  commitment  (Bogdanis,  Vangelakoudi,  &  Maridaki,  
2008).  Conversely,  if  exercise  lipid  use  is  not  reduced  with  overweight/obesity,  mitochondrial  function  
would,  apparently,  be  sufficient  (Fisher-­Wellman  et  al.,  2014;;  Holloszy,  2008).  In  this  case,  an  exercise  
metabolic  rate  at  which  lipid  oxidation  is  maximal  (i.e.,  at  the  so-­called  “FATmax”)  might  be  preferred  to  
improve  metabolic  health  irrespective  of  body-­fat  loss  by  optimally  perturbing  the  IMTG  pool  (Dumortier  et  
al.,  2003;;  Thompson,  Townsend,  Boughey,  Patterson,  &  Bassett,  1998;;  Venables  &  Jeukendrup,  2008)  
and/or  changing  its  relationship  with  muscle  mitochondria  (Devries  et  al.,  2013).  
The  primary  aim  of  this  systematic  review  was  to  formulate  a  consensus  opinion  regarding  the  
influence  of  overweight/obesity  on  exercise  lipid  oxidation  from  the  existing  research.  A  secondary  aim  
was  to  inform  future  research  by  determining  the  degree  to  which  conflicting  results  might  be  explained  by  
factors  that  were  unaccounted  for  and/or  inadequately  controlled  in  prior  investigations.  
3.2  Methods  
This  systematic  review  was  performed  in  accordance  with  the  Preferred  Reporting  Items  for  
Systematic  Reviews  and  Meta-­Analysis  (PRISMA)  guidelines  and  is  registered  in  the  PROSPERO  
database  (PROSPERO  2015:CRD42015027519).  
   3.2.1  Search  Strategy  
Two  researchers  independently  conducted  a  search  and  selected  the  articles  included  in  this  
review.  The  search,  which  was  undertaken  on  June  30,  2017,  was  performed  using  the  databases  
PubMed,  ProQuest,  ISI  Web  of  Science/,  and  the  Cochrane  Library.  The  general  search  strategy  was  
employed  within  the  PubMed  database  and  subsequently  applied  to  the  other  three  sources.  Search  
terms  were:  (a)  “obes”  or  “overweight”;;  (b)  “substrate  utilization”  or  “lipid  oxidation”  or  “fat  oxidation”;;  and  





a  peer-­reviewed  journal  published  in  English,  and  (b)  reported  findings  from  an  IRB-­approved  clinical  trial  
of  human  subjects.  Following  extraction,  reference  lists  of  remaining  studies  were  examined  so  that  
relevant  articles  not  flagged  by  the  original  search  could  be  considered.    
   3.2.2  Study  Selection:  Inclusion  and  Exclusion  Criteria  
Articles  were  included  if  they  presented  original  research  that  provided  information  regarding  the  
influence  of  overweight/obesity  on  fuel  utilization  during  exercise  in  generally-­healthy  (i.e.,  without  
metabolic,  cardiopulmonary,  neurological,  or  musculoskeletal  disease  and/or  not  taking  medication  that  
might  affect  fuel  metabolism)  sedentary  adults  (>18  years).  Accordingly,  for  a  study  to  be  included,  
subjects  had  to  have  been  stratified  into  one  of  at  least  two  distinct  groups  defined  according  to  either  
Body  Mass  Index  (BMI)  or  body-­fat  percentage.  Articles  were  excluded  if  they  assessed:  (a)  older  adults  
(>65  years),  (b)  individuals  with  chronic  disease  and/or  exercise  limitations,  and  (c)  physically-­active  
subjects  (e.g.,  recreational  or  competitive  athlete).    
3.2.3  Data  Extraction  and  Synthesis  
Once  the  selection  process  was  complete,  one  author  extracted  the  following  information  from  
included  articles:  author(s),  journal,  date  of  publication,  sample  size,  subject  characteristics  (e.g.,  age,  
sex,  BMI,  percent  body  fat,  maximal/peak  rate  of  oxygen  consumption  [V̇O2max/V̇O2peak]),  criterion-­exercise  
characteristics  (e.g.,  mode,  intensity  and  duration),  aim(s),  hypothesis(es),  methodological  design,  
primary  outcomes  and  additional  relevant  findings.  
3.2.4  Quality  Assessment  
Methodological  quality  assessment  was  performed  on  two  levels.  We  combined  relevant  
questions  from  three  widely-­accepted  scales  (PEDro,  MINORS,  and  NIH)  to  assess  general  
methodological  quality  while  also  utilizing  a  custom-­designed  tool  to  assess  the  degree  to  which  12  
factors  that  can  affect  exercise  lipid  use  regardless  of  body  fatness  were  adequately  controlled.  In  each  
case,  two  researchers  provided  independent  assessments  by  judging  items  as  either  absent/insufficient,  
present/insufficient  or  present/sufficient  (score  =  0,  1  or  2,  respectively).  Scores  were  subsequently  
averaged  to  provide  a  single  rating  per  study  for  each  level  of  assessment.  Regardless  of  assessed  







Figure  1  illustrates  the  flow  diagram  for  this  systematic  review.  A  total  of  1,144  articles  were  
identified  during  the  database  search  (1,141)  and  through  additional  sources  (3),  and  after  duplicates  
were  removed,  685  articles  were  considered  for  inclusion.  Once  titles,  abstracts,  and/or  manuscripts  were  
assessed,  it  was  determined  that  24  satisfied  the  inclusion  criteria.  The  investigations  detailed  in  these  24  
articles  were  all  cross-­sectional;;  however,  three  also  included  longitudinal  components.  Specifically,  two  
involved  16  weeks  of  energy  restriction  for  the  obese  group  (Kanaley,  Cryer,  &  Jensen,  1993;;  Kanaley,  
Weatherup-­Dentes,  Alvarado,  &  Whitehead,  2001),  while  one  included  12  weeks  of  endurance  training  for  
both  groups  (Devries  et  al.,  2013).  For  the  former  two,  the  lipid-­oxidizing  comparison  between  lean  and  
obese  subjects  was  made  for  the  baseline  measurement  only  (Kanaley  et  al.,  1993;;  Kanaley  et  al.,  2001),  
while  the  latter  involved  comparisons  between  groups  both  before  and  after  the  training  intervention  
(Devries  et  al.,  2013).  
In  17  of  the  24  included  studies,  a  comparison  of  the  capacity  for  whole-­body  (Ardevol  et  al.,  
1998;;  Balcı,  2012;;  Chatzinikolaou  et  al.,  2008;;  Devries  et  al.,  2013;;  Ezell  et  al.,  1999;;  Goodpaster  et  al.,  
2002;;  Grams,  Kueck,  Haufe,  Tegtbur,  &  Nelius,  2017;;  Horowitz  &  Klein,  2000;;  Keim,  Belko  &  Barbieri,  
1996;;  Lanzi  et  al.,  2014;;  Mittendorfer  et  al.,  2004;;  Perez-­Martin  et  al.,  2001;;  Santiworakul,  Chuaychoo,  
Kriengsinyos,  Saengsirisuwan,  &  Jalayondeja  2014;;  Slusher  et  al.,  2015;;  Steffan,  Elliott,  Miller,  &  
Fernhall,  1999;;  Thyfault  et  al.,  2004;;  Wong  &  Harber,  2006),  or  whole-­body  and  source-­specific  
(Goodpaster  et  al.,  2002;;  Horowitz  &  Klein,  2000;;  Mittendorfer  et  al.,  2004;;  Thyfault  et  al.,  2004)  lipid  
oxidation  during  exercise  between  non-­overweight/obese  (most  often  called  “lean,”  but  also  referred  to  as  
“control,”  “leaner,”  “never  obese,”  “nonobese,”  and  “normal  weight”)  and  overweight/obese  subjects  was  a  
primary  purpose.  In  two  of  these  studies,  the  effect  of  weight  loss  was  also  investigated  by  comparing  
lean  subjects  with  obese  subjects  who  had  lost  weight;;  however,  a  third  group  comprising  obese  subjects  
who  had  not  lost  weight  was  also  included  for  comparison  (Ezell  et  al.,  1999;;  Thyfault  et  al.,  2004).  






Figure  3.1.  PRISMA  flow  diagram  
  
Another  study  investigated  the  effect  of  time  of  day  on  exercise  lipid  use;;  however,  normal  and  
obese  subjects  were  included  and  stratified  into  separate  groups  with  a  comparison  between  groups  at  
each  time  of  day  provided  (Mohebbi  &  Azizi,  2011).  In  the  other  six  studies,  the  primary  purpose  was  to  
investigate  differences  due  to  subject  characteristics  other  than  overweight/obesity;;  however,  a  
comparison  between  normal-­weight  and  overweight/obese  subjects  was  also  included.  For  example,  in  
one  investigation,  the  objective  was  to  determine  whether  differences  in  exercise  lipid  oxidation  exist  
between  lean  and  obese  African  American  and  lean  and  obese  Caucasian  women  (Hickner  et  al.,  2001).  
However,  results  of  a  two-­way  (i.e.,  race  ×  body  composition)  ANOVA  were  presented  so  that  the  





Similarly,  in  two  studies,  the  authors’  objective  was  to  determine  whether  substrate  utilization  during  
exercise  differs  in  subjects  with  T2D  compared  to  nondiseased  controls  (Colberg  et  al.,  1996;;  Larsen  et  
al.,  2009).  However,  the  methodology  included  both  a  lean  and  obese  control  group  so  that  a  comparison  
of  the  effect  of  obesity  without  the  potential  confounding  influence  of  the  disease  was  also  reported  
(Colberg  et  al.,  1996;;  Larsen  et  al.,  2009).  In  two  other  studies,  the  purpose  was  to  determine  whether  the  
relationship  between  free  fatty  acid  (FFA)  availability  and  lipid  oxidation  is  different  for  obese  subjects  
with  different  types  of  body-­fat  distribution  (Kanaley  et  al.,  1993;;  Kanaley  et  al.,  2001).  However,  non-­
obese  subjects  were  also  assessed  and  a  comparison  across  the  three  groups  was  provided  (Kanaley  et  
al.,  1993;;  Kanaley  et  al.,  2001).  Finally,  in  one  study,  a  group  of  endurance-­trained  subjects  was  included  
to  assess  24-­hour  substrate  use  in  trained  individuals  compared  to  untrained  obese  individuals  on  
exercise  and  non-­exercise  days  (Melanson  et  al.,  2009).  However,  a  group  of  untrained  lean  subjects  was  
also  included  and  a  comparison  of  substrate  use  exclusive  to  the  exercise  bout  was  provided  (Melanson  
et  al.,  2009).    
3.3.1  Subject  Characteristics  
3.1.1  Sex  and  Race  
Table  3.1  presents  the  characteristics  of  the  subjects  assessed  in  the  24  included  studies.  In  nine  
studies,  males  were  assessed  exclusively  (Balcı,  2012;;  Chatzinikolaou  et  al.,  2008;;  Goodpaster  et  al.,  
2002;;  Lanzi  et  al.,  2014;;  Larsen  et  al.,  2009;;  Mittendorfer  et  al.,  2004;;  Mohebbi  &  Azizi,  2011;;  
Santiworakul  et  al.,  2014;;  Wong  &  Harber,  2006),  while  females  were  studied  exclusively  in  nine  other  
investigations  (Ardevol  et  al.,  1998;;  Devries  et  al.,  2013;;  Ezell  et  al.,  1999;;  Hickner  et  al.,  2001;;  Horowitz  
&  Klein,  2000;;  Kanaley  et  al.,  1993;;  Kanaley  et  al.,  2001;;  Steffan  et  al.,  1999;;  Thyfault  et  al.,  2004).  In  six  
studies,  both  male  and  female  subjects  were  included  (Clberg  et  al.,  1996;;  Grams  et  al.,  2017;;  Keim  et  
al.,  1996;;  Melanson  et  al,  2009;;  Perez-­Martin  et  al.,  2001;;  Slusher  et  al.,  2015);;  however,  only  three  of  
these  included  a  report  of  results  according  to  sex  either  exclusively  (Grams  et  al.,  2017)  or  in  addition  to  
collectively  (Keim  et  al.,  1996;;  Perez-­Martin  et  al.,  2001).  Only  one  study  included  mention  of  race  with  







3.3.2  Stratification  Criteria  for  Body  Fatness  
In  13  studies,  BMI  was  used  exclusively  to  stratify  subjects  into  groups  (Ardevol  et  al.,  1998;;  
Balcı,  2012;;  Devries  et  al.,  2013;;  Goodpaster  et  al.,  2002;;  Hickner  et  al.,  2001;;  Kanaley  et  al.,  2001;;  
Melanson  et  al.,  2009;;  Mittendorfer  et  al.,  2004;;  Mohebbi  &  Azizi,  2011;;  Perez-­Martin  et  al.,  2001;;  
Santiworakul  et  al.,  2014;;  Slusher  et  al.,  2015;;  Thyfault  et  al.,  2004).  In  two  of  these  studies,  the  
classification  system  endorsed  by  the  World  Health  Organization  (WHO)  was  used  to  define  “normal”  and  
“overweight”  groups  (BMI,  <25  and  ≥25  kg∙m-­2,  respectively)  (Balcı,  2012;;  Perez-­Martin  et  al.,  2001),  
while  in  another,  the  cut-­off  point  was  arbitrary  (28  kg∙m-­2)  (Hickner  et  al.,  2001).  Additionally,  in  one  
study,  the  WHO  system  was  used  to  stratify  three  groups  by  differentiating  obese  (BMI,  ≥30  kg∙m-­2)  from  
overweight  subjects  (Mittendorfer  et  al.,  2004),  while  in  another,  the  authors  used  a  BMI  of  30  kg∙m-­2    as  a  
cut-­off  point  to  differentiate  an  “obese”  from  “control”  group  (Ardevol  et  al.,  1998).  We  chose  to  include  the  
latter  study  because  the  mean  ±  SD  for  the  control  group  was  20.9  ±  0.5  kg∙m-­2  (n  =  8)  (Ardevol  et  al.,  
1998).  In  the  other  eight  studies  that  used  BMI  exclusively,  the  authors  chose  to  classify  in  zones  to  
provide  separation;;  for  example,  obese  (Devries  et  al.,  2013;;  Melanson  et  al.,  2009;;  Mohebbi  &  Azizi,  
2011;;  Slusher  et  al.,  2015),  or  extremely-­obese  (Thyfault  et  al.,  2004),  compared  to  normal-­weight  
subjects  using  the  WHO  criterion  (“extremely  obese”  BMI,  ≥35  kg∙m-­2)  or  obese  subjects  compared  to  
control  subjects  with  BMI  <23  (Santiworakul  et  al.,  2014)  or  <24  (Goodpaster  et  al.,  2002;;  Kanaley  et  al.,  
2001)  kg∙m-­2.    
In  four  studies,  body-­fat  percentage  was  used  exclusively  to  stratify  subjects  with  various  criteria  
employed;;  for  example,  obese  and  lean  designations  as  >25%  and  <16%,  respectively  (Wong  &  Harber,  
2006),  an  obese/lean  cut-­off  point  of  30%  for  women  (Keim  et  al.,  1996;;  Steffan  et  al.,  1999),  and  20%  for  
men  (Keim  et  al.,  1996)  or  age-­specific  (20–39  years  or  40–59  years)  overweight/normal-­weight  cut-­off  
points  for  women  (32.5  and  34.5%)  and  men  (20.5  and  22.5%)  (Grams  et  al.,  2017).  In  two  other  studies,  
body-­fat  percentage  was  used  in  conjunction  with  BMI;;  for  example,  obese  subjects  possessing  a  body-­
fat  percentage  >30%  with  BMI  >29  kg∙m-­2  compared  to  “never-­obese”  controls  with  body-­fat  percentage  
no  more  than  ‘slightly  above  30%’  and  BMI  <27  kg∙m-­2    (mean  ±  SD,  20.6  ±  0.9  kg∙m-­2;;  n  =  5)  (Ezell  et  al.,  
1999)  or  obese  subjects  with  body-­fat  percentage  >40%  and  BMI  of  35.0–39.9  kg∙m-­2    compared  to  lean  





other  studies,  the  mean  ±  SD  for  BMI  (Colberg  et  al.,  1996)  or  both  BMI  and  body-­fat  percentage  
(Chatzinikolaou  et  al.,  2008;;  Kanaley  et  al.,  1993;;  Lanzi  et  al.,  2014;;  Larsen  et  al.,  2009)  for  each  group  
was  provided  to  illustrate  the  difference(s);;  however,  no  mention  was  made  of  a  specific  criterion  that  was  
employed  to  establish  the  separation.  
3.3.3  Fat-­free  Mass  
In  eight  of  the  24  included  studies,  FFM  was  either  not  measured  (Chatzinikolaou  et  al.,  2008;;  
Slusher  et  al.,  2015;;  Thyfault  et  al.,  2004)  or  measured,  but  not  reported  (Ezell  et  al.,  1999;;  Melanson  et  
al.,  2009;;  Perez-­Martin  et  al.,  2001;;  Santiworakul  et  al.,  2014;;  Steffan  et  al.,  1999).  In  the  other  16  
studies,  the  overweight/obese  group  possessed  a  higher  FFM  in  all  but  two  cases  (Grams  et  al.,  2017;;  
Kanaley  et  al.,  1993).  However,  in  some  studies,  this  difference  was  only  present  for  overweight/obese  
subjects  with  specific  characteristics;;  for  example,  female,  but  not  male  (Keim  et  al.,  1996),  obese,  but  not  
overweight  (Mittendorfer  et  al.,  2004)  and  upper-­  but  not  lower-­body  situated  obesity  (Kanaley  et  al.,  
2001).    
3.3.4  Aerobic  Fitness  
In  three  of  the  24  included  studies,  V̇O2peak/max  was  either  not  measured  (Perez-­Martin  et  al.,  
2001)  or  measured,  but  not  reported  (Ardevol  et  al.,  1998;;  Santiworakul  et  al.,  2014).  For  the  other  21  
studies,  12  included  a  report  of  V̇O2peak/max  expressed  relative  to  FFM  and  in  11  of  those  investigations,  
values  did  not  differ  between  groups  (Devries  et  al.,  2013;;  Goodpaster  et  al.,  2002;;  Hickner  et  al.,  2001;;  
Horowitz  &  Klein,  2000;;  Kanaley  et  al.,  1993;;  Kanaley  et  al.,  2001;;  Keim  et  al.,  1996;;  Mittendorfer  et  al.,  
2004;;  Mohebbi  &  Azizi,  2011;;  Steffan  et  al.,  1999;;  Wong  &  Harber,  2006),  although  in  one  of  these  
studies,  this  was  the  case  for  African  American  women  only  (Hickner  et  al.,  2001).  In  the  other  
investigation  (Lanzi  et  al.,  2014)  and  for  the  Caucasian  women  in  the  aforementioned  study  (Hickner  et  
al.,  2001),  overweight/obese  subjects  demonstrated  lower  values.  In  contrast,  overweight/obese  subjects  
demonstrated  lower  values  in  11  of  the  14  studies  that  included  a  report  of  V̇O2peak/max  expressed  relative  
to  BM  (Ardevol  et  al.,  1998;;  Balcı,  2012;;  Grams  et  al.,  2017;;  Lanzi  et  al.,  2014;;  Larsen  et  al.,  2009;;  
Melanson  et  al.,  2009;;  Mohebbi  &  Azizi,  2011;;  Slusher  et  al.,  2015;;  Steffan  et  al.,  1999;;  Thyfault  et  al.,  
2004;;  Wong  &  Harber,  2006),  with  no  difference  present  in  the  other  three  studies  (Chatzinikolaou  et  al.,  





absolute  terms  was  also  included,  no  difference  (Ezell  et  al.,  1999;;  Goodpaster  et  al.,  2002;;  Grams  et  al.,  
2017;;  Hickner  et  al.,  2001;;  Horowitz  &  Klein,  2000;;  Keim  et  al.,  1996;;  Lanzi  et  al.,  2014;;  Mittendorfer  et  
al.,  2004;;  Slusher  et  al.,  2015;;  Steffan  et  al.,  1999;;  Thyfault  et  al.,  2004),  or  a  greater  value  (Keim  et  al.,  
1996;;  Wong  &  Harber,  2006)  was  observed  for  the  overweight/obese  group.  Finally,  in  seven  of  the  24  
included  studies,  the  word  “matched”  was  used  to  describe  how  the  groups  compared  with  respect  to  
CRF  (Devries  et  al.,  2013;;  Ezell  et  al.,  1999;;  Goodpaster  et  al.,  2002;;  Horowitz  &  Klein,  2000;;  Kanaley  et  
al.,  1993;;  Keim  et  al.,  1996;;  Mittendorfer  et  al.,  2004);;  however,  specific  mention  of  how  the  matching  was  
accomplished  was  only  provided  in  one  case  (i.e.,  pair-­wise  range  matching  for  V̇O2peak  per  FFM;;  range,  
±3  ml∙kg-­1∙min-­1)  (Keim  et  al.,  1996).  One  other  study  included  an  analysis  of  lean  and  obese  subgroups  
(n  =  8  each)  matched  for  V̇O2peak  per  FFM  to  support  the  primary  study’s  findings  for  the  entire  group    
(n  =  16  each)  (Lanzi  et  al.,  2014).  
3.3.5  Insulin  Responsiveness  
In  14  studies,  fasting  plasma  insulin  concentration  was  used  to  infer  insulin  responsiveness  
(Ardevol  et  al.,  1998;;  Colberg  et  al.,  1996;;  Devries  et  al.,  2013;;  Ezell  et  al.,  1999;;  Goodpaster  et  al.,  2002;;  
Horowitz  &  Klein,  2000;;  Kanaley  et  al.,  1993;;  Lanzi  et  al.,  2014;;  Larsen  et  al.,  2009;;  Melanson  et  al.,  
2009;;  Mittendorfer  et  al.,  2004;;  Perez-­Martin  et  al.,  2001;;  Slusher  et  al.,  2015;;  Thyfault  et  al.,  2004).  In  all  
but  two  cases  where  no  difference  was  detected  between  groups  (Melanson  et  al.,  2009;;  Mittendorfer  et  
al.,  2004),  the  obese  group  possessed  a  higher  value  suggesting  lower  insulin  sensitivity  (IS).  
Furthermore,  in  six  studies,  insulin  responsiveness  was  assessed  using  HOMA-­IR  either  exclusively  
(Chatzinikolaou  et  al.,  2008)  or  in  addition  to  fasting  plasma  insulin  concentration  (Devries  et  al.,  2013;;  
Lanzi  et  al.,  2014;;  Larsen  et  al.,  2009,  Slusher  et  al.,  2015;;  Thyfault  et  al.,  2004.  In  these  six  studies,  
HOMA-­IR  confirmed  lower  IS  in  the  overweight/obese  group  in  all  but  two  cases  (Chatzinikolaou  et  al.,  
2008;;  Larsen  et  al.,  2009).  Conversely,  in  nine  studies,  no  assessment  of  insulin  responsiveness  was  
reported  (Balcı,  2012;;  Grams  et  al.,  2017;;  Hickner  et  al.,  2001;;  Kanaley  et  al.,  2001;;  Keim  et  al.,  1996;;    
Mohebbi  &  Azizi,  2011;;  Santiworakul  et  al.,  2014;;  Steffan  et  al.,  1999;;  Wong  &  Harber,  2006).    
3.3.6  Menstrual  Phase  
Four  of  the  15  studies  that  included  females  as  subjects  involved  control  of  the  subject’s  





all  four  cases,  the  researchers  chose  to  test  during  the  follicular  phase  with  three  providing  more  detail;;  
for  example,  days  1–14  (Horowitz  &  Klein,  2000),  days  3–9  (Kanaley  et  al.,  2001),  or  days  6–11  (Ezell  et  
al.,  1999).      
3.3.7  Diet  
In  14  studies,  participants  performed  exercise  in  the  fasted  state  with  no  longer-­term  dietary  
control  (Ardevol  et  al.,  1998;;  Balcı,  2012;;  Chatzinikolaou  et  al.,  2008;;  Devries  et  al,  2013;;  Grams  et  al.,  
2017;;  Hickner  et  al.,  2001;;  Keim  et  al.,  1996;;  Larsen  et  al.,  2009;;  Mohebbi  &  Azizi,  2011;;  Perez-­Martin  et  
al.,  2001;;  Slusher  et  al.,  2015;;  Steffan  et  al.,  1999;;  Thyfault  et  al.,  2004;;  Wong  &  Harber,  2006).  A  greater  
degree  of  short-­term  dietary  control  was  established  in  other  included  studies;;  for  example,  in  addition  to  
an  overnight  fast,  in  two  studies,  subjects  performed  exercise  after  a  standardized  meal  (Horowitz  &  
Klein,  2000)  or  meal  plus  snack  (Mittendorfer  et  al.,  2004)  the  evening  before,  while  in  three  others,  a  
standardized  breakfast  was  provided  prior  to  the  test  (Ezell  et  al.,  1999;;  Melanson  et  al.,  2009;;  
(Santiworakul  et  al.,  2014).  Finally,  in  seven  studies,  some  form  of  longer-­term  dietary  control  was  in  
place  prior  to  testing.  For  example,  subject-­specific  diets  were  prescribed  in  two  of  these  investigations;;  
specifically,  a  eucaloric  diet  with  set  macronutrient  proportions  for  3  (energy  content  based  on  3-­day  
recall)  (Ezell  et  al.,  1999)  or  4  (energy  content  estimated  based  on  FFM  with  activity  factor)  (Melanson  et  
al.,  2009)  days  plus  breakfast  prior  to  the  test.  The  other  five  studies  with  prolonged  dietary  control  
included  the  same  generic  diet  for  all  subjects;;  for  example,  a  “balanced  diet”  comprising  the  same  
macronutrient  and  energy  content  for  21  (obese  subjects)  or  4  (lean  subjects)  days  (Lanzi  et  al.,  2014)  or  
a  diet  containing  ≥200  g  of  carbohydrate  daily  for  3  days  (Colberg  ete  al.,  1996;;  Goodpaster  et  al.,  2002;;  
Kanaley  et  al.,  2001),  or  “at  least  two  weeks”  (Kanaley  et  al.,  1993)  prior  to  an  overnight  fast  before  
testing.  
With  respect  to  the  “fasted  state,”  it  was  defined  in  four  studies  in  a  general  manner  as  the  
condition  during  the  morning  following  an  overnight  fast  (Ardevol  et  al.,  1998;;  Colberg  et  al.,  1996;;  
Goodpaster  et  al.,  2002;;  Horowitz  &  Klein,  2000),  while  in  other  cases,  a  specific  timeframe  was  provided;;  
for  example,  4  (Wong  &  Harber,  2006);;  4–6  (Steffan  et  al.,  1999);;  5–6  (evening  session)  (Mohebbi  &  
Azizi,  2011);;  8  (Hickner  et  al.,  2001;;  Slusher  et  al.,  2015);;  8–12  (morning  session)  (Mohebbi  &  Azizi,  





2013;;  Grams  et  al.,  2017;;  Kanaley  et  al.,  2001;;  Lanzi  et  al.,  2014;;  Perez-­Martin  et  al.,  2001;;  Thyfault  et  
al.,  2004);;  or  15  (Balcı,  2012))  hours.  In  two  other  studies,  the  “fasted”  (Chatzinikolaou  et  al.,  2008)  or  
“post-­absorptive”  (Keim  et  al.,  1996)  state  was  not  defined.  Finally,  in  the  three  studies  that  required  
exercise  to  be  performed  following  breakfast,  the  time  interspersed  was  60  (Melanson  et  al.,  2009),  90  
(Ezell  et  al.,  1999),  or  180  (Santiworakul  et  al.,  2014)  minutes.  
3.3.8  Criterion  Exercise  Challenge  
3.3.8.1  Exercise  Mode  
Table  3.1  presents  the  characteristics  of  the  criterion  exercise  bout(s)  that  was/were  used  to  
assess  substrate  selectivity.  In  23  of  the  24  studies,  endurance  exercise  was  studied—specifically,  
conventional  leg  cycle  ergometry  (Ardevol  et  al.,  1998;;  Colberg  et  al.,  1996;;  Devries  et  al.,  2013;;  Ezell  et  
al.,  1999;;  Goodpaster  et  al.,  2002;;  Grams  et  al.,  2017;;  Hickner  et  al.,  2001;;  Kanaley  et  al.,  1993;;  Keim  et  
al.,  1996;;  Lanzi  et  al.,  2014;;  Larsen  et  al.,  2009;;  Melanson  et  al.,  2009;;  Perez-­Martin  et  al.,  2001;;  Thyfault  
et  al.,  2004;;  Wong  &  Harber,  2006);;  recumbent  cycling  (Horowitz  &  Klein,  2000;;  Mittendorfer  et  al.,  2004);;  
treadmill  exercise  (Balcı,  2012;;  Kanaley  et  al.,  2001;;  Mohebbi  &  Azizi,  2011;;  Slusher  et  al.,  2015;;  Steffan  
et  al.,  1999);;  vacuuming  (MET  level  >3;;  hence,  included)  (Grams  et  al.,  2017);;  floor  walking  (Grams  et  al.,  
2017);;  platform  stepping  (Grams  et  al.,  2017);;  or  mode  not  stated  (Santiworakul  et  al.,  2014).  In  one  of  
these  studies,  in  addition  to  leg  ergometry,  subjects  performed  arm  cranking  so  that  a  comparison  across  
different  modes  of  exercise  could  be  made  (Larsen  et  al.,  2009).  In  the  one  included  study  that  did  not  
involve  what  would  be  considered  endurance  exercise,  30  minutes  of  circuit  resistance  training  with  sets  
performed  intermittently  for  10-­12  repetitions  at  70-­75%  of  the  one-­repetition-­maximum  weight  was  used  
(Chatzinikolaou  et  al.,  2008).  
3.3.8.2  Exercise  Duration    
Thirteen  of  the  23  studies  that  involved  endurance  exercise  to  assess  substrate  selectivity  
required  one  testing  session  during  which  a  single  continuous  bout  at  a  fixed  work  rate  (i.e.,  constant-­
work-­rate  exercise;;  CWR)  was  performed  with  duration  set  at  30  (Kanaley  et  al.,  2001;;  Slusher  et  al.,  
2015;;  Wong  &  Harber,  2006);;  40  (Colberg  et  al.,  1996);;  60  (Devries  et  al.,  2013;;  Ezell  et  al.,  1999;;  
Goodpaster  et  al.,  2002;;  Melanson  et  al.,  2009;;  Thyfault  et  al.,  2004);;  90  (Horowitz  &  Klein,  2000;;  





energy  expenditure  would  reach  300  kilocalories  for  each  subject  (~30  and  ~28  minutes  for  lean  and  
obese  subjects,  respectively)  (Santiworakul  et  al.,  2014).  Another  study  also  involved  CWR  during  a  
single  exercise  session;;  however,  in  this  case,  two  10-­minute  bouts  at  different  work  rates  were  
performed  in  succession  (Hickner  et  al.,  2001).  Six  “activities  of  daily  living”  were  performed  in  succession  
with  2  minutes  of  recovery  between  in  another  study  (Grams  et  al.,  2017).  For  the  purpose  of  this  review,  
only  the  final  four  (vacuuming,  floor  walking,  platform  stepping  and  leg  cycling)  were  considered  
“exercise”  (MET  level  reported  as  >3)  and  they  were  performed  in  a  CWR  manner  for  12,  6,  12,  and  12  
minutes,  respectively  (Grams  et  al.,  2017).  In  two  other  studies,  subjects  were  required  to  perform  two  
CWR  bouts  on  separate  days  with  duration  set  at  15  (Steffan  et  al.,  1999)  or  45  (Balcı,  2012)  minutes.  In  
these  two  studies,  substrate  selectivity  was  also  assessed  during  a  third  testing  session  using  an  
incremental  “Bruce  protocol”  (3-­minute  stages  performed  in  succession)  that  was  “open  ended”  (i.e.,  
continued  until  termination  criteria  were  achieved;;  specifically,  heart  rate  of  220  minus  age,  ventilatory  
equivalent  for  O2  “close  to  30  l∙min-­1”  and  RER  >1.15  (Balcı,  2012)  or  at  least  two  of  the  following:  a  
plateau  in  V̇O2,  RER  ≥1.1,  rating  of  perceived  exertion  ≥18  and/or  “volitional  fatigue”  (Steffan  et  al.,  1999).  
Incremental  protocols  were  used  exclusively  in  the  other  six  investigations  that  involved  endurance  
exercise;;  however,  in  two  of  these  studies,  close-­ended  paradigms  were  employed.  Specifically,  one  
study  required  subjects  to  perform  four  6-­minute  bouts  in  succession  (Perez-­Martin  et  al.,  2001)  while  
another  involved  four  (women)  or  five  (men)  5-­minute  bouts  performed  intermittently  with  5  minutes  of  rest  
interspersed  (Keim  et  al.,  1996).  The  other  four  investigations    involved  open-­ended  tests  with  two  
utilizing  3-­minute  stages  until  an  RER  of  1.0  (Mohebbi  &  Azizi,  2011)  or  limit  of  tolerance  (Ardevol  et  al.,  
1998)  was  reached,  and  another  comprising  6-­minute  stages  performed  until  a  criterion  RER  (>1.0)  or  
power  output  (>65%  of  the  previously-­determined  peak)  was  achieved  (Lanzi  et  al.,  2014).  The  fourth  
investigation  that  involved  the  assessment  of  substrate  selectivity  during  open-­ended  incremental  testing  
included  both  a  leg  and  arm  protocol  performed  until  limit  of  tolerance  on  separate  days.  For  the  leg  test,  
stage  length  was  set  at  5  minutes  until  an  RER  of  1.0  was  achieved,  after  which  2-­minute  stages  were  
employed  (Larsen  et  al.,  2009).  For  the  arm  test,  three  6-­minute  stages  were  completed  and  a  5-­minute  






3.3.8.3  Exercise  Intensity  
In  14  of  the  17  studies  that  included  assessment  of  substrate  use  during  CWR  (see  above),  work  
rate  was  calculated  relative  to  the  V̇O2peak/max  achieved  during  a  maximal  incremental  test;;  for  example,  
40%  (Colberg  et  al.,  1996);;  45%  (Kanaley  et  al.,  1993);;  50%  (Devries  et  al.,  2013;;  Grams  et  al.,  2017;;  
Goodpaster  et  al.,  2002;;  Horowitz  &  Klein,  2000;;  Mittendorfer  et  al.,  2004;;  Steffan  et  al.,  1999;;  Thyfault  et  
al.,  2004);;  55%  (Melanson  et  al.,  2009);;  60–65%  (Ezell  et  al.,  1999);;  65%  (Hickner  et  al.,  2001);;  70%  
(Kanaley  et  al.,  2001);;  or  75%  (Slusher  et  al.,  2015;;  Steffan  et  al.,  1999).  In  one  of  these  studies,  a  two-­
bout  series  was  performed  with  the  first-­bout  work  rate  set  at  the  same  absolute  power  output  (15  W)  for  
all  subjects  instead  (Hickner  et  al.,  2001).  In  one  of  the  other  three  CWR  studies,  walking  and  running  
bouts  were  performed  at  1.0  km·hr-­1  below  and  above  the  preferred  walk/run  transition  speed  (Balcı,  
2012),  while  in  another,  vacuuming,  floor  walking  and  platform  stepping  were  regulated  by  subjects  at  
their  “usual  pace”  (Grams  et  al.,  2017).  In  the  other  two  investigations,  the  imposed  work  rate  was  that  
which  was  aligned  with  the  “ventilatory  threshold”  estimated  by  assessing  the  V̇CO2/V̇O2  relationship    
(“V-­slope  method”)  (Santiworakul  et  al.,  2014)  or  ventilatory-­equivalent-­for-­CO2  response  (Wong  &  
Harber,  2006)  during  an  initial  incremental-­exercise  test.    
A  number  of  different  intensity-­loading  paradigms  were  used  in  the  eight  included  studies  that  
assessed  substrate  utilization  during  incremental  exercise.  In  six  studies,  work-­rate  increments  were  
prescribed  in  the  same  absolute  terms  for  all  subjects.  For  example,  in  two  studies  that  used  treadmill  
exercise,  the  modified  Bruce  Protocol,  which  starts  at  2.7  km·hr-­1  with  0%  (Balcı,  2012)  or  5%  (Steffan  et  
al.,  1999)  grade  and  progresses  to  2.7  km·hr-­1/10%  grade  with  grade  increases  of  2%  per  stage  thereafter  
(stage  speeds  at  4.0,  5.5,  6.8,  8.1,  8.9,  9.7,  10.5,  11.3  and  12.1  km·hr-­1),  was  used.  In  another  treadmill  
study,  substrate  oxidation  was  assessed  at  3.5  km·hr-­1/1%  grade,  followed  by  speed  increases  of  1.0  
km·hr-­1  for  four  stages  and  grade  increases  of  2%  thereafter  (Mohebbi  &  Azizi,  2011).  For  three  other  
studies,  stages  at  the  same  absolute  work  rate  were  performed  during  cycle  ergometry—specifically,  0-­W  
leg  cycling  followed  by  30-­W  work-­rate  increments  (Ardevol  et  al.,  1998;;  Keim  et  al.,  1996)  or  exercise  at  
95  or  20  W  followed  by  work-­rate  increments  of  35  or  15  W  for  leg  and  arm  cycling,  respectively  (Larsen  
et  al.,  2009).  Conversely,  the  other  two  of  the  eight  studies  that  included  incremental  exercise  involved  





cycled  at  20%  of  their  peak  work  rate  measured  previously  on  an  incremental  test  followed  by  work-­rate  
increments  of  7.5%  per  stage  (Lanzi  et  al.,  2014),  while  in  the  other,  the  subject’s  initial  work  rate  was  set  
at  20%  of  their  estimated  peak  work  rate  with  four  subsequent  increases  of  10%  per  stage  (Perez-­Martin  
et  al.,  2001).      
3.3.9  The  Effect  of  Overweight/Obesity  on  Exercise  Lipid  Use  
Table  3.2  presents  the  findings  regarding  exercise  lipid  use  for  the  included  studies  and  the  
outcome  measure(s)  that  was/were  cited  to  draw  the  conclusions.  Thirteen  of  the  24  studies  provided  no  
evidence  that  the  null  hypothesis  regarding  the  capacity  for  exercise  lipid  use  in  overweight/obese  
compared  to  normal-­weight  subjects  should  be  rejected  (Ardevol  et  al.,  1998;;  Balcı,  2012;;  Colberg  et  al.,  
1996;;  Devries  et  al.,  2013;;  Ezell  et  al.,  1999;;  Kanaley  et  al.,  1993;;  Melanson  et  al.,  2009;;  Mittendorfer  et  
al.,  2004;;  Santiworakul  et  al.,  2014;;  Slusher  et  al.,  2015;;  Steffan  et  al.,  1999;;  Thyfault  et  al.,  2004;;  Wong  
&  Harber,  2006).  Outcome  measures  used  to  support  this  conclusion  were:  (a)  RQ/RER  (Ardevol  et  al.,  
1998;;  Colberg  et  al.,  1996;;  Devries  et  al.,  2013;;  Ezell  et  al.,  1999;;  Melanson  et  al.,  2009;;  Steffan  et  al.,  
1999;;  Thyfault  et  al.,  2004;;  Wong  &  Harber,  2006);;  (b)  total  lipid  oxidation  in  absolute  terms  (Ezell  et  al.,  
1999;;  Kanaley  et  al.,  1993),  relative  to  BM  (Ezell  et  al.,  1999)  and  FFM  (Ezell  et  al.,  1999),  in  kilocalories  
(Santiworakul  et  al.,  2014)  and/or  as  a  percentage  of  total  energy  expenditure  (Colberg  et  al.,  1996;;  
Santiworakul  et  al.,  2014);;  (c)  lipid  oxidation  rate  in  absolute  terms  (Balcı,  2012;;  J.  A.  Kanaley  et  al.,  
1993;;  Slusher  et  al.,  2015)  or  relative  to  BM  (Colberg  et  al.,  1996;;  Devries  et  al.,  2013;;  Thyfault  et  al.,  
2004)  and/or  FFM  (Devries  et  al.,  2013;;  Mittendorfer  et  al.,  2004);;  and  (d)  maximal  lipid  oxidation  rate  in  
absolute  terms  (Balcı,  2012),  relative  to  FFM  (Balcı,  2012)  or  as  an  RER  (Balcı,  2012),  heart  rate  (Balcı,  
2012),  V̇O2  relative  to  BM  (Balcı,  2012)  and/or  percentage  of  V̇O2max  (Balcı,  2012).    
This  conclusion  was  drawn  from  four  of  the  nine  studies  on  men  exclusively  (Balcı,  2012;;  
(Mittendorfer  et  al.,  2004;;  Santiworakul  et  al.,  2014;;  Wong  &  Harber,  2006),  six  of  the  nine  on  women  
exclusively  (Ardevol  et  al.,  1998;;  Devries  et  al.,  2013;;  Ezell  et  al.,  1999;;  Kanaley  et  al.,  1993;;  Steffan  et  
al.,  1999;;  Thyfault  et  al.,  2004)  and  three  of  the  six  on  a  mixed  group  (Colberg  et  al.,  1996;;  Melanson  et  
al.,  2009;;  Slusher  et  al.,  2015).  The  conclusion  was  supported  by  12  of  the  17  studies  that  involved  CWR  
endurance  exercise  (Balcı,  2012;;  Colberg  et  al.,  1996;;  Devries  et  al.,  2013;;  Ezell  et  al.,  1999;;  Kanaley  et  





Steffan  et  al.,  1999;;  Thyfault  et  al.,  2004;;  Wong  &  Harber,  2006),  and  three  of  the  eight  for  which  
incremental  endurance  exercise  was  assessed  (Ardevol  et  al.,  1998;;  Balcı,  2012;;  Steffan  et  al.,  1999).  
With  respect  to  mode,  the  conclusion  was  supported  by  9  of  17  studies  that  involved  leg  cycling  (Ardevol  
et  al.,  1998;;  Colberg  et  al.,  1996;;  Devries  et  al.,  2013;;  Ezell  et  al.,  1999;;  Kanaley  et  al.,  1993;;  Melanson  et  
al.,  2009;;  Mittendorfer  et  al.,  2004;;  Thyfault  et  al.,  2004;;  Wong  &  Harber,  2006),  three  of  five  that  involved  
treadmill  exercise  (Balcı,  2012;;  Slusher  et  al.,  2015;;  Steffan  et  al.,  1999)  and  one  study  for  which  the  
mode  was  not  stated  (Santiworakul  et  al.,  2014).  
Seven  of  the  24  studies  included  a  report  of  a  reduced  capacity  for  lipid  oxidation  in  
overweight/obese  compared  to  normal-­weight  subjects  for  some  (Grams  et  al.,  2017;;  Hickner  et  al.,  2001;;  
Keim  et  al.,  1996;;  Lanzi  et  al.,  2014;;  Mohebbi  &  Azizi,  2011)  or  all  (Chatzinikolaou  et  al.,  2008;;  Perez-­
Martin  et  al.,  2001)  of  the  outcome  measures,  subject  populations  and/or  modes  that  were  assessed.  
Outcome  measures  used  to  support  this  conclusion  were:  (a)  RER  (Chatzinikolaou  et  al.,  2008;;  Hickner  
et  al.,  2001;;  Keim  et  al.,  1996;;  Perez-­Martin  et  al.,  2001);;  (b)  total  lipid  oxidation  as  a  percentage  of  total  
energy  expenditure  (Grams  et  al.,  2017);;  (c)  lipid  oxidation  rate  in  absolute  terms  (Grams  et  al.,  2017;;  
(Hickner  et  al.,  2001;;  Lanzi  et  al.,  2014;;  Perez-­Martin  et  al.,  2001)  and/or  relative  to  FFM  (Hickner  et  al.,  
2001;;  Keim  et  al.,  1996;;  Lanzi  et  al.,  2014;;  Mohebbi  &  Azizi,  2011;;  Perez-­Martin  et  al.,  2001);;  (d)  maximal  
lipid  oxidation  rate  expressed  as  a  power  output  (Perez-­Martin  et  al.,  2001),  percentage  of  V̇O2peak/max  
(Lanzi  et  al.,  2014;;  Mohebbi  &  Azizi,  2011),  WRmax  (Lanzi  et  al.,  2014)  or  HRmax  (Lanzi  et  al.,  2014)  and/or  
as  a  zone  (Lanzi  et  al.,  2014);;  and  (e)  crossover  point  in  absolute  and  relative  terms  as  a  work  rate  and  
percentage  of  WRmax,  respectively  (Perez-­Martin  et  al.,  2001).  
This  conclusion  was  drawn  from  three  of  the  nine  studies  on  men  exclusively  (Chatzinikolaou  et  
al.,  2008;;  Lanzi  et  al.,  2014;;  Mohebbi  &  Azizi,  2011),  one  of  the  nine  on  women  exclusively  (Hickner  et  al.,  
2001),  and  three  of  the  six  on  a  mixed  group  (Grams  et  al.,  2017;;  Keim  et  al.,  1996;;  Perez-­Martin  et  al.,  
2001).  The  conclusion  was  supported  by  two  of  the  17  studies  that  involved  CWR  endurance  exercise  
(Grams  et  al.,  2017;;  Hickner  et  al.,  2001)  and  four  of  the  eight  that  assessed  incremental  endurance  
exercise  (Keim  et  al.,  1996;;  Lanzi  et  al.,  2014;;  Mohebbi  &  Azizi,  2011;;  Perez-­Martin  et  al.,  2001).  With  
respect  to  mode,  the  conclusion  was  supported  by  four  of  17  studies  that  involved  leg  cycling  (Hickner  et  





treadmill  exercise  (Mohebbi  &  Azizi,  2011)  and  the  single  studies  that  involved  resistance  training  
(Chatzinikolaou  et  al.,  2008)  and  activities  of  daily  living  (Grams  et  al.,  2017).  Finally,  two  studies  
indicated  subject-­population  specificity  for  drawing  this  conclusion  as  a  reduced  capacity  for  lipid  
oxidation  with  overweight/obesity  was  present  for  female,  but  not  male  subjects  (Keim  et  al.,  1996)  and  
for  female  subjects  when  compared  to  Caucasian,  but  not  African  American  normal-­weight  controls  
(Hickner  et  al.,  2001).      
Five  of  the  23  studies  included  a  report  of  an  increased  capacity  for  lipid  oxidation  in  
overweight/obese  compared  to  normal-­weight  subjects  for  some  (Goodpaster  et  al.,  2002;;  Kanaley  et  al.,  
2001;;  Lanzi  et  al.,  2014;;  Larsen  et  al.,  2009)  or  all  (Horowitz  &  Klein,  2000)  of  the  outcome  measures  
and/or  subject  populations  that  were  assessed.  Outcome  measures  used  to  support  this  conclusion  were:  
(a)  RER  (Goodpaster  et  al.,  2002;;  Kanaley  et  al.,  2001;;  Lanzi  et  al.,  2014);;  (b)  lipid  energy  expenditure  as  
a  percentage  of  total  energy  expenditure  (Goodpaster  et  al.,  2002;;  Horowitz  &  Klein,  2000);;  (c)  lipid  
oxidation  rate  in  absolute  terms  (Lanzi  et  al.,  2014)  and/or  relative  to  FFM  (Horowitz  &  Klein,  2000;;  
Kanaley  et  al.,  2001;;  Lanzi  et  al.,  2014);;  and  (d)  maximal  lipid  oxidation  rate  as  a  percentage  of  
V̇O2peak/max  (Larsen  et  al.,  2009)  and  as  an  RER  (Lanzi  et  al.,  2014).    
This  conclusion  was  drawn  from  three  of  the  nine  studies  on  men  exclusively  (Goodpaster  et  al.,  
2002;;  Lanzi  et  al.,  2014;;  Larsen  et  al.,  2009)  and  two  of  the  nine  on  women  exclusively  (Horowitz  &  Klein,  
2000;;  Kanaley  et  al.,  2001).  The  conclusion  was  supported  by  three  of  the  17  studies  that  involved  CWR  
endurance  exercise  (Goodpaster  et  al.,  2002;;  Horowitz  &  Klein,  2000;;  Kanaley  et  al.,  2001)  and  two  of  the  
eight  for  which  incremental  endurance  exercise  was  assessed  (Lanzi  et  al.,  2014;;  Larsen  et  al.,  2009).  
With  respect  to  mode,  the  conclusion  was  supported  by  three  of  17  studies  that  involved  leg  cycling  
(Goodpaster  et  al.,  2002;;  Horowitz  &  Klein,  2000;;  Lanzi  et  al.,  2014),  one  of  five  that  involved  treadmill  
exercise  (Kanaley  et  al.,  2001)  and  the  only  study  that  involved  arm  cranking  (Larsen  et  al.,  2009).    
Eight  of  the  24  included  studies  returned  equivocal  findings  based  on  multiple  outcome  
measures,  subject  populations  and/or  exercise  characteristics  that  were  included  for  assessment  
(Goodpaster  et  al.,  2002;;  Grams  et  al.,  2017;;  Hickner  et  al.,  2001;;  Kanaley  et  al.,  2001;;  Keim  et  al.,  1996;;  
Lanzi  et  al.,  2014;;  Larsen  et  al.,  2009;;  Mohebbi  &  Azizi,  2011)  (see  Table  3.2).  Seven  of  the  17  studies  





can  influence  whether  the  null  hypothesis  regarding  the  comparison  of  exercise  lipid  use  for  
overweight/obese  compared  to  normal-­weight  subjects  should  be  accepted  or  rejected  (Goodpaster  et  al.,  
2002;;  Grams  et  al.,  2017;;  Hickner  et  al.,  2001;;  Kanaley  et  al.,  2001;;  Lanzi  et  al.,  2014;;  Larsen  et  al.,  
2009;;  Mohebbi  &  Azizi,  2011).  Interestingly,  two  of  three  studies  that  included  a  report  of  sex-­specific  
results  confirmed  that  an  overweight/obesity-­related  decrement  was  present  for  male,  but  not  female  
subjects  (Grams  et  al.,  2017;;  Keim  et  al.,  1996;;  cf.  Perez-­Martin  et  al.,  2001)  and  a  similar  disparity  was  
identified  for  African  American  compared  to  Caucasian  women  in  the  only  study  to  provide  comparisons  
based  on  race  (Hickner  et  al.,  2001).  Furthermore,  findings  from  one  of  two  studies  that  included  two  
distinct  groups  of  obese  subjects  based  on  fat-­deposition  pattern  suggested  that  this  factor  can  influence  
the  conclusion  at  least  based  on  one  of  two  outcome  measures  that  was  reported  (Kanaley  et  al.,  2001;;  
cf.  Kanaley  et  al.,  1993).  Finally,  findings  from  one  of  three  studies  that  included  assessment  of  lipid  
oxidation  at  different  time  points  during  CWR  exercise  (Kanaley  et  al.,  2001;;  cf.  Ezell  et  al.,  1999;;  
Goodpaster  et  al.,  2002);;  four  of  nine  that  included  assessment  at  different  exercise  intensities/work  rates  
(Hickner  et  al.,  2001;;  Keim  et  al.,  1996;;  Lanzi  et  al.,  2014;;  Mohebbi  &  Azizi,  2011;;  cf.  Ardevol  et  al.,  1998;;  
Balcı,  2012;;  Larsen  et  al.,  2009;;  Perez-­Martin  et  al.,  2001;;  Steffan  et  al.,  1999);;  and  both  studies  that  
included  assessment  of  different  exercise  modes  (Grams  et  al.,  2017;;  Larsen  et  al.,  2009)  showed  that  
each  of  these  characteristics  of  the  exercise  session  can  exert  an  influence  that  affects  the  conclusion  
that  is  drawn.  
3.4  Quality  Assessment  of  Included  Studies  
The  quality-­assessment  scores  of  the  included  studies  are  provided  in  Tables  3.3  and  3.4.  The  
mean  ±  SD  score  for  general  methodological  quality  was  1.51  ±  0.14  (median,  1.46;;  range:  1.29–1.79)  
while  our  custom-­designed  tool  revealed  an  average  score  of  0.93  ±  0.27  (median,  0.83;;  range:  0.58–
1.42)  for  the  degree  to  which  important  factors  that  can  affect  exercise  lipid  utilization,  regardless  of  body  
fatness  were  adequately  controlled.  
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Table  3.2  (continued)  
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3.5.1  Lipid  Reliance  During  Exercise  for  Overweight/Obese  and  Normal-­weight  Individuals  
This  purpose  of  this  systematic  review  was  to  form  a  consensus  opinion  regarding  the  degree  to  
which  overweight/obese  individuals  rely  on  lipid  as  fuel  during  exercise  compared  to  normal-­weight  
counterparts.  After  reviewing  the  literature,  we  found  that  some  or  all  relevant  outcome  measures  cited  in  
21  of  the  24  included  studies  indicate  that  the  null  hypothesis  regarding  an  influence  of  obesity  on  
exercise  lipid  use  cannot  be  rejected  (Table  3.1).  This  means  that  the  preponderance  of  evidence  
suggests  that  obese  and  non-­obese  subjects  rely  on  lipid  to  a  similar  extent  during  exercise.  However,  
eight  of  these  21  studies  also  include  report  of  a  significant  difference  in  exercise  lipid  use  for  
overweight/obese  compared  to  normal-­weight  subjects  based  on  other  exercise  characteristics  (e.g.,  
mode,  duration,  intensity  and  work  rate),  subject  factors  (e.g.,  sex,  race  and  fat-­deposition  pattern)  and/or  
outcome  measures  included  in  for  assessment  (Table  3.22).  Furthermore,  numerous  factors  should  be  
controlled  to  validly  test  this  hypothesis  and  our  quality-­assessment  tool,  which  was  specifically  designed  
to  measure  how  well  these  variables  were  accounted  for,  revealed  low  ratings  for  many  of  the  included  
studies  (Table  3.4).  Collectively,  these  findings  suggest  that  more  research  is  required  to  clarify  what  is,  in  
all  likelihood,  a  multifactorial  complex  influence  of  overweight/obesity  on  exercise  metabolism.    
3.5.2  Subject  Characteristics  that  Might  Influence  Exercise  Lipid  Use  Irrespective  of  Body  Fatness  
3.5.2.1  Sex  
Six  of  the  24  included  studies  assessed  both  male  and  female  subjects;;  however,  only  three  
controlled  for  the  potential  influence  of  sex  by  reporting  results  for  male  and  female  subjects  separately.  
All  three  provide  evidence  that  male  obese  subjects  oxidize  lipid  less  effectively  during  exercise  
compared  to  normal-­weight  counterparts  (Grams  et  al.,  2017;;  Keim  et  al.,  1996;;  Perez-­Martin  et  al.,  
2001),  while  two  of  the  three  studies  suggest  that  this  is  not  the  case  for  female  subjects.  Specifically,  
Keim  et  al.  (1996)  found  an  obesity-­related  reduction  in  lipid-­oxidation  rate  when  cycling  at  40,  50,  and  
60%  V̇O2max  that  was  exclusive  to  male  subjects,  while  Grams  et  al.  (2017)  reported  that  male  obese  
subjects  satisfied  energy  expenditure  during  physical  activities  of  daily  living  and  leg  cycling  with  a  lower  
contribution  from  lipid  compared  to  normal-­weight  counterparts.  Conversely,  obesity-­related  decrements  





2017).  Collectively,  these  findings  suggest  that  males  might  be  more  susceptible  to  an  obesity-­related  
decline  in  exercise  lipid  use,  which  resonates  because  sexual  dimorphism  with  regard  to  exercise  
metabolism  has  been  confirmed  for  normal-­weight  individuals.  Specifically,  a  number  of  studies  indicate  
that  females  rely  more  on  lipid  during  exercise  at  a  given  percentage  of  V̇O2max/peak  compared  to  males  
(Blatchford,  Knowlton,  &  Schneider,  1985;;  Carter,  Rennie,  &  Tarnopolsky,  2001;;  Froberg  &  Pedersen,  
1984;;  Horton,  Pagliassotti,  Hobbs,  &  Hill,  1998;;  Tarnopolsky,  MacDougall,  Atkinson,  Tarnopolsky,  &  
Sutton,  1990).  The  reason(s)  for  this  enhanced  capacity  is/are  unclear,  but  might  relate  to  increased    
β-­  (Horton  et  al.,  1998)  and/or  decreased  α-­adrenergic  (Hellström,  Blaak,  &  Hagström-­Toft,  1996;;  
Mittendorfer,  Horowitz,  &  Klein,  2002)  activity  resulting  in  greater  FFA  circulation/uptake  (Blatchford  et  al.,  
1985;;  Mittendorfer  et  al.,  2002),  greater  uptake  of  a  given  level  of  circulating  FFA  (Tarnopolsky  et  al.,  
1990),  and/or  greater  storage/utilisation  of  IMTG  (Tarnopolsky  et  al.,  1990).  Regardless  of  this  distinction,  
however,  a  greater  capacity  for  exercise  lipid  use  for  females  raises  the  possibility  that  females  possess  
inherent  characteristics  that  allow  them  to  fend  off  a  decline  in  the  ability  to  oxidize  lipid  that  accompanies  
overweight/obesity.  In  support  of  this  contention,  findings  from  eight  of  the  nine  included  studies  that  
assessed  females  exclusively  suggest  an  unchanged  (Ardevol  et  al.,  1998;;  Devries  et  al.,  2013;;  Ezell  et  
al.,  1999;;  Kanaley  et  al.,  1993;;  Steffan  et  al.,  1999;;  Thyfault  et  al.,  2004)  or  enhanced  (Horowitz  &  Klein,  
2000;;  Kanaley  et  al.,  2001)  capacity  for  exercise  lipid  use  in  the  overweight/obese  compared  to  normal-­
weight  group.  However,  for  the  nine  included  studies  that  assessed  males  exclusively,  only  three  found  
evidence  that  lipid  use  was  reduced  with  obesity  (Chatzinikolaou  et  al.,  2008;;  Lanzi  et  al.,  2014;;  Mohebbi  
&  Azizi,  2011),  and  other  subject  characteristics  could  influence  exercise  fuel  use  irrespective  of  body  
fatness  and  sex  (e.g.,  race,  fat-­deposition  pattern,  IS  and,  for  female  subjects,  phase  of  menstrual  cycle)  
that  were  not  controlled  in  the  aforementioned  two  studies.  To  clarify  ambiguity  regarding  the  influence  of  
sex  on  exercise  fuel  use  with  overweight/obesity,  future  research  should  include  both  male  and  female  
subjects  with  results  determined  according  to  sex.  
3.5.2.2  Race  
Research  suggests  that  African  Americans  demonstrate  a  reduced  capacity  for  lipid  oxidation  at  
rest  (Chitwood,  Brown,  Lundy,  &  Dupper,  1996;;  Weyer,  Snitker,  Bogardus,  &  Ravussin,  1999),  during  





Sunyer,  &  Albu,  2006).  However,  only  one  included  study  controlled  for  the  potential  influence  of  race  
when  comparing  exercise  lipid  use  for  overweight/obese  compared  to  normal-­weight  subjects.  
Importantly,  Hickner  et  al.  (2001)  found  a  higher  RER  and  lower  rate  of  lipid  oxidation  for  obese  African  
American  and  Caucasian  women  when  cycling  at  15  W;;  however,  this  was  only  the  case  when  lean  
Caucasian  women  represented  the  control  subjects.  Conversely,  an  ~30%  lower  rate  of  lipid  oxidation  
demonstrated  by  lean  African  American  compared  to  Caucasian  women  during  the  cycling  bout  was  
quantitatively  similar  to  that  observed  in  obese  subjects  of  both  races  (Hickner  et  al.,  2001).  The  
reason(s)  for  a  reduced  capacity  for  lipid  oxidation  in  African  American  subjects  is/are  unclear,  but  might  
relate  to  reduced  IS  and  mitochondrial  capacity  (DeLany  et  al.,  2014)  and/or  a  lower  proportion  of  type  I  
muscle  fibers  along  with  greater  activity  of  “anaerobic”  metabolic  enzymes  (Ama  et  al.,  1986).  Regardless  
of  this  distinction,  however,  an  “obesity-­like”  decrement  in  exercise  lipid  use  for  normal-­weight  African  
American  subjects  suggests  that  races  should  be  studied  separately  in  future  research  investigating  the  
influence  of  body  fatness  on  exercise  metabolism.    
3.5.2.3  Fat-­free  Mass  
If  a  comparison  of  the  capacity  for  lipid  use  is  made  using  an  absolute  measurement  (e.g.,  lipid  
oxidation  rate  in  g∙min-­1  or  µmol∙min-­1  and/or  total  lipid  oxidation  in  grams,  µmol  or  kilocalories),  it  is  
important  to  express  the  value  relative  to  the  subject’s  FFM  because  it  will  be  influenced  by  the  amount  of  
metabolically-­active  tissue  they  possess  (Goodpaster  et  al.,  2002).  Conversely,  if  relative  measurements  
(e.g.,  RER  or  lipid  use  as  a  percentage  of  total  energy  expenditure)  are  cited,  no  adjustment  is  required.  
In  19  of  the  24  included  studies,  absolute  measurements  were  recognized  as  some  (Balcı,  2012;;  Colberg  
et  al.,  1996;;  Devries  et  al.,  2013;;  Ezell  et  al.,  1999;;  Goodpaster  et  al.,  2002;;  Grams  et  al.,  2017;;  Hickner  
et  al.,  2001;;  Kanaley  et  al.,  2001;;  Keim  et  al.,  1996;;  Lanzi  et  al.,  2014;;  Perez-­Martin  et  al.,  2001;;  
Santiworakul  et  al.,  2014;;  Thyfault  et  al.,  2004)  or  all  (Horowitz  &  Klein,  2000;;  Kanaley  et  al.,  1993;;  
Larsen  et  al.,  2009;;  Mittendorfer  et  al.,  2004;;  Mohebbi  &  Azizi,  2011;;  Slusher  et  al.,  2015)  outcome  
measures  and  in  eight  cases,  some  (Balcı,  2012;;  Grams  et  al.,  2017;;  Larsen  et  al.,  2009;;  Santiworakul  et  
al.,  2014)  or  all  (Colberg  et  al.,  1996;;  Kanaley  et  al.,  1993;;  Slusher  et  al.,  2015;;  Thyfault  et  al.,  2004)  were  
stated  with  no  adjustment  made  for  FFM.  Interestingly,  in  seven  of  these  eight  studies,  when  the  





measures,  no  difference  was  reported  (Balcı,  2012;;  Colberg  et  al.,  1996;;  Kanaley  et  al.,  1993;;  Larsen  et  
al.,  2009;;  Santiworakul  et  al.,  2014;;  Slusher  et  al.,  2015;;  Thyfault  et  al.,  2004).  Given  that  
overweight/obese  subjects  typically  possess  greater  FFM,  failure  to  express  an  absolute  measurement  of  
lipid  oxidation  relative  to  FFM  could  cause  a  type  II  error  by  masking  an  obesity-­related  decrement  that  
might  be  present.  However,  in  three  of  those  seven  studies,  relative  measures  were  also  reported  that  
indicated  similar  exercise  lipid  use  regardless  of  body  fatness  (Colberg  et  al.,  1996;;  Santiworakul  et  al.,  
2014;;  Thyfault  et  al.,  2004)  while  in  two  others,  support  was  provided  by  values  of  the  maximal  rate  of  
lipid  oxidation,  which  were  normalized  to  FFM  even  though  lipid  oxidation  rates  for  individual  stages  of  the  
test  were  not  (Balcı,  2012;;  Larsen  et  al.,  2009).  Alternatively,  for  the  11  studies  that  included  a  report  of  
total  lipid  oxidation  or  lipid  oxidation  rate  as  a  function  of  FFM,  only  four  suggest  no  difference  in  the  
adjusted  measurement  between  groups  (Devries  et  al.,  2013;;  Ezell  et  al.,  1999;;  Goodpaster  et  al.,  2002;;  
Mittendorfer  et  al.,  2004).  Conversely,  for  the  other  seven,  one  provides  conclusive  evidence  that  the  
FFM-­adjusted  rate  of  lipid  oxidation  is  reduced  for  overweight/obese  compared  to  normal-­weight  subjects  
(Perez-­Martin  et  al.,  2001),  and  four  others  suggest  that  it  can  be  the  case,  but  only  under  certain  
circumstances;;  for  example,  in  Caucasian,  but  not  African  Americans  (Hickner  et  al.,  2001);;  for  male,  but  
not  females  (Keim  et  al.,  1996);;  and  during  exercise  at  higher,  but  not  lower  intensities  (Lanzi  et  al.,  2014;;  
Mohebbi  &  Azizi,  2011).  Collectively,  these  observations  are  consistent  with  the  contention  that  neglecting  
the  need  to  normalize  an  absolute  measurement  of  lipid  oxidation  can  “mask”  a  deficiency  associated  
with  the  overweight/obese  condition.  Finally,  the  two  other  studies  that  included  a  report  of  lipid  oxidation  
rate  as  a  function  of  FFM  provide  evidence  that  the  adjusted  rate  is  greater  for  overweight/obese  subjects  
(Horowitz  &  Klein,  2000;;  Kanaley  et  al.,  2001)  if  sufficient  duration  for  the  increment  to  manifest  is  allowed  
(e.g.,  30,  but  not  15  minutes;;  Kanaley  et  al.,  2001).  Once  again,  this  ambiguity  likely  reflects  confounding  
effect(s)  of  other  variables  that  can  influence  exercise  lipid  use  irrespective  of  body  fatness  that  were  not  
controlled  in  these  investigations.  Nevertheless,  in  future  research,  the  authors  should  recognize  the  
influence  of  FFM  on  absolute  measurements  of  lipid  use  and  the  corresponding  need  to  control  for  this  







3.5.2.4  Aerobic  Fitness  
Endurance-­trained  individuals  demonstrate  an  enhanced  capacity  to  oxidize  lipid  during  exercise  
(Costill,  Fink,  Getchell,  Ivy,  &  Witzmann,  1979;;  Jansson  &  Kaijser,  1987)  and  longitudinal  studies  confirm  
a  decrease  in  carbohydrate  reliance  and  increase  in  lipid  use  during  endurance  exercise  at  the  same  
absolute  work  rate  after  chronic  endurance  training  (Martin  et  al.,  1993;;  Phillips  et  al.,  1996).  
Consequently,  it  has  been  suggested  that  to  properly  test  the  hypothesis  that  exercise  lipid  use  is  altered  
with  overweight/obesity,  lean  and  obese  subjects  must  be  matched  for  “aerobic  fitness”  (Goodpaster  et  
al.,  2002).  However,  only  seven  of  the  24  included  studies  made  mention  of  such  matching  and  all  used  
V̇O2peak/max  as  the  proxy  measure  (Devries  et  al.,  2013;;  Ezell  et  al.,  1999;;  Goodpaster  et  al.,  2002;;  
Horowitz  &  Klein,  2000;;  Kanaley  et  al.,  1993;;  Keim  et  al.,  1996;;  Mittendorfer  et  al.,  2004).  This  could  be  
problematic  because  the  aspect  of  aerobic  fitness  that  limits  the  rate  of  lipid  oxidation  is  likely  different  
than  that  which  limits  the  rate  of  O2  consumption.  Specifically,  the  capacity  to  oxidise  lipid  is  dictated  by  
peripheral  factors  (e.g.,  mitochondrial  mass  and  oxidative  enzyme  activity)  which  allow  a  particular  
metabolic  rate  to  be  sustained  with  minimal  perturbation  of  mitochondrial  phosphorylation  and  redox  
potentials  (Bassett  Jr  &  Howley,  2000).  Conversely,  V̇O2peak/max  is  generally  limited  by  convective  and/or  
diffusive  steps  along  the  O2-­transport  cascade  (Wagner,  2000).  Consequently,  it  is  not  surprising  that  
training-­related  changes  in  mitochondrial  capacity  and  V̇O2peak/max  can  be  dissociated  (Henriksson  &  
Reitman,  1977;;  Örlander,  Kiessling,  Karlsson,  &  Ekblom,  1977.  With  respect  to  lipid  oxidation,  this  has  
resonance  because  Ara  et  al.  (2011)  reported  a  peak  rate  of  lipid  oxidation  that  occurs  at  a  higher  work  
rate  relative  to  V̇O2peak/max  in  obese  and  post-­obese  compared  to  control  subjects  despite  similar  
V̇O2peak/max  values.  Collectively,  these  findings  suggest  that  the  aspect  of  aerobic  fitness  that  should  be  
matched  to  properly  assess  whether  lipid  use  is  altered  with  overweight/obesity  is  related  to  muscle  
metabolic  as  opposed  to  central  circulatory  capacity  and  a  parameter  that  reflects  this  capacity  is  the  
highest  metabolic  rate  that  can  be  sustained  without  perturbation  of  cellular  physophorylation  and  redox  
states  (i.e.,  the  metabolic  rate  at  the  “lactate  threshold”;;  V̇O2LT).  The  influence  of  differences  in  V̇O2LT  for  
subjects  matched  according  to  V̇O2peak/max  can  be  accounted  for  when  normalizing  exercise  intensity  
across  subjects  (see  below).  





3.5.2.5  Insulin  Sensitivity  
Excess  adiposity,  particularly  in  the  abdominal  region  (Carey,  Jenkins,  Campbell,  Freund,  &  
Chisholm,  1996),  is  often  accompanied  by  a  loss  of  IS,  which  means  that  the  capacity  for  insulin-­
mediated  glucose  uptake  by  skeletal  muscle  is  blunted.  While  this  IR  does  not  adversely  affect  
contraction-­mediated  glucose  uptake  (Goodyear  &  Kahn,  1998),  evidence  suggests  that  overweight/  
obese  IR  subjects  demonstrate  a  reduced  contribution  from  muscle  glycogen  and  increased  contribution  
from  lipids  during  exercise  compared  to  BMI-­matched  subjects  without  IR  (Braun  et  al.,  2004).  
Interestingly,  evolutionary  preservation  of  IR  has  been  suggested  to  reflect  its  ‘usefulness’  for  protecting  
survival  in  circumstances  where  glucose  sparing  takes  priority  (e.g.,  acute  trauma  and  prolonged  fasting)  
(Soeters  &  Soeters,  2012).  Collectively,  these  observations  raise  the  intriguing  possibility  that  exercise  
lipid  reliance  might  be  altered  with  IR  irrespective  of  body  fatness  and  if  this  is  the  case,  a  comparison  of  
exercise  lipid  use  between  overweight/obese  and  normal-­weight  subjects  could  be  confounded  by  the  
difference  in  IS  that  would  typically  be  present.  Interestingly,  12  of  the  15  included  studies  that  contained  
a  report  of  IS  found  a  lower  value  in  the  overweight/obese  group  (Ardevol  et  al.,  1998;;  Colberg  et  al.,  
1996;;  Devries  et  al.,  2013;;  Ezell  et  al.,  1999;;  Goodpaster  et  al.,  2002;;  Horowitz  &  Klein,  2000;;  Kanaley  et  
al.,  1993;;  Lanzi  et  al.,  2014;;  Larsen  et  al.,  2009;;  Perez-­Martin  et  al.,  2001;;  Slusher  et  al.,  2015;;  Thyfault  et  
al.,  2004);;  however,  no  attempt  was  made  to  control  for  IR  in  any  of  the  studies  assessed  in  this  review.  
Indeed,  only  one  included  mention  of  its  potential  influence  with  Goodpaster  et  al.  (2002)  reporting  that  
despite  relative  hyperinsulinemia,  fasting  insulin  levels  were  not  associated  with  exercise  fatty-­acid  
oxidation  for  the  obese  individuals  they  assessed.  This  implies  that  IR  was  not  responsible  for  the  higher  
proportional  contribution  of  lipid  to  exercise  energy  expenditure  they  found  for  these  subjects  (Goodpaster  
et  al.,  2002).  Nevertheless,  it  seems  reasonable  to  suggest  that  future  research  designed  to  determine  
how  exercise  lipid  use  is  influenced  by  overweight/obesity  should  include  matching  of  the  IS  status  of  the  
two  groups  (i.e.,  by  recruiting  normal-­weight  control  subjects  with  a  level  of  IR  that  matches  the  
overweight/obese  group  or  recruiting  overweight/obese  subjects  without  IR).  
3.5.2.6  Menstrual  Phase  
As  part  of  its  role  as  the  primary  female  sex  hormone,  estrogen  improves  numerous  aspects  of  





Hevener,  2013).  It  is,  therefore,  not  surprising  that  a  number  of  studies  confirm  increased  exercise  lipid  
use  during  the  luteal  phase  of  the  menstrual  cycle  when  circulating  estrogen  level  is  high  (Campbell,  
Angus,  &  Febbraio,  2001;;  Wenz,  Berend,  Lynch,  Chappell,  &  Hackney,  1997;;  Zderic,  Coggan,  &  Ruby,  
2001).  However,  only  four  of  the  nine  included  studies  that  assessed  female  subjects  exclusively  involved  
control  for  this  factor  and,  interestingly,  two  of  these  report  greater  exercise  lipid  use  for  overweight/obese  
compared  to  normal-­weight  subjects  (Horowitz  &  Klein,  2000;;  Kanaley  et  al.,  2001).  Importantly,  both  of  
these  assessed  females  during  the  follicular  phase  when  the  cyclical  increment  in  the  capacity  for  
exercise  lipid  use  would  be  absent  (Wenz  et  al.,  1997).  Conversely,  the  five  investigations  that  involved  
the  exclusive  study  of  women  without  controlling  for  their  menstrual  phase  provide  no  evidence  for  an  
overweight/obesity-­related  increment  (Ardevol  et  al.,  1998;;  Devries  et  al.,  2013;;  Hickner  et  al.,  2001;;  
Steffan  et  al.,  1999;;  Thyfault  et  al.,  2004).  One  possible  explanation  is  that  a  propensity  for  greater  
exercise  lipid  oxidation  associated  with  overweight/obesity  in  women  might  only  be  identifiable  when  the  
methodology  ensures  that  control  subjects  are  not  experiencing  their  cyclical  elevation.  Consequently,  
much  like  what  has  been  recommended  for  sex-­comparative  studies  (Devries,  Hamadeh,  Phillips,  &  
Tarnopolsky,  2006),  it  stands  to  reason  that  comparisons  of  exercise  metabolism  between  overweight/  
obese  and  normal-­weight  women  should  be  performed  in  both  phases  of  the  menstrual  cycle  to  elucidate  
the  effect  of  overweight/obesity  on  exercise  lipid  use  for  women  with  both  low  and  high  levels  of  
circulating  estrogen.  
3.5.2.7  Fat-­deposition  Pattern  
While  it  is  typical  to  refer  to  a  generic  influence  of  overweight/obesity  on  myriad  aspects  of  
physiology,  there  is  growing  appreciation  that  in  many  cases,  the  influence  can  be  markedly  different  
depending  upon  where  excess  fat  is  situated.  For  example,  greater  visceral  and  ectopic  deposition  and  a  
lower  percentage  localized  subcutaneously  in  the  gluteofemoral  region  are  patterns  associated  with  IR  
and  dyslipidemia  (Patel  &  Abate,  2013;;  Stefan,  Schick,  &  Häring,  2017).  This  distinction  resonates  with  
respect  to  exercise  fuel  use  because  a  key  factor  believed  to  underpin  the  disparity  is  the  degree  to  which  
lipolysis  is  stimulated  in  these  regions  by  circulating  epinephrine  (Jansson  &  Kaijser,  1987).  Interestingly,  
it  has  been  shown  that  normal-­weight  women  with  a  lower  abdominal-­to-­lower-­body  fat-­mass  ratio  





higher  proportion  of  fat  located  centrally  (Isacco,  Thivel,  Duclos,  Aucouturier,  &  Boisseau,  2014).  
Furthermore,  compared  to  normal-­weight  women  with  a  high  abdominal-­to-­lower-­body  fat-­mass  ratio,  
normal-­weight  women  with  a  lower  ratio  mobilize  and  oxidize  more  lipid  during  45  minutes  of  CWR  cycling  
at  65%  V̇O2max  in  association  with  differences  in  circulating  hormones  related  to  lipolysis  (e.g.,  growth  
hormone,  insulin  and  atrial  natriuretic  peptide)  (Isacco  et  al.,  2013).  Considering  these  findings,  fat-­
deposition  pattern  is  another  variable  that  could  confound  a  comparison  of  exercise  lipid  use  for  
overweight/obese  compared  to  normal-­weight  subjects.  However,  only  two  included  studies  were  
constructed  with  overweight/obese  subjects  classified  into  two  groups  according  to  fat-­deposition  pattern  
and  results  suggest  that  the  decrement  in  the  capacity  for  exercise  lipid  use  reported  for  normal-­weight  
women  with  upper-­  compared  to  lower-­body  adiposity  is  not  present  in  obese  subjects.  Specifically,  
despite  demonstrating  a  lower  increase  in  FFA  availability  compared  to  lower-­body  obese  and  non-­obese  
subjects  (Kanaley  et  al.,  1993),  upper-­body  obese  women  oxidized  a  similar  amount  of  lipid  during  150  
minutes  of  CWR  cycling  at  45%  V̇O2peak  (Kanaley  et  al.,  1993)  and  demonstrated  similar  RER  and  
average  lipid  oxidation  rate  during  30  minutes  of  CWR  cycling  at  70%  V̇O2peak  (Kanaley  et  al.,  2001).  
Collectively,  these  findings  suggest  that  obese  subjects  with  different  fat-­deposition  patterns  can  be  
grouped  together  when  comparing  exercise  fuel  use  with  normal-­weight  subjects.  However,  given  the  
aforementioned  findings  for  normal-­weight  subjects,  it  still  might  be  necessary  to  control  for  this  factor  to  
decrease  the  likelihood  of  type  II  error  by  reducing  the  variability  in  criterion  measurement  of  lipid  use  for  
subjects  in  the  control  group  against  which  overweight/obese  subjects  are  compared.      
3.5.2.8  Acute  and  “Long-­term”  Dietary  Habits  
It  is  well  established  that  a  subject’s  dietary  habits  influence  substrate  utilization.  For  example,  
Black,  Prentice,  and  Coward  (1986)  demonstrated  that  the  macronutrient  ratio  of  food  intake  (i.e.,  the  
“food  quotient”;;  FQ)  approximates  RQ  for  subjects  in  energy  balance  and  more  recently,  Miles-­Chan,  
Dulloo,  and  Schutz  (2015)  confirmed  that  the  principal  exogenous  factor  that  influences  post-­absorptive  
RQ  is  dietary  FQ.  Specifically,  these  authors  found  a  positive  relationship  between  percent  dietary  
carbohydrate  intake  and  post-­absorptive  RQ  under  both  normo-­  and  under-­/overfeeding  conditions  with  
an  average  increase  from  ~0.80  to  ~0.90  in  response  to  an  increase  in  carbohydrate  ingestion  from  30  to  





carbohydrate  (Gregory  et  al.,  2011)  or  fat  (Helge  et  al.,  2001)  content  of  the  diet  in  this  manner  also  
influences  RQ  during  exercise,  which  implies  that  a  controlled  feeding  period  should  be  imposed  prior  to  
assessing  exercise  lipid  use.  However,  unlike  carbohydrate  oxidation,  which  adapts  rapidly  in  response  to  
changes  in  carbohydrate  intake  (Abbott  et  al.,  1988;;  Acheson  et  al.,  1984),  lipid  oxidation  responds  slowly  
when  a  high-­fat  diet  is  implemented  (Flatt,  1995;;  Schrauwen,  van  Marken  Lichtenbelt,  Saris,  &  
Westerterp,  1997)  with  a  time  course  further  lengthened  by  obesity  (Thomas  et  al.,  1992)  and  a  family  
history  of  T2D  (Ukropcova  et  al.,  2007).  Being  that  a  balanced  controlled  diet  might  reflect  a  change  in  
lipid  intake  for  some  subjects,  this  implies  that  dietary  control  prior  to  testing  exercise  metabolism  should  
be  more  extensive  than  a  simple  acute  manipulation  such  as  testing  in  the  fasted  state  or  the  fasted  state  
following  ingestion  of  a  standardized  meal.  It  is  also  important  to  recognize  that  energetic  intake  should  
be  closely  matched  to  expenditure  during  any  controlled-­feeding  period  because  lipid  is  the  predominant  
substrate  used/stored  in  response  to  short-­term  fluctuations  in  energy  balance  (Abbott  et  al.,  1988).  
Finally,  following  any  period  of  dietary  control,  to  ensure  that  the  metabolic  response  to  exercise  will  not  
be  affected  by  the  final  meal  of  the  feeding  regimen,  subjects  should  be  tested  after  a  sufficient  period  of  
fasting  (e.g.,  >6  hours)  (Montain,  Hopper,  Coggan,  &  Coyle,  1991).    
Given  the  profound  influence  of  prior  feeding  habits  on  substrate  oxidation,  it  is  surprising  that  
only  seven  of  the  24  included  studies  involved  anything  more  than  acute  dietary  control  (Colberg  et  al.,  
1996;;  Ezell  et  al.,  1999;;  Goodpaster  et  al.,  2002;;  Kanaley  et  al.,  1993);;  Kanaley  et  al.,  2001;;  Lanzi  et  al.,  
2014;;  Melanson  et  al.,  2009).  Moreover,  in  four  of  those  seven,  a  general  guideline  regarding  a  minimum  
amount  of  carbohydrate  intake  was  all  that  was  provided  (Colberg  et  al.,  1996;;  Goodpaster  et  al.,  2002;;  
Kanaley  et  al.,  1993;;  Kanaley  et  al.  2001),  while  in  two  others,  subjects  were  not  tested  in  the  fasted  state  
after  completing  their  controlled  period  (Ezell  et  al.,  1999;;  Melanson  et  al.,  2009).  Hence,  acute  and  long-­
term  dietary  control  with  macronutrient  standardization  in  energy  balance  was  only  enforced  in  one  of  the  
included  studies  and,  unfortunately,  the  results  from  this  study  are  inconclusive  because  obese  subjects  
oxidized  lipid  more,  less  or  equally  as  effectively  as  normal-­weight  subjects  during  exercise  depending  
upon  the  outcome  measure  that  was  considered  (Lanzi  et  al.,  2014).  Future  studies  designed  to  clarify  





composition  and  energy  balance  for  an  extended  period  to  ensure  weight  stability  with  similar  prevailing  
FQ.  
3.5.3  Exercise  Variables  That  Might  Influence  Exercise  Lipid  Use  Irrespective  of  Body  Fatness  
3.5.3.1  Mode  
The  two  modes  of  exercise  most  often  used  for  exercise  testing  are  treadmill  walking/running  and  
leg-­cycle  ergometry  (Beltz  et  al.,  2016).  Consequently,  it  is  not  surprising  that  23  of  the  24  included  
studies  involved  one  of  these  modes  of  exercise.  However,  in  one  of  those  23,  arm  cranking  was  
performed  in  addition  to  leg  cycling  so  that  potential  differences  in  substrate  use  in  arm  compared  to  leg  
muscle  could  be  explored  (Larsen  et  al.,  2009).  Specifically,  citing  research  indicating  that  arm  muscles  
retain  a  better  capacity  for  glucose  clearance  in  older  hypertensive  individuals  (Olsen,  Sacchetti,  Dela,  
Ploug,  &  Saltin,  2005)  and  patients  with  T2D  (Reynolds  IV,  Supiano,  &  Dengel,  2007),  Larsen  et  al.  
(2009)  hypothesized  that  the  influence  of  T2D  on  exercise  metabolism  would  be  different  for  the  two  
modes  of  exercise.  However,  in  addition  to  lean  control  subjects  against  which  exercise  substrate  use  by  
subjects  with  T2D  was  compared,  these  researchers  also  included  a  group  of  healthy  obese  control  
subjects;;  hence,  a  comparison  of  the  capacity  for  exercise  lipid  use  for  healthy  obese  compared  to  
normal-­weight  subjects  in  arm  compared  to  leg  muscle  could  also  be  made.  Interestingly,  these  authors  
found  that  the  maximal  rate  of  lipid  oxidation  during  incremental  exercise  occurred  at  a  higher  percentage  
of  V̇O2max  for  obese  compared  to  lean  subjects  during  arm  cranking,  but  not  leg  cycling  (Larsen  et  al.,  
2009).  While  lipid  oxidation  rates  at  the  variety  of  intensities  investigated  during  the  test  or  the  maximal  
lipid  oxidation  rate  were  not  different  between  obese  and  lean  subjects,  this  finding  suggests  that  testing  
of  the  upper-­body  musculature  might  allow  for  an  obesity-­related  increment  in  exercise  lipid  use  to  be  
identified.  The  reason(s)  for  different  metabolic  activity  in  arm  compared  to  leg  muscle  is/are  unclear,  but  
might  be  related  to  differences  in  muscle  phenotype  (Larsen  et  al.,  2009),  which  resonates  because  a  
high  proportion  of  type  I  fibres  provides  a  greater  ‘window’  for  the  loss  of  IS  that  occurs  with  T2D  (Gaster,  
Staehr,  Beck-­Nielsen,  Schrøder,  &  Handberg,  2001).  Collectively,  these  findings  appear  to  provide  further  
support  for  our  contention  that  state  of  IR  is  an  important  factor  to  control  when  assessing  exercise  





indicate  that  future  studies  of  exercise  metabolism  with  overweight/obesity  should  include  both  leg  and  
arm  ergometry  (in  particular,  utilizing  the  CWR  exercise  model).      
3.5.3.2  Duration    
During  prolonged  moderate-­intensity  exercise,  reliance  on  muscle  glycogen  decreases  while  
whole-­body  rate  of  lipid  oxidation  increases  in  association  with  increased  availability  and  oxidation  of  
plasma  FFA  (Romijn  et  al.,  1993;;  van  Aggel-­Leijssen,  Saris,  Hul,  &  van  Baak,  2001).  If  the  time  course  of  
this  up-­regulation  of  lipid  use  is  different  for  overweight/obese  compared  to  normal-­weight  subjects,  the  
duration  of  an  exercise  bout  used  to  assess  exercise  metabolism  must  be  selected  accordingly.  In  this  
regard,  Kanalay  et  al.  (2001)  observed  a  similar  rate  of  lipid  oxidation  for  obese  and  non-­obese  women  
after  15  minutes  of  treadmill  walking  at  70%  V̇O2max;;  however,  for  the  obese  women,  lipid-­oxidation  rate  
increased  from  minute  15  to  minute  30  whereas  for  non-­obese  women,  it  did  not.  The  end  result  was  that  
30  minutes  of  exercise  required  the  same  energy  expenditure,  but  30%  more  lipid  oxidation  for  obese  
women.  Unfortunately,  these  researchers  terminated  exercise  at  30  minutes;;  hence,  it  cannot  be  
determined  whether  non-­obese  subjects  would  have  eventually  “caught  up.”  Nevertheless,  these  findings  
imply  that  a  longer  duration  of  exercise  is  required  to  reveal  an  obesity-­related  increment  that  might  be  
present  and  findings  by  Horowitz  and  Klein  (2000)  provide  further  support.  Specifically,  these  researchers  
found  that  whole-­body  lipid  oxidation  from  60–90  minutes  of  cycling  at  ~54%  V̇O2max  was  ~25%  greater  
for  obese  compared  to  lean  women  (Horowitz  &  Klein,  2000).  Conversely,  Goodpaster  et  al.  (2002)  
reported  that  the  lower  RER  they  observed  for  obese  compared  to  lean  men  at  30,  45,  and  60  minutes  of  
cycling  at  50%  V̇O2max  was  also  present  at  minute  15,  which  suggests  that  a  longer  exercise  challenge  
might  not  be  required  to  reveal  an  obesity-­related  increase.  Finally,  other  than  the  three  studies  
mentioned  above,  the  other  10  included  studies  that  involved  assessment  of  lipid  oxidation  for  CWR  
bouts  ≥30  minutes  in  length  provided  no  evidence  of  a  greater  capacity  for  exercise  lipid  use  for  
overweight/obese  subjects  (Balcı,  2012;;  Colberg  et  al.,  1996;;  Devries  et  al.,  2013;;  Ezell  et  al.,  1999;;  
Kanaley  et  al.,  1993;;  Melanson  et  al.,  2009;;  Mittendorfer  et  al.,  2004;;  Slusher  et  al.,  2015;;  Thyfault  et  al.,  
2004;;  Wong  &  Harber,  2006).  Hence,  the  preponderance  of  evidence  suggests  that  an  obesity-­related  
increase  in  exercise  lipid  use  was  not  masked  by  insufficient  duration.  Nevertheless,  it  seems  reasonable  





should  involve  criterion  exercise  challenges  that  are  at  least  30  minutes  in  length  to  allow  any  duration-­
dependent  increase  in  lipid  mobilisation  and  subsequent  oxidation  to  occur  (Pillard  et  al.,  2007).  This  is  
also  important  to  consider  in  light  of  the  practice  of  using  incremental  exercise  with  relatively  short  stages  
to  assess  substrate  use  for  the  work  rate  maintained  during  the  stage;;  for  example,  as  was  done  in  eight  
of  the  24  included  studies  (Ardevol  et  al.,  1998;;  Balcı,  2012;;  Keim  et  al.,  1996;;  Lanzi  et  al.,  2014;;  Larsen  
et  al.,  2009;;  Mohebbi  &  Azizi,  2011;;  Perez-­Martin  et  al.,  2001;;  Steffan  et  al.,  1999).  Indeed,  Steffan  et  al.  
(1999)  confirmed  that  changes  in  RER  after  3  minutes  of  CWR  exercise  at  both  50  and  75%  V̇O2max  
resulted  in  significant  differences  at  both  minutes  8  and  15  compared  to  the  value  measured  at  minute  
three  and  that  which  was  measured  during  a  3-­minute  stage  of  an  incremental  bout.  The  authors  rightly  
concluded  that  “steady-­state”  substrate  use  cannot  be  predicted  from  graded-­exercise  tests  (Steffan  et  
al.,  1999).    
3.5.3.3.  Intensity    
It  is  well  established  that  intensity  of  effort  influences  the  proportional  use  of  substrate  during  
physical  activity.    For  example,  in  support  of  the  ‘crossover  concept’  (Brooks  &  Mercier,  1994),  Venables  
et  al.  (2005)  assessed  300  healthy  men  and  women  during  incremental  treadmill  exercise  and  found  that  
carbohydrate  oxidation  continued  to  increase  from  low  to  high  work  rate  while  lipid  use  only  did  so  until  an  
intermediate  intensity  was  encountered.  Indeed,  once  the  peak  rate  of  lipid  use  was  reached,  lipid  
reliance  decreased  progressively  until  its  contribution  became  negligible  at  the  highest  work  rates  (e.g.,  
≥~84%  V̇O2max).  The  observation  that  the  highest  rate  of  lipid  oxidation  occurs  at  an  intermediate  relative  
work  rate  (e.g.,  ~48%  V̇O2max)  forms  the  basis  for  using  moderate-­intensity  exercise  to  asses  lipid-­
oxidizing  capacity  during  exercise.  However,  Venables  et  al.  (2005)  also  observed  considerable  inter-­
subject  variability  with  the  maximal  rate  occurring  anywhere  between  25  and  77%  of  V̇O2max  in  the  cohort  
they  recruited.  Consequently,  it  stands  to  reason  that  exercise  intensity  should  be  assigned  for  such  
testing  in  a  subject-­specific  manner.  The  traditional  way  to  normalize  endurance-­exercise  intensity  is  by  
quantifying  work  rate  relative  to  the  subject’s  V̇O2max  based  on  the  assumption  that  different  individuals  
exercising  at  the  same  percentage  of  V̇O2max  will  experience  similar  physiological  challenges.  However,  it  
is  now  well  established  that  the  metabolic  response  to  an  increasing  exercise  work  rate  is  not  linear  with  





Lansley,  Dimenna,  Bailey,  &  Jones,  2011).  Consequently,  exercise  performed  at  the  same  percentage  of  
V̇O2max  can  represent  a  markedly  different  physiological  challenge  (including  the  ability  to  satisfy  the  
required  energy  turnover  via  lipid  oxidation)  for  two  V̇O2max-­matched  subjects.  Specifically,  assigning  
exercise  intensity  relative  to  V̇O2max  fails  to  account  for  other  important  parameters  of  aerobic  fitness;;  for  
example,  the  lactate  threshold  (LT)  and  the  asymptote  of  the  hyperbolic  relationship  between  power  
production  and  time  to  exhaustion  (i.e.,  the  “critical  power”;;  CP),  which  serve  as  the  upper  boundaries  of  
the  moderate-­  and  heavy-­intensity  domains,  respectively  (DiMenna  &  Jones,  2009).  Importantly,  
Venables  et  al.  (2005)  showed  that  LT,  which  occurred  at  ~65%  V̇O2max  in  their  group  of  subjects  (range,  
45–89%),  was  aligned  with  a  higher  work  rate  compared  to  the  maximal  rate  of  lipid  oxidation.  
Consequently,  in  lieu  of  a  direct  measurement  of  the  maximal  rate  of  lipid  oxidation,  it  seems  reasonable  
to  conclude  that  tests  designed  to  assess  exercise  lipid  use  should  be  performed  at  intensities  below  LT  
with  the  specific  work  rate  assigned  relative  to  it.    
Fourteen  of  the  17  included  studies  that  involved  CWR  exercise  and  three  of  the  eight  that  
involved  incremental  exercise  were  designed  with  exercise  intensity  assigned  relative  to  V̇O2max.  
Moreover,  in  the  five  other  studies  that  involved  incremental  testing,  stages  were  performed  at  the  same  
absolute  work  rates  for  all  subjects.  Conversely,  only  two  studies  involving  CWR  exercise  were  designed  
with  intensity  assigned  relative  to  “VT”  (i.e.,  “ventilatory  threshold,”  which  is  one  of  myriad  terms  used  to  
describe  LT  (Binder  et  al.,  2008),  and  in  both  cases,  exercise  was  performed  at  VT,  which  implies  that  
most  subjects  were  operating  at  an  intensity  that  exceeded  that  which  allowed  for  their  maximal  capacity  
for  lipid  use  (Santiworakul  et  al.,  2014;;  Wong  &  Harber,  2006).  Furthermore,  in  one  of  those  studies,  the  
parameter  was  identified  according  to  the  ventilatory  equivalent  for  CO2,  which  is  the  point  at  which  
respiratory  compensation  begins  (i.e.,  the  “second  ventilatory  threshold”  or  VT2)  (Wong  &  Harber,  2006).  
Importantly,  VT2  emerges  subsequent  to  the  initial  VT  (i.e.,  VT1)  during  incremental  tests  with  sufficient  
sensitivity  to  reveal  the  “isocapnic  region”  within  which  arterial  partial  pressure  of  CO2  is  maintained  
despite  lactic  acidosis  (Whipp,  Davis,  &  Wasserman,  1989).  Conversely,  Santiworakul  et  al.  (2014)  used  
the  V-­slope  method  for  identification,  which  would  be  preferred  because  it  reveals  VT1  (and,  therefore,  





lipid-­oxidizing  capacity  at  LT  for  obese  compared  to  lean  subjects;;  however,  a  number  of  other  factors  
were  poorly  controlled  in  this  study  (Table  3.4)  so  their  finding  should  be  interpreted  with  caution.  
3.5.4  Evidence  in  Favor  of  a  Limitation  in  Lipid  Oxidation  During  Exercise    
for  Overweight/Obese  Subjects  
  
Despite  similar  rates  of  skeletal-­muscle  fatty-­acid  uptake  compared  to  normal-­weight  
counterparts,  obese  individuals  demonstrate  lower  rates  of  lipid  oxidation  during  fasting  when  lipid  use  
should  predominate  (Kelley  et  al.,  1999).  With  this  in  mind,  it  is  attractive  to  speculate  a  mitochondrial  
defect  underpinning  the  overweight/obese  condition  that  would  also  create  a  limitation  during  moderate-­
intensity  exercise  where  lipid  should  still  contribute  significantly  as  fuel  (Goodpaster  et  al.,  2002).  
However,  only  seven  of  the  24  studies  in  this  review  provide  any  evidence  that  obese  subjects  have  a  
reduced  capacity  for  exercise  lipid  use  compared  to  non-­obese  counterparts  (Chatzinikolaou  et  al.,  2008;;  
Grams  et  al.,  2017;;  Hickner  et  al.,  2001;;  Keim  et  al.,  1996;;  Lanzi  et  al.,  2014;;  Mohebbi  et  al.,  2011;;  Perez-­
Martin  et  al.,  2001).  Furthermore,  in  one  of  those  studies,  Chatzinikolaou  et  al.  (2008)  reported  a  higher  
RER  for  obese  compared  to  lean  men  during  30  minutes  of  intermittent  circuit  resistance  training,  a  
physical  activity  during  which  lipid  would  not  be  expected  to  contribute  to  a  great  extent  in  healthy  
individuals.  Consequently,  the  practical  relevance  of  this  finding  can  be  questioned.  Conversely,  five  
studies  indicating  an  obesity-­related  decrement  involved  a  comparison  during  stationary  cycling,  which  
likely  represents  exercise  during  which  such  a  decrement  would  be  more  relevant.  Specifically,  stationary  
cycling  would  typically  be  recommended  as  a  low-­impact  activity  for  overweight/obese  individuals  to  
reduce  body  fat  and  improve  metabolic  health.  A  reduced  capacity  for  lipid  oxidation  during  this  type  of  
exercise  would,  therefore,  be  important  to  consider  when  determining  the  appropriate  training  program  to  
manage  and/or  treat  the  disease.  However,  it  is  important  to  note  that  in  four  of  those  five  studies,  the  
conclusion  must  be  prefaced  because  the  decrement  was  only  present  under  certain  circumstances.  For  
example,  Lanzi  et  al.  (2014)  found  that  while  obese  subjects  demonstrated  a  lower  rate  of  lipid  oxidation  
per  FFM  at  higher  exercise  intensities  (i.e.,  65–85%  V̇O2peak),  their  lipid  use  at  moderate  (35–60%  
V̇O2peak)  intensities  was  not  different  compared  to  lean  counterparts.  Moreover,  while  obese  subjects  
experienced  their  maximal  rate  of  lipid  oxidation  at  a  lower  relative  exercise  intensity  compared  to  normal-­
weight  individuals  (~47  vs.  ~57%  of  peak  power  output),  the  rate  of  lipid  oxidation  at  that  apex  (~6  





demonstrated  a  lower  RER  and  higher  rates  of  lipid  oxidation  at  low  exercise  intensities  (20–55%  and  20–
30%  V̇O2peak,  respectively)  in  that  study  (Lanzi  et  al.,  2014).  This  discrepancy  exemplifies  why  it  is  
important  to  pay  careful  attention  to  the  method  used  to  normalize  exercise  intensity  when  exercise  
metabolism  is  being  assessed  (see  above).  Moreover,  subject  characteristics  other  than  
overweight/obesity  can  play  a  role.  For  example,  Hickner  et  al.  (2001)  reported  a  higher  RER  during  
cycling  at  the  same  absolute  work  rate  (15  W)  for  obese  African  American  and  Caucasian  women;;  
however,  this  was  only  the  case  when  lean  Caucasian  women  represented  the  control  subjects.  
Conversely,  when  obese  women  of  both  races  were  compared  to  lean  African  American  women,  no  
differences  were  present.  This  suggests  that  some  genotypes  and/or  phenotypes  might  convey  a  lipid  
metabolic  defect  regardless  of  body  fatness.  Hickner  et  al.  (2001)  also  found  no  difference  between  
exercise  RER  for  obese  subjects  of  both  races  compared  to  lean  African  American  women  when  subjects  
cycled  at  the  same  relative  intensity  (65%  V̇O2peak);;  however,  in  this  case,  Caucasian,  but  not  African  
American  obese  women,  possessed  a  decrement  compared  to  their  lean  Caucasian  counterparts.  In  
addition  to  subject  characteristics,  this  again  exemplifies  how  the  method  used  to  assign  intensity  can  
affect  the  conclusion.  More  evidence  of  the  potential  confounding  influence  of  intensity  assignment  and  
subject  characteristics  other  than  overweight/obesity  comes  from  the  work  of  Keim  et  al.  (1996),  who  had  
subjects  cycle  at  the  same  absolute  work  rates  (30,  60,  90,  and  120  W  for  all  subjects  with  an  additional  
bout  at  150  W  for  male  subjects)  and  found  that  fatter  men  had  a  higher  RER  when  cycling  at  120  W  
compared  to  leaner  men.  However,  no  differences  were  present  for  men  at  the  four  other  work  rates  or  for  
women  at  any  of  the  work  rates  they  performed.  Furthermore,  these  researchers  used  each  subject’s  
V̇O2/work-­rate  relationship  from  the  incremental  protocol  to  estimate  substrate-­oxidation  rates  at  30%,  
40%,  50%,  and  60%  of  their  measured  V̇O2max  and  found  a  different  pattern  for  fatter  compared  to  leaner  
men  (Keim  et  al.,  1996).  Specifically,  lipid-­oxidation  rate  tended  to  increase  for  leaner  men  as  exercise  
intensity  increased  whereas  for  fatter  men,  it  decreased.  Consequently,  lipid-­oxidation  rate,  which  did  not  
differ  between  groups  at  30%  V̇O2max,  was  significantly  lower  for  fatter  compared  to  leaner  subjects  at  
40%,  50%,  and  60%  V̇O2max.  Conversely,  body-­fat  percentage  was  not  associated  with  substrate-­
oxidation  rates  for  female  subjects  at  any  of  the  estimated  work  rates  and  regardless  of  body  fatness,  like  





estimated  in  this  study  (Keim  et  al.,  1996).  These  findings  with  respect  to  sex  cohere  with  those  of  Grams  
et  al.  (2017)  who  reported  that  overweight  men  use  less  kilocalories  of  lipid  per  minute  compared  to  lean  
counterparts  when  cycling  for  10  minutes  at  50%  V̇O2max  while  overweight  women  do  not.  However,  it  is  
important  to  note  that  this  was  not  the  case  during  12  minutes  of  self-­paced  stepping,  which  was  also  
performed  in  this  study  as  both  sexes  experienced  an  overweight-­related  decrement  during  this  activity  
(Grams  et  al.,  2017).  Finally,  in  the  one  study  that  indicated  an  obesity-­related  decrement  during  treadmill  
exercise,  Mohebbi  and  Azizi  (2011)  found  that  obese  men  demonstrated  a  lower  lipid-­oxidation  rate  
during  incremental  exercise  at  higher  work  rates  (60–80%  V̇O2max),  but  lipid  use  at  lower  work  rates  (20–
50  V̇O2max)  and  the  maximal  rate  of  lipid  oxidation  were  not  different  compared  to  normal-­weight  controls.  
Collectively,  these  findings  suggest  that  if  a  decrement  in  exercise  lipid  use  is  present  for  obese  
compared  to  non-­obese  subjects,  its  identification  requires  careful  consideration  of  the  mode  and  intensity  
of  the  criterion  exercise  and  the  race  and  sex  of  the  subject.      
Of  the  24  included  studies,  only  one  provides  unmitigated  evidence  to  support  the  contention  that  
exercise  lipid  use  is  reduced  for  overweight/obese  subjects.  Specifically,  Perez-­Martin  et  al.  (2001)  
stratified  subjects  of  both  sexes  into  normal  and  overweight  groups  and  found  that  overweight  subjects  
demonstrated  a  higher  RER  and  lower  rate  of  lipid  oxidation  for  all  stages  of  an  incremental  cycling  
protocol  comprising  6-­minute  bouts  at  30%,  40%,  50%,  and  60%  of  their  estimated  maximal  work  rate.  
Furthermore,  the  maximal  rate  of  lipid  oxidation  and  the  crossover  point  from  predominantly  lipid  to  
carbohydrate  fuel  occurred  at  lower  relative  work  rates  for  the  overweight  subjects  (Perez-­Martin  et  al.,  
2001).  In  a  separate  assessment,  these  researchers  confirmed  that  when  similar  6-­minute  bouts  were  
performed  on  separate  days,  V̇O2  and  V̇CO2  values  were  not  different,  which  suggests  that  substrate  
oxidation  rates  were  not  affected  by  the  sequential  nature  of  the  incremental  protocol.  However,  the  
degree  to  which  6  minutes  of  exercise  at  a  given  work  rate  is  sufficient  for  all  subjects  to  achieve  
substrate-­oxidation  rates  that  faithfully  reflect  the  subject’s  “true”  capacity  for  lipid  oxidation  at  that  work  
rate  can  be  questioned  (Kanaley  et  al.,  2001;;  Steffan  et  al.,  1999).    
4.4  The  Influence  of  Overweight/Obesity  on  the  Source  of  Exercise  Lipid  Use  
In  contrast  to  the  aforementioned  line  of  reasoning,  there  are  a  number  of  reasons  why  obese  





counterparts.  Firstly,  it  is  intuitive  that  greater  fat  mass  in  adipose  tissue  of  obese  individuals  could  
provide  for  greater  plasma  FFA  availability  in  response  to  a  given  exercise  challenge.  However,  a  review  
of  the  literature  confirms  an  obesity-­related  downregulation  of  lipolysis  per  given  quantity  of  fat  mass  
(Karpe,  Dickmann,  &  Frayn,  2011)  and  reduced  lipolytic  response  to  exercise  for  overweight/obese  
subjects  (Mittendorfer  et  al.,  2004).  Alternatively,  the  “window”  for  lipid  contribution  as  fuel  might  be  
widened  by  the  IR  that  often  accompanies  obesity,  which  has  been  linked  to  a  decrease  in  muscle  
glycogen  use  during  exercise  (Braun  et  al.,  2004).  Interestingly,  obesity  is  also  associated  with  greater  
storage  of  lipid  as  IMTG  (Goodpaster  et  al.,  2002),  which  could  serve  to  fill  the  void  created  by  this  
decreased  reliance  on  muscle  glycogen  (Braun  et  al.,  2004;;  Goodpaster  et  al.,  2002).  Finally,  it  is  well  
established  that  IR  is  accompanied  (and  possibly  caused  by)  elevated  IMTG  (Goodpaster,  Thaete,  
Simoneau,  &  Kelley,  1997).  Although  cause/effect  characteristics  remain  to  be  clarified,  these  
associations,  therefore,  suggest  a  series  of  obesity-­related  changes  involving  accumulation  of  lipid  in  
muscle  and  blunting  of  IS  that  conspire  to  create  a  different  pattern  of  exercise  fuel  use  overweight/obese  
individuals  with  IR  compared  to  normal-­weight  individuals  without  it.  The  four  included  studies  that  
involved  stable-­isotope  infusion  to  determine  the  source  of  oxidized  lipid  in  addition  to  the  whole-­body  
measurement  derived  from  indirect  calorimetry  provide  important  insight  in  this  regard.  Specifically,  in  
three  of  those  studies  (Goodpaster  et  al.,  2002;;  Horowitz  &  Klein,  2000;;  Mittendorfer  et  al.,  2004),  the  
contribution  of  non-­plasma  lipid  (presumably  predominantly  IMTG)  was  increased  with  obesity  while  in  the  
other  (Thyfault  et  al.,  2004),  an  ~15%  increase  that  did  not  reach  statistical  significance  was  observed.  
However,  this  enhanced  ability  to  utilize  IMTG  for  obese  subjects  only  allowed  for  greater  whole-­body  
lipid  oxidation  in  two  of  these  studies  (Goodpaster  et  al.,  2002;;  Horowitz  &  Klein,  2000).  Conversely,  in  
the  other  two,  obese  subjects  demonstrated  a  concomitant  reduction  in  the  ability  to  oxidize  plasma  FFA  
such  that  a  similar  whole-­body  rate  of  lipid  oxidation  was  observed  compared  to  normal-­weight  subjects  
(Mittendorfer  et  al.,  2004;;  Thyfault  et  al.,  2004).  Consequently,  mixed  conclusions  regarding  the  degree  to  
which  exercise  lipid  use  is  increased,  decreased  or  unaffected  for  overweight/obese  individuals  might  be  
attributable  at  least  in  part  to  a  difference  in  the  net  effect  of  changes  in  the  non-­plasma  and  plasma  
contributions  with  some  overweight/obese  subjects  able  to  maintain  the  capacity  for  plasma  lipid  along  





might  have  to  do  with  the  degree  to  which  lipolytic  activity  is  reduced  in  association  with  obesity.  For  
example,  in  addition  to  an  increased  reliance  on  nonsystemic  fatty  acids  and  decreased  reliance  on  
systemic  fatty  acids,  Mittendorfer  et  al.  (2004)  reported  an  inverse  relationship  between  adiposity  and  the  
lipolytic  response  to  exercise  that  they  linked  to  reductions  in  peak  plasma  epinephrine  concentration  and  
adipose-­tissue  catecholamine  sensitivity.  The  end  result  was  that  unlike  lean  controls,  it  was  FFA  
availability,  not  uptake,  that  rate  limited  plasma  lipid  oxidation  in  their  overweight/obese  male  subjects  
(Mittendorfer  et  al.,  2004).  However,  other  studies  provide  no  evidence  of  such  a  limitation.  For  example,  
Lanzi  et  al.  (2014)  found  reduced  lipolytic  activity  at  all  work  rates  encountered  during  incremental  
exercise  for  obese  males;;  however,  the  increased  quantity  of  adipose  tissue  compensated  for  the  deficit  
thereby  allowing  for  greater  FFA  availability  during  exercise  and,  by  extension,  greater  and  unaffected  
lipid-­oxidation  rates  at  low  and  moderate  intensities,  respectively.  Indeed,  these  researchers  only  
observed  lower  lipid-­oxidation  rates  for  obese  subjects  at  higher  intensities,  which  is  consistent  with  the  
existence  of  a  “downstream”  limitation  once  these  work  rates  were  encountered.  Moreover,  Horowitz  and  
Klein  (2000)  found  similar  whole-­body  lipolytic  activity  for  women  with  abdominal  obesity  compared  to  
lean  controls,  while  Goodpaster  et  al.  (2002)  reported  an  ~50%  greater  rate  of  uptake  of  FFA  during  
exercise  for  obese  males  despite  similar  reliance  on  these  sources.    
Collectively,  the  contrasting  reports  detailed  above  suggest  a  complex  interplay  with  regard  to  the  
capacity  to  maintain  plasma  FFA  availability/uptake/oxidation  alongside  an  obesity-­related  increase  in  
IMTG  availability/oxidation  with  this  interplay  ultimately  dictating  the  net  effect  on  whole-­body  lipid  
oxidation.  Specific  factors  that  might  influence  this  interplay  are  subject  sex,  fat-­deposition  pattern,  and/or  
degree  of  obesity;;  however,  the  degree  to  which  IR  is  present  and  has  progressed  might  be  the  most  
important  one  to  consider.  Blaak  et  al.  (2000)  found  that  total  lipid  oxidation  was  similar  for  patients  with  
T2D  compared  to  healthy  subjects  matched  for  body  composition  during  60  minutes  of  moderate-­intensity  
cycling  although  the  patients  demonstrated  an  increased  reliance  on  triglyceride-­derived  lipids  to  
compensate  for  a  lower  exercise-­induced  rate  of  appearance/oxidation  of  plasma  FFA  (Blaak,  van  Aggel-­
Leijssen,  Wagenmakers,  Saris,  &  van  Baak,  2000).  This  contrasts  findings  by  Braun  et  al.  (2004),  who  
reported  similar  FFA  concentrations  along  with  increased  lipid  contribution  to  energy  expenditure  during  





to  women  without  IR  matched  for  body  composition.  Although  the  source  of  oxidized  lipid  was  not  
reported  in  this  study,  it  seems  reasonable  to  conclude  that  an  increased  reliance  on  IMTG  to  fill  the  void  
created  by  deceased  muscle  glycogen  use  in  association  with  the  initial  stages  of  insulin  desensitization  
had  not  yet  been  offset  by  the  decrease  in  plasma  lipid  use  that  ultimately  accompanies  its  progression  to  
T2D  (Blaak  et  al.,  2000).  A  sequence  of  alterations  that  might  explain  the  relationship  between  
overweight/obesity  and  the  progression  from  IR  to  T2D  and  how  that  relationship  dictates  whether  








Figure  3.2.  Relationship  between  overweight/obesity  and  the  progression  from  IR  to  T2D  
  
3.6  Conclusion  
The  contention  that  there  is  a  lipid-­oxidizing  decrement  associated  with  overweight/obesity  comes  
predominantly  from  research  indicating  that  obese  individuals  demonstrate  lower  rates  of  lipid  oxidation  
during  fasting  when  lipid  use  should  predominate.  With  respect  to  moderate-­intensity  exercise  where  lipid  
should  still  contribute  significantly,  it  is  difficult  to  reconcile  how  a  “normal”  capacity  for  lipid  oxidation  
could  be  maintained  if  such  a  deficiency  is  present.  Nevertheless,  we  found  that  the  preponderance  of  





normal-­weight  counterparts.  Moreover,  it  is  possible  that  exercise  lipid  use  might  be  enhanced  for  
overweight/obese  subjects  due  to  an  increased  presence  of  and  contribution  from  muscle  lipid  stores.  
Regardless  of  this  distinction,  however,  if  the  capacity  for  exercise  lipid  use  is,  indeed,  preserved  in  
overweight/obese  subjects,  it  refutes  the  contention  that  a  lipid-­oxidizing  defect  contributes  to  the  
overweight/obese  condition  and  supports  the  importance  of  exercise  as  an  adjunct  to  diet  for  both  loss  of  
body  fat  and  maintenance/restoration  of  metabolic  health.  
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Chapter  4  –  Controlled  Clinical  Trial  
4.1  Assessing  Defects  in  Functional  Substrate  Selectivity  in  Individuals    
at  Risk  for  Type  2  Diabetes  
  
4.1.1   Research  Question  
Do  individuals  with  the  overweight/obese  condition  rely  on  lipid  oxidation  to  a  greater,  lesser,  or  
the  same  extent  during  a  physiologically-­equivalent  exercise  challenge  compared  to  age-­,  gender-­,  and  
fitness-­matched  normal-­weight  subjects?  
4.1.2   Hypothesis  #1  
Rates  of  lipid  oxidation  during  exercise,  adjusted  for  fat-­free  mass,  will  be  lower  in  individuals  with  
the  overweight/obese  conditions.    
4.1.3   Hypothesis  #2  
The  lower  rates  of  lipid  oxidation  will  be  related  to  changes  associated  with  the  loss  of  metabolic  
health  (e.g.,  insulin  resistance)  rather  than  the  overweight/obese  state  per  se.  
4.2   Methods  
4.2.1   Setting  
The  research  was  conducted  at  the  Mt.  Sinai  St.  Luke’s  Hospital,  Division  of  Endocrinology,  
Diabetes,  and  Metabolism,  Clinical  Research  Unit.  The  protocol  included  informed  consent,  screening,  
and  all  tests  and  procedures  involved  in  this  application.  Participants  were  recruited  via  printed  flyers,  
online  advertisement,  and  presentations  at  schools  and  community  centers  in  the  area.  The  research  was  
approved  by  the  Institutional  Review  Board  (IRB)  of  ICAHN  School  of  Medicine  at  Mount  Sinai,  Mount  
Sinai  Hospital,  New  York,  New  York.  
4.2.2   Study  Design  
4.2.2.1   Participants  and  Recruitment  Methods  
Both  men  and  women  (age  18-­45  years)  of  all  races  were  invited  to  participate  in  this  cross-­
sectional  study.  To  maximize  recruitment  potential,  we  used  multiple  mediums  and  vehicles,  including  
contacting  community  neighborhood  leaders,  reaching  out  to  student  and  staff  at  the  nearby  Columbia  
University,  advertising  online  (e.g.  Craigslist,  Inc.),  and  posting  flyers  in  the  neighborhood.  Below  is  our  

















Figure  4.1.  IRB-­approved  flyer  
4.2.3  Inclusion  and  Exclusion  Criteria  
   4.2.3.1  Inclusion  Criteria  
Inclusion  criteria  were  participants  should  be  non-­diabetic,  sedentary  (≤2  x  30  min  of  exercise  per  
week)  men  and  women  of  all  races  aged  18-­45.  Eligible  participants  were  recruited  and  stratified  into  four  
groups  matched  for  age,  fat-­free  mass,  and  cardiorespiratory  fitness  level  (see  Table  4.1).  
Table  4.1  
Participant  Groupings    





overweight/obese   ≥26  kg∙m
-­2,  <35  kg∙m-­2   FH+   ≥2  
Metabolically  healthy    
but  overweight/obese   ≥26  kg∙m
-­2,  <35  kg∙m-­2   FH-­   ≤1  
Metabolically  unhealthy  
normal  weight   ≥19  kg∙m
-­2,  ≤24  kg∙m-­2   FH+   ≥2  
Metabolically  healthy    
but  normal  weight   ≥19  kg∙m





•   Family  History  of  DM  (FH+)  was  defined  as  a  first-­degree  relative  (parents  or  siblings)  with  
type  2  diabetes    
•   Metabolic-­syndrome  risk  factors  were  based  on  the  definition  set  by  the  American  Heart  
Association,  World  Health  Organization,  and  the  National  Heart,  Lung,  and  Blood  Institute.  
These  included:    
•   waist  circumference  ≥35  inches  for  females  and  ≥40  inches  for  men  or  waist-­to-­hip  ratio  
>0.85  for  females  and  <0.90  for  men;;  
•   triglycerides  ≥150  mg∙dl-­1  or  receiving  drug  therapy  for  hyperlipidemia;;  
•   HDL  ≤50  mg∙dl-­1  for  females  and  ≤40  mg∙dl-­1  for  males;;  
•   blood  pressure  >130/85  mmHg  or  receiving  drug  therapy  for  hypertension;;  and  
•   fasting  blood  glucose  ≥100  mg∙dl-­1  or  receiving  drug  therapy  for  hyperglycemia.    
In  order  to  participate,  FH+,  metabolically  unhealthy  normal-­weight  and  overweight/obese  
participants  had  to  possess  two  or  more  of  the  metabolic  syndrome  risk  factors.  Conversely,  metabolically  
healthy  normal-­weight  and  overweight/obese  participants  had  to  be  free  from  FH+  and  possess  one  or  
less  of  the  metabolic-­syndrome  risk  factors.    
4.2.3.2   Exclusion  Criteria  
The  exclusion  criteria  were  as  follows:  
•   having  experienced  weight  change  ≥±3  kg  within  the  past  three  months;;  
•   taking  any  medications  that  might  affect  insulin  or  fat  metabolism;;  
•   smoking  within  the  past  6  months;;  
•   consuming  >2  oz  ethanol  per  day;;  
•   having  irregular  menstrual  cycle  (females);;  
•   being  pregnant;;  
•   possessing  any  indication  of  having  any  known  cardiovascular  disease  (e.g.,  coronary  artery  
disease,  previous  myocardial  infarction,  angina,  ischemic  heart  disease,  coronary  syndrome,  
congestive  heart  failure,  valvular  heart  disease,  cardio  myopathy),  pulmonary  disease  (e.g.,  





illness  as  per  the  discretion  of  the  principal  investigator  that  might  interfere  with  the  capacity  
to  exercise;;  
•   possessing  fasting  blood  sugar  >126  mg∙dl-­1  and/or  2-­hour  post  oral  glucose  tolerance  test  
>200  mg∙dl-­1;;  
•   demonstrating  an  age-­  and  gender-­appropriate  V̇O2peak  better  than  “average”  as  defined  by  
the  American  College  of  Sports  Medicine.  
4.2.4   Study  Timelines    
After  screening  and  the  determination  of  eligibility,  the  duration  of  an  individual  subject’s  
participation  in  this  study  was  10  days.  The  duration  anticipated  to  enroll  all  study  subjects  was  24  
months.  The  anticipated  date  for  the  investigators  to  complete  this  study  was  30  months  from  the  
approved  start  date.  
4.2.5   Procedures  
4.2.5.1   Screening    
The  screening  process  included  three  phases:  (a)  initial  phone  screening  to  collect  basic  
demographic,  clinical,  and  physical  activity  information;;  (b)  comprehensive  on-­site  medical  evaluation,  
which  included  physical  examination,  diabetes  screening,  blood  work,  and  resting  ECG;;  and  (c)  maximal  
exercise  testing  (“Ramp  Exercise  Test”)  to  evaluate  cardiorespiratory  fitness.  
4.2.5.2   Initial  Phone  Screening    
Initial  phone  screening  was  conducted  for  any  individual  who  contacted  our  center  and  expressed  
interest  in  participating  in  the  study.  We  developed  and  used  a  screening  script  to  keep  the  phone  
screening  consistent  and  efficient.  The  script  had  four  parts:  (a)  a  brief  overview  of  the  study,  including  
purpose,  protocol,  significances,  commitment,  and  incentives;;  (b)  basic  demographic  information  such  as  
name,  date  of  birth,  sex,  race,  weight,  height,  physical  address,  email,  and  phone  number;;  (c)  clinical  
information  such  as  weight  history  and  weight  change  in  the  past  3  months,  smoking  habits,  alcohol  
consumption,  exercise  and  physical  activity  behavior,  current  medical  conditions,  medications,  
supplements,  over  the  counters,  family  history  of  diabetes  (siblings  and  parents),  and  (for  females)  
menstruation,  pregnancy,  oral-­contraceptive  medicine,  and  date  of  last  ;;  (d)  comprehensive  physical  





participants  who  satisfied  the  inclusion/exclusion  criteria  outlined  above  were  invited  to  the  second  
screening  phase,  the  on-­site  comprehensive  medical  examination.    
4.2.5.3   Comprehensive  On-­site  Medical  Evaluation  
Participants  underwent  a  comprehensive  medical  examination  that  included  blood  work,  physical  
examination,  and  ECG,  and  a  standard  test  to  screen  for  diabetes  to  determine  if  they  were  eligible  to  
participate  in  this  study.  Screening  required  approximately  4  hours  during  one  morning  after  an  overnight  
fast  (12  hours  for  which  participants  did  not  eat  or  drink  anything  except  water  and  did  not  chew  anything  
containing  calories,  such  as  regular  gum  with  sugar).  The  total  amount  of  blood  which  was  taken  during  
screening  was  7  cc  (6  cc  for  blood-­lipid  analysis  and  1  cc  for  blood-­glucose  analysis),  which  is  about  1.5  
teaspoons  (teaspoon  equals  ~5  cc).  This  provided  enough  blood  for  general  blood  chemistry  and  
diabetes  screening.    
4.2.5.3.1   Diabetes  screening  
To  ensure  that  a  participant  did  not  have  diabetes,  he  or  she  underwent  an  Oral  Glucose  
Tolerance  Test  (OGTT).  The  test  was  performed  at  approximately  9:00  am  after  a  12-­hour  overnight  fast.  
A  small  portion  of  blood  (0.5  cc)  was  taken  from  a  vein  in  the  arm  for  the  microfuge  tube/glucose  analyzer  
for  blood  glucose  reading,  and  participants  then  consumed  a  sweet  drink  containing  75  grams  of  glucose.  
For  the  next  two  hours,  participants  remained  quietly  reading  or  resting  in  the  lab,  after  which  another    
0.5  cc  of  blood  was  taken  for  the  same  purpose  to  conclude  the  test.    
4.2.5.3.2   Medical  examination    
A  physician  or  other  certified  medical  professionals  performed  a  comprehensive  physical  and  
medical  history  to  ensure  that  participants  were  eligible  for  this  study.  A  participant’s  height,  weight,  waist  
circumference,  blood  pressure,  and  heart  rate  were  obtained  and  recorded.  Approximately  6  cc  of  blood  
was  taken  to  measure  blood  lipids  (for  example,  cholesterol)  and  also  to  perform  a  complete  blood  count  
and  regular  blood  chemistries  (basic  metabolism  and  liver  panel).  The  blood  was  drawn  from  the  same  
site  where  the  blood  was  taken  during  the  Oral  Glucose  Tolerance  Test  (see  above).  Participants  also  
underwent  a  resting  EKG  to  ensure  they  could  safely  participate  in  an  exercise  test.  During  this  visit,  they  
completed  a  dietary-­preference  questionnaire,  which  included  food  likes,  food  dislikes,  food  allergies,  





preferences/restrictions.  We  also  asked  each  participant  about  their  living  situation  and  access  to  kitchen  
and  refrigerator  so  that  the  food  given  during  the  protocol  was  not  only  based  on  their  liking  and  needs,  
but  also  on  their  resources,  environment,  and  lifestyle.  Upon  physician  approval,  only  participants  who  
satisfied  the  inclusion/exclusion  criteria  outlined  above  were  invited  to  the  third  screening  phase,  the  
maximal  exercise  test  (Ramp  Cycle  Test).  
4.2.5.4   Ramp  Cycle  Test  
This  procedure  was  performed  to  measure  the  participants’  cardiorespiratory  fitness.  They  
performed  this  test  one  time,  immediately  after  the  RMR  test  (described  below)  while  they  were  still  
fasting.  The  night  before  this  test,  participants  followed  the  directions  given  to  them  by  the  investigators;;  
for  example,  they  should  not  engage  in  moderate  or  strenuous  physical  activity  and  they  should  abstain  
from  ingesting  caffeine  or  alcohol  for  48  hours  prior  to  initiation  of  the  testing  protocol.  The  test  was  
performed  on  a  cycle  ergometer.  During  this  test,  the  subject  was  connected  to  a  Care  Fusion  Encore  
Vmax  System  in  order  to  collect  gas-­exchange  data.  Participants  breathed  through  a  mouthpiece  that  
was  connected  through  tubing  attached  to  the  machine.  During  the  test,  their  blood  pressure,  heart  rate,  
and  heart  activity  were  continually  monitored  for  safety.  As  the  test  progressed,  they  were  required  to  
gradually  work  harder  until  they  reached  their  individual  level  of  tolerance.  Once  they  reached  that  point,  
the  test  was  ceased  and  a  cool-­down  cycling  (e.g.,  at  25  W)  was  performed  for  5–10  minutes.  To  assess  
whether  the  V#O2peak  from  this  test  represented  the  true  V#O2max,  subjects  then  performed  a  verification  
bout,  which  involved  a  square-­wave  transition  in  work  rate  to  that  which  was  achieved  upon  completion  of  
the  ramp  test,  after  which  subjects  pedaled  until  they  reached  a  limit  of  tolerance  once  again  (typically    
2–3  minutes).  A  licensed  physician  was  present  for  each  of  these  tests.  If  a  subject  felt  ill  at  any  time  
during  the  test,  he  or  she  was  instructed  to  stop  exercising  immediately  and  inform  the  tester  to  receive  
proper  medical  treatment  if  needed.  Upon  the  successful  completion  of  the  test,  those  demonstrating  an  
age  and  gender-­appropriate  V#O2peak  of  “average”  or  lower,  as  defined  by  the  American  College  of  Sports  
Medicine,  were  invited  to  participate  in  the  study,  whereas  those  demonstrating  a  value  better  than  







4.2.6   Study  Protocol  
4.2.6.1   Testing  Protocol  and  Timeline    
Table  4.2  
Substrate  Selectivity  Testing  Protocol  
Substrate  Selectivity  Testing  Protocol  
   9-­day  Weight  Maintenance  Controlled  Diet  Period    (15%  protein,  50%  carbohydrate,  35%  fat)  















Participation  in  this  study  extended  over  a  period  of  9  days.  During  this  time,  each  participant  
reported  to  the  lab  three  times  to  conduct  five  different  tests.  The  9-­day  substrate-­selectivity  testing  
protocol  consisted  of  two  distinct  exercise  tests  (CWRE;;  Day  4  and  Day  7);;  a  body  composition  
assessment  (BC;;  Day  7);;  one  resting  metabolic  rate  test  (RMR;;  Day  9);;  and  a  test  to  measure  insulin  
resistance  (OGTT:  Day  9).  All  tests  and  procedures  are  explained  in  detailed  below.  Participants  were  
required  to  follow  a  9-­day  weight  maintenance  controlled  dietary  protocol  designed  to  keep  their  weight  
from  changing  and  continue  their  present  level  of  physical  activity  over  the  course  of  the  study.  They  were  
provided  with  food  and  dietary  guidelines  that  were  specifically  designed  to  make  sure  they  did  not  gain  
or  lose  weight  during  the  course  of  the  study.  Eating  plan  and  caloric  load  were  individualized  for  each  
participant  based  on  the  comprehensive  dietary  questionnaire  they  completed  during  screening  and  the  
resting  metabolic  rate  they  demonstrated  prior  to  protocol  initiation.    
4.2.6.2   Diet  Intervention  and  Follow-­up  
To  ensure  weight  stability  and  similar  macronutrient  composition  between  subjects  during  the  
entire  testing  period,  subjects  adhered  to  a  9-­day  weight-­maintenance  controlled  diet  period.  The  caloric  
load  was  calculated  based  on  the  subjects’  resting  metabolic  rate  (150%  RMR),  which  has  been  shown  to  
ensure  weight  stability  at  this  activity  level.  The  diet  was  comprised  of  15%  protein,  50%  carbohydrate,  
and  35%  fat.  This  macronutrient  proportionality  was  in  accordance  with  the  USDA  guidelines  for  a  healthy  
eating  pattern  for  adults.  During  the  screening  process,  participants  completed  a  dietary  preference  





was  designed  by  a  clinical  dietitian  and  individually  tailored  to  include  a  wide  choice  of  foods  based  on  
subject  preference  and  any  restrictions  they  might  have.  To  determine  a  diet  that  was  appropriate,  the  
clinical  dietitian  met  with  the  subject  to  derive  a  fixed  menu  for  each  day  and  the  subject  only  ate  what  
was  written  on  this  menu.  The  food  was  provided  in  the  form  of  frozen  and  fresh  foods.  If  a  subject  had  to  
purchase  any  items,  he  or  she  was  reimbursed  according  to  hand-­in  receipts.  Subjects  received  specific  
instructions  about  the  meal  plan  and  portion  sizing  to  ensure  that  they  ate  the  correct  amount.  During  this  
time,  they  continued  their  previous  level  of  physical  activity  and  also  weighed  themselves  daily  so  that  
they  could  report  their  weight  to  the  study  coordinator.  The  diet  was  adjusted  if  necessary  to  make  sure  a  
subject’s  weight  did  not  change.  Moreover,  each  participant  was  required  to  fill  out  a  diet  adherence  sheet  
that  outlined  in  detail  what  he  or  she  ate  and  how  much  of  the  food  provided  was  consumed.    
4.2.6.3   Resting  Metabolic  Rate  Test  (RMR)  
Each  participant  performed  this  procedure  two  times:  (a)  prior  to  protocol  initiation  to  measure  
metabolic  rate  and  total  energetic  requirement  for  the  9-­day  weight-­maintenance  diet;;  and  (b)  at  protocol  
conclusion  (Day  9)  to  measure  resting  substrate  selectivity  (i.e.,  rates  of  lipid  and  carbohydrate  oxidation)  
after  9  days  of  energy  and  weight  stability.  The  night  before  this  test,  participants  followed  the  directions  
given  to  them  by  the  investigators;;  for  example,  they  did  not  engage  in  moderate  or  strenuous  physical  
activity  and  they  abstained  from  ingesting  caffeine  or  alcohol.  The  RMR  test  was  done  in  the  morning  
after  the  subjects  had  not  consumed  any  calorie-­containing  foods  or  beverages  for  12  hours.  The  duration  
of  the  test  was  approximately  1  hour,  during  which  the  subject  lay  quietly  in  bed  with  a  large,  comfortable  
plastic  hood  placed  over  his  or  her  head.  This  hood  was  connected  to  a  machine  that  analyzed  gas  
exchange.    
4.2.6.4   Constant  Work-­Rate  Exercise  Test  (CWRE)  
On  Day  3  and  Day  6,  participants  underwent  a  constant-­work-­rate  exercise  test  to  assess  the  
energy  and  fuel  they  used  during  moderate-­intensity  exercise.  Unlike  the  ramp  test  described  above,  this  
test  did  not  require  maximal  exertion.  The  test  was  performed  in  the  morning  after  12  hours  of  overnight  
fasting.  The  night  before  this  test,  subjects  followed  the  directions  given  to  them  by  the  investigators  (see  
above).  During  this  test,  they  were  again  connected  to  the  Vmax  system  to  collect  gas-­exchange  data  





minutes  of  the  test,  participants  cycled  freely  with  the  work  rate  set  at  0  W.  After  that,  the  work  rate  was  
increased  in  a  square-­wave  manner  to  a  predetermined  level  and  remained  fixed  for  the  next  55  minutes.  
Participants  were  allowed  to  listen  to  music  of  their  choice  during  the  cycling  bout.  A  licensed  physician  
was  in  proximity  and  available  to  address  any  emergency  that  may  occur.  Appropriate  emergency  
equipment  was  present  in  the  room.  If  a  participant  felt  ill  at  any  time  during  the  tests,  he  or  she  was  
instructed  to  stop  exercising  immediately  and  tell  the  tester  in  order  to  receive  proper  medical  treatment  if  
needed.    
4.2.6.5   Body  Composition  Measurements  (Bod  Pod)  
On  Day  6,  body  composition  was  assessed  using  a  Bod  Pod.  The  BOD  POD  Gold  Standard  Body  
Composition  Tracking  System,  manufactured  and  distributed  exclusively  by  COSMED  USA,  is  an  air  
displacement  plethysmograph  that  uses  whole-­body  densitometry  to  determine  body  composition  (fat  and  
lean  tissue)  in  adults  and  children.  In  this  research  application,  to  control  for  any  differences  that  may  
have  been  present  between  subjects/groups  in  the  amount  of  fat-­free  mass,  lipid  and  carbohydrate  
oxidation  were  expressed  relative  to  fat-­free  mass  obtained  from  this  measurement.  For  this  test,  
participants  were  asked  to  sit  calmly  with  their  hands  on  their  lap  in  the  chamber  with  a  window  while  
wearing  a  swim  cap  and  tight-­fitting  underwear.  
4.2.6.6   Oral  Glucose  Tolerance  Test  (OGTT)  
On  Day  9,  participants  underwent  an  OGTT  to  assess  insulin  sensitivity.  The  test  was  performed  
immediately  following  the  RMR  test  while  the  participants  were  still  fasting.  After  the  IV  was  inserted,  two  
4-­cc  tubes  of  blood  were  collected  for  plasma  insulin  and  glucose  analysis.  After  that,  the  participants  
drank  a  75g  sugary  drink,  after  which  an  additional  two  4-­cc  tubes  of  blood  were  collected  at  30  minutes,  
60  minutes,  90  minutes,  and  120  minutes  following  ingestion.  Blood  samples  obtained  were  processed  
and  plasma  and  serum  stored  immediately  in  a  -­70  degree  Fahrenheit  freezer  located  in  the  facility  in  
proximity  to  the  testing  room  until  processing.    
4.3  Results  
Prior  to  conducting  each  analysis,  the  requisite  assumptions  of  normality  and  homogeneity  of  
variance  were  investigated  using  visual  inspection  and  statistical  tests.  Regarding  the  former  assumption,  





of  interest.  Results  indicated  that  the  observations  for  each  of  the  resting  and  exercise  conditions  met  
requirements  of  normality.  Figure  1  below  presents  the  Q-­Q  plots  for  fat  oxidation  rate  in  mg∙min-­1,  
adjusted  for  kg  fat-­free  mass,  for  the  70%  (A)  and  100%  (B)  GET  constant  work-­rate  exercise  tests.  As  is  
evident  from  the  plots  below,  the  assumption  of  normality  was  upheld  in  the  present  data.  Levene’s  tests  
of  homogeneity  of  variance  suggested  that  no  violations  to  this  assumption  were  evident  for  the  
aforementioned  variables.    








Figure  4.2.  Q-­Q  plots  for  fat  oxidation  rate  in  mg  min-­1  
  
4.3.1  Subject  Characteristics    
The  physical  characteristics  of  the  groups  (i.e.,  metabolically  healthy  normal  weight,  MHNW;;  
metabolically  unhealthy  normal  weight,  MUNW;;  metabolically  healthy  obese,  MHO;;  and  metabolically  
unhealthy  obese,  MUNW)  are  presented  in  Table  4.3  below.  Based  on  the  results  of  ANOVA  and  planned  
contrasts  investigations  conducted  for  each  variable,  individuals  in  the  MHO  and  MUO  groups  had,  on  
average,  higher  body  mass,  percent  body  fat,  BMI,  and  waist  circumference  compared  to  individuals  in  
the  MHNW  and  MUNW  groups  (p  <  .05).  One-­way  ANOVA  also  revealed  a  significant  difference  in  mean  
age  between  the  groups  (F(3,25)  =  3.669,  p  <  .05).  However,  a  follow-­up  analysis  with  planned  contrasts  
and  Tukey’s  post-­hoc  indicated  that  the  different  in  mean  age  only  existed  between  the  MHNW  and  the  
MUO  groups  (p  <  .05).  Fat-­free  mass  and  blood  glucose  during  fasting  and  2-­hr  post  75g  glucose  drink  







Subject  Characteristics    
Variable   MHNW   MUNW   MHO   MUO   p-­Value  
N   8  (4M,  4F)   7  (4M,  3F)   8  (4M,  4F)   7  (5M,  2F)     












Age,  yr   25.8  ±  2.9   31.4  ±  4.9   31.6  ±  7.8   35.3  ±  5.0   p  <  .05  
Body  Mass,  kg   63.0  ±  9.6   67.5  ±  7.5   84.1  ±6.2     96.0  ±13.2   p  <  .05  
FFM,  kg   49.3  ±  11.6   47.3  ±  6.6   54.7  ±  9.5   58.9  ±  12.4   NSD  
Body  Fat,  %   21.6  ±  9.0   29.6  ±  3.3   33.6  ±  10.6   38.8  ±  9.0   p  <  .05  
BMI,  kg∙m2   23.0  ±  1.3   23.4  ±  1.2   30.2  ±  3.3   31.9  ±3.3   p  <  .05  
WC,  in   28.3  ±  4.3   33.3  ±  2.4   35.9  ±  2.7   40.4  ±  5.8     p  <  .05  
WHR   0.76  ±  0.07   0.86  ±  0.05   0.81  ±  0.08   0.90  ±  0.10     p  <  .05  
FBG,  mg∙dl-­1   93.7  ±  4.4   99.9  ±  9.0   92.3  ±  10.2   99.5  ±  8.4   NSD  
2-­hrs,  mg∙dl-­1   100.2  ±  17.7   119.4  ±  38.6   107.6  ±  12.3   124.3  ±  35.9   NSD  
Values  are  mean±SD.  M,  male;;  F,  female;;  BMI,  body  mass  index;;  WC,  waist  circumference;;  WHR,  waist-­to-­hip  ratio;;  
FBG,  fasting  blood  glucose;;  2-­hrs,  blood  glucose  post  2-­hrs  75g  glucose  drink;;  HDL,  high-­density  lipoprotein;;  FFM,  fat-­
free   mass;;   MHNW,   metabolically   healthy   normal   weight   ;;   MUNW,   metabolically   unhealthy   normal   weight;;   MHO,  
metabolically  healthy  obese;;  MUO,  metabolically  unhealthy  obese;;  NSD,  no  significant  difference.  
  
4.3.2  Incremental  Test  Parameters  
Maximal  exercise  testing  was  performed  to  determine  GET  and  cardiorespiratory  fitness  level  
(V̇O2max)  (Table  4.4).  One-­way  ANOVA  and  follow-­up  planned  contrasts  for  specific  group  differences  
indicated  no  statistical  differences  between  the  groups  in  any  of  the  Peak  or  GET  values  below  (p  >  .05).    
Table  4.4  
Incremental  Test  Parameters  
Variable   MHNW   MUNW   MHO   MUO   P-­Value  
N   8  (4  M,  4F)   7  (4M,  3F)   8  (4M,  4F)   7  (5M,  2F)     
WRpeak,  W   175  ±  42   150  ±  21     183  ±  46   184  ±  37   NSD  
V̇O2max,  ml∙min-­1   2213  ±  629   1880  ±  320   2275  ±  518   2427  ±  601   NSD  
V̇O2max,  ml∙min-­1∙kgFFM-­1   44.4  ±  5.0   40.1  ±  6.8   41.7  ±  6.0   41.1  ±  4.3   NSD  
70%  GET,  W   46  ±  13   39  ±  9   52  ±  19   49  ±  14   NSD  
70%  GET,  %  WRpeak   26  ±  5   27  ±  5   28  ±  5   26  ±  4   NSD  
100%  GET,  W   66  ±  19   56  ±  13   75  ±  27   70  ±  20   NSD  
100%  GET,  %  WRpeak   53  ±  7   51  ±  5   54  ±  7   55  ±  5   NSD  
100%  GET,  ml∙min-­1   1146  ±  262   981  ±  189   1217  ±  279   1332  ±  391   NSD  
Values  are  mean±SD.  M,  male;;  F,  female;;  WRpeak,  peak  work  rate;;  V̇O2peak,  peak  rate  of  oxygen  consumption;;  GET,  
gas  exchange  threshold;;  MHNW,  metabolically  healthy  normal  weight  ;;  MUNW,  metabolically  unhealthy  normal  weight;;  





4.3.3  Weight  and  Energy  Stability  
Participants  were  required  to  follow  a  9-­day  controlled  dietary  regiment  with  a  specific  number  of  
calories  and  macronutrient  composition  to  ensure  weight  and  energy  stability  within  and  between  subjects  
during  the  assessment  period.  Tables  4.5  and  4.6  below  present  data  related  to  mean  weight  (kg),  weight  
change,  and  95%  CI,  by  group,  recorded  on  the  first  and  last  day  of  the  assessment  period,  and  diet  
adherence.  Weight  change  was  not  significantly  different  between  the  group  (F(3,26)  =  1.009,  p  =  0.4).  
Diet  adherence  was  similar  between  the  groups  and  significantly  high  overall  (90%).  Each  participant  
received,  on  average,  20  food  items  to  eat  each  day.  On  average,  1.4  food  items  were  excluded  each  
day,  whereas  0.6  were  added.  
  
Table  4.5  
Weight  and  Energy  Stability  
Group   Day  1   Day  9   Weight  Change   95%  CI    
MHNW   63.1  ±  9.8   62.8  ±  9.3   0.3  ±  0.9   [-­0.4,  1.1]  
MUNW   68.0  ±  7.2   67.3  ±  7.3   0.6  ±  0.9   [-­0.1,  1.4]  
MHO   83.4  ±  5.7   82.5  ±  5.9   0.9    ±  0.8   [0.2,  1.5]  
MUO   97.2  ±  13.5   96.2  ±  13.0   1.0  ±  0.7   [0.3,  1.7]  
Values  are  mean±SD  for  body  weight  in  kg.    
  
Table  4.6  
Average  Dietary  Adherence,  %,  by  Group    
Group   MHNW   MUNW   MHO   MUO   Overall    
Adherence,  %   93  ±  4   91  ±  8   84  ±  16   89  ±  5   90  ±  9  
Exclusion,  #   1.3  ±  0.7   1.6  ±  1.4   2.9  ±  2.9   1.9  ±  1.0   1.9  ±  1.0  
Inclusion,  #   0.3  ±  0.2   0.3  ±  0.3   1.0   1.2   0.8  ±  0.8   0.6  ±  0.7  
Values  are  presented  as  percent  from  total,  and  actual  numbers.  %  Adherence  indicates  the  total  #  of  items  
prescribed  vs.  eaten.  Exclusion   indicates   the   total  number  of   items   that  were  prescribed,  but  not  eaten  
(“omitted”).  Inclusion  includes  the  total  number  of  items  that  were  eaten,  but  not  prescribed  (“added”).      
  
For  the  present  investigation,  a  series  of  ANOVAs  were  conducted  to  evaluate  the  differences  
between  the  four  groups  of  interest:  MHNW,  MUNW,  MHO,  MUNW.  Specifically,  the  analyses  identified  
differences  between  the  four  groups  in  fat  oxidation,  expressed  as  both  RER  and  as  a  rate  (mg∙min-­1)  





GET).  In  addition,  planned  contrasts  were  examined  to  evaluate  any  differences  between  MHNW  and  
MUO  (Research  Question  #1)  and  between  MUNW  and  MHO  (Research  Question  #2)  with  alpha  levels  
adjusted  according  to  the  step-­down  procedure  outlined  by  Holm.  Effect  sizes  were  also  investigated  
based  on  the  omega-­squared  statistic,  and  correlation  coefficients  were  used  to  examine  the  planned  
contrast  analyses.  Finally,  Tukey’s  post-­hoc  analyses  were  used  to  explore  remaining  comparisons  
between  groups.  
To  reduce  within-­group  error  variance  and  more  accurately  assess  the  effect  of  the  experimental  
manipulation,  a  series  of  ANCOVAs  were  also  conducted  using  GET  (ml/*min,  adjusted  for  kg  body  
weight)  as  a  covariate,  following  the  same  process  outlined  above  for  the  ANOVAs,  planned  contrasts,  
and  Sidak’s  post-­hoc  analyses.  Partial  Eta  Squared,  instead  of  Omega  Square,  was  used  to  assess  effect  
size  for  the  ANCOVA.      
4.3.4  Lipid  Oxidation  During  Basal  Condition  After  Eight  Days  of  a  Weight-­Stable    
and  Energy-­Balanced  Dietary  Protocol    
  
A  one-­way  ANOVA  and  follow-­up  planned  contrasts  analysis  indicated  no  significant  differences  
between  the  groups  for  lipid  oxidation,  expressed  as  RER  or  as  mg∙min-­1  adjusted  for  FFM  (Table  4.7).  
Figure  2  below  presents  a  graphical  depiction  of  lipid  oxidation  as  (A)  RER  and  as  (B)  mg∙min-­1  adjusted  
for  FFM  for  each  of  the  four  groups.  Resting  energy  expenditure,  expressed  as  kcal∙min-­1,  adjusted  for  kg  





Lipid  Oxidation  During  Basal  Condition  After  Eight  Days  of  a  Weight-­Stable  and    
Energy-­Balanced  Dietary  Protocol    
  
Variable   MHNW   MUNW   MHO   MUO   p-­Value  
N   8  (4  M,  4F)   7  (4M,  3F)   8  (4M,  4F)   7  (5M,  2F)     
REE,  kcal∙min-­1∙kgFFM-­1   1164  ±  508   1448  ±  161   1406  ±  233   1724  ±  315   NSD  
RER   0.82  ±  0.05   0.84  ±  0.05   0.81  ±  0.05   0.85  ±  0.05   NSD  
Fat  Oxidation,  mg∙min-­
1∙kgFFM-­1  
1.16  ±0.50   1.12  ±  0.46   1.16  ±  0.48   1.04  ±  0.35   NSD  
Values  are  mean±SD.  M,  male;;  F,  female;;  REE,  resting  energy  expenditure;;  V̇O2,  rate  of  oxygen  consumption;;  RER,  
respiratory  exchange  ratio;;  MHNW,  metabolically  healthy  normal  weight  ;;  MUNW,  metabolically  unhealthy  normal  















Figure  4.3.  Lipid  oxidation  during  basal  condition  after  eight  days  of  a  weight-­stable  and  energy-­balanced  
dietary  protocol  as  RER  (A)  and  as  mg∙min-­1  adjusted  for  kg  fat-­free  mass  (B).  
  
4.3.5  Lipid  Oxidation  During  the  70%  GET  Constant  Work-­Rate  Exercise  
In  the  one-­way  ANOVA  (Table  4.8),  lipid  oxidation,  expressed  in  mg∙min-­1  adjusted  for  kg  fat-­free  
mass,  was  significantly  different  (F(3,26)  =  4.058,  p  <  .05)  between  the  groups,  with  a  large  effect  size    
(w2  =  .25).  Total  energy  burn,  expressed  in  kcal∙min-­1  adjusted  for  fat-­free  mass,  and  lipid  oxidation,  
expressed  as  RER,  were  similar  between  the  groups  (p  >  .05).  Planned  contrasts  were  examined  to  
assess  group  differences  in  order  to  answer  each  of  the  research  questions  outlined  above.  These  results  
revealed  a  statistically  significant  difference  between  MHNW  and  MUO  (mean  ±  SD:  3.86  ±  1.10  vs.  2.73  
±  0.93;;  t  (26)  =  2.282,  p  <  .05)  with  a  medium  effect  size  (r  =  0.41),  and  between  MUNW  and  MHO  (mean  
±  SD:  2.35  ±  0.41  vs.  3.65  ±  1.15;;  t  (26)  =  -­2.685,  p  <  .025)  with  a  medium  effect  size  (r  =  0.47).  In  
addition,  Tukey  post-­hoc  analyses  also  revealed  a  significant  difference  between  MHNW  and  MUNW  
groups  (p  <  .05).    
When  ANCOVA  was  applied  to  evaluate  group  differences  in  lipid  oxidation  while  accounting  for  
variability  attributed  to  differences  in  GET  (ml/min/kg  BW),  both  RER  (p  =  .005,  h2  =  0.40)  and  lipid  
oxidation,  expressed  as  mg*min*kg  FFM,  were  significantly  different  between  the  groups.  Planned  
contrasts  and  Sidak  post-­hoc  analyses  were  also  examined  and  revealed  a  statistically  significant  






vs.  MHO  (p  =  .009),  and  MHNW  vs.  MUNW  (p  <  .05).  In  addition  to  lipid  oxidation  as  mg*min*kg  FFM,  
RER  was  also  significantly  different  between  MHNW  vs.  MUO  (p  =  .001).        
  
Table  4.8  
Lipid  Oxidation  During  the  70%  GET  Constant  Work-­Rate  Exercise  (one-­way  ANOVA)  
Variable   MHNW   MUNW   MHO   MUO   P-­Value   Omega  Squared  
N   8  (4  M,  4F)   7  (4M,  3F)   8  (4M,  4F)   7  (5M,  2F)        
Total  Energy,      
kcal∙min-­1∙kgFFM-­1  
0.08  ±  0.02   0.07  ±  0.01   0.09  ±  0.01   0.09  ±  0.01   NSD   -­-­-­  




3.9  ±  1.1   2.4  ±  0.4   3.7  ±  1.2   2.7  ±  0.9   0.012   0.25  
Values  are  mean±SD.  M,  male;;  F,  female;;  RER,  respiratory  exchange  ratio;;  MHNW,  metabolically  healthy  
normal  weight;;  MUNW,  metabolically  unhealthy  normal  weight;;  MHO,  metabolically  healthy  obese;;  MUO,  






















4.3.6  Lipid  Oxidation  During  the  100%  GET  Constant  Work-­Rate  Exercise  
In  the  one-­way  ANOVA  (Table  4.9),  RER  and  total  energy  in  kcal∙min-­1  adjusted  for  fat-­free  mass  
were  similar  between  the  groups  (p  >  .05).  However,  lipid  oxidation  rate  in  mg∙min-­1  adjusted  for  kg  fat-­
free  mass  was  approaching  statistical  significance  (F(3,26)  =  2.674,  p  =  .068),  with  a  large  effect  size    
(w2  =  0.15).  Similar  trends  were  observed  when  planned  contrasts  analyses  were  conducted  to  assess  
differences  between  the  designated  groups  (p  >  .05).  Accounting  for  variability  attributed  to  differences  in  
GET  (ml*min*kg  BW)  with  the  ANCOVA  resulted  in  a  similar,  albeit  smaller  p-­value  (p  =  .061),  and  a  
similar,  albeit  bigger  effect  size  (h2  =  0.46).    
Table  7  
Lipid  Oxidation  During  the  100%  GET  Constant  Work-­Rate  Exercise  
Variable   MHNW   MUNW   MHO   MUO   P-­Value   Omega  Squared  
N   8  (4  M,  4F)   7  (4M,  3F)   8  (4M,  4F)   7  (5M,  2F)        
Total  Energy,      
kcal∙min-­1∙kgFFM-­1  
0.12  ±  0.03   0.10  ±  0.03   0.12  ±  0.03   0.12  ±  0.02   NSD   -­-­-­  




3.9  ±  1.7   2.1  ±  0.7   2.9  ±  1.1   2.6  ±  1.3   .068   0.15  
Values  are  mean±SD.  M,  male;;  F,  female;;  RER,  respiratory  exchange  ratio;;  MHNW,  metabolically  healthy  
normal  weight;;  MUNW,  metabolically  unhealthy  normal  weight;;  MHO,  metabolically  healthy  obese;;  MUO,  











Figure  4.5  (for  illustration  purposes  only).  Group  means  for  lipid  oxidation  rate  in  mg∙min-­1  adjusted  for    






4.3.7  Lipid  Oxidation  During  the  70%  GET  Constant  Work-­Rate  Exercise  (Independent  t-­test)    
An  independent  t-­test  was  conducted  to  assess  differences  in  RER  and  lipid  oxidation  as  mg∙  
min-­1  adjusted  for  kg  fat-­free  mass,  between  normal  weight  (MHNW  +  MUNW;;  n  =  14)  and  
overweight/obese  (MHO  +  MUO;;  n  =  15)  individuals  (Table  4.10).  Effect  sizes  were  also  investigated  
based  on  correlation  coefficients.  Lipid  oxidation  was  similar  between  the  groups.    
    
Table  4.10  
Lipid  Oxidation  During  the  70%  GET  Constant  Work-­Rate  Exercise  (Independent  t-­test)    
Variable   Normal  Weight   Overweight∙Obese   P-­Value   Correlation  Coefficient  
N   15  (8  M,  7  F)   15  (9  M,  6  F)        
RER     0.89  ±  0.04   0.89    ±0.04   NSD   -­-­-­  
Fat  Oxidation  Rate,    
mg∙min-­1∙kgFFM-­1  
3.1  ±  1.1   3.2  ±  1.1   NSD   -­-­-­  
Values  are  mean±SD.  M,  male;;  F,  female;;  RER,  respiratory  exchange  ratio;;  NSD,  no  significant  difference  
  
4.4  Discussion    
The  main  original  finding  from  this  investigation  is  that  a  reduced  rate  of  lipid  oxidation  during  
exercise  in  association  with  the  overweight/obese  condition  was  only  observed  when  the  “metabolic  
health”  of  the  overweight/obese  subject  was  also  compromised.  Moreover,  normal-­weight  individuals  with  
a  similar  derangement  in  metabolic  profile  also  demonstrated  a  lower  lipid  oxidation  rate  during  exercise,  
while  “metabolically-­healthy”  overweight/obese  subjects  possessed  a  capacity  that  was  not  different  
compared  to  their  metabolically-­healthy  normal-­weight  counterparts.  Collectively,  these  findings  
supported  our  experimental  hypotheses  and  suggest  that  the  lower  rate  of  lipid  use  that  has  been  
reported  for  overweight/obese  subjects  in  some  previous  investigations  reflects  the  loss  of  metabolic  
health  often  associated  with  excessive  fat  deposition,  as  opposed  to  the  overweight/obese  condition    
per  se.  
In  the  present  study,  we  assessed  the  capacity  for  exercise  lipid  use  during  stationary  cycling  at  
work  rates  where  lipid  should  still  contribute  significantly  to  energetic  demand.  Specifically,  subjects  
cycled  at  work  rates  assigned  relative  to  the  “gas-­exchange  threshold”  (GET),  which  approximates  the  





work  rate  at  LT  has  been  shown  to  be  correlated  with  the  one  that  allows  for  the  maximal  capacity  for  lipid  
use  (Achten  &  Jeukendrup,  2004);;  hence,  assigning  work  rate  relative  to  GET  should  allow  for  a  
consistent  comparison  across  subjects.  Consequently,  the  ~40%  and  ~25%  reductions  in  the  rate  of  lipid  
use  at  70%  GET  that  we  observed  in  association  with  metabolic  compromise  in  normal-­weight  and  
overweight/obese  subjects,  respectively,  suggest  that  the  metabolic  health  of  an  individual  is  a  key  
determinant  that  influences  his  or  her  capacity  to  use  lipid  as  fuel  effectively.  This  coheres  with  findings  
from  Ghanassia  et  al.  (2006)  who  observed  a  lower  maximal  rate  of  lipid  oxidation  in  sedentary  subjects  
with  type  2  diabetes  compared  to  age-­,  sex-­  and  BMI-­matched  sedentary  controls  with  normal  glucose  
tolerance.  Indeed,  patients  with  type  2  diabetes  demonstrated  a  lower  lipid  oxidation  rate  at  five  different  
exercise  work  rates  that  were  assessed  in  that  study.  Importantly,  our  metabolically-­unhealthy  subjects  
did  not  yet  possess  type  2  diabetes;;  hence,  our  findings  implicate  an  impaired  capacity  for  lipid  oxidation  
during  exercise  that  manifests  early  during  the  progression  of  insulin  desensitization.  A  similar  conclusion  
can  be  drawn  from  the  findings  of  Robinson,  Hattersley,  Frost,  Chambers,  and  Wallis  (2015)  who  reported  
that  the  maximal  lipid  oxidation  rate  was  positively  correlated  with  insulin  sensitivity  in  healthy  
recreationally-­active  men.  
The  present  findings  might  help  to  clarify  previous  ambiguity  regarding  the  influence  of  
overweight/obesity  on  the  capacity  for  exercise  lipid  use.  Specifically,  while  the  preponderance  of  
evidence  suggests  that  overweight/obese  individuals  oxidized  lipid  during  exercise  similarly  compared  to  
their  normal-­weight  counterparts,  seven  of  24  studies  that  made  this  comparison  did  include  evidence  of  
an  overweight/obesity-­related  reduction  during  exercise  (see  Chapter  3  for  review).  However,  one  of  
these  studies  involved  intermittent  bouts  of  resistance  training  (i.e.,  an  activity  for  which  lipid  use  would  
not  be  expected  to  contribute  to  a  great  extent),  while  others  involved  an  incremental  exercise  challenge  
where  the  time  to  achieve  and  work  at  “steady  state”  was  limited.  This  is  important  to  consider  because  in  
a  study  that  included  assessment  of  substrate  use  during  both  incremental  (Bruce  protocol;;  3-­minute  
stages)  and  constant-­work-­rate  (15  minutes)  treadmill  bouts,  Steffan  et  al.  (1999)  found  that  RER  values  
measured  at  8  and  15  minutes  of  the  constant  work-­rate  bout  were  significantly  less  than  and  not  
correlated  with  the  values  measured  during  the  3-­minute  stage  of  the  incremental  test  at  the  same  





was  assessed  in  the  present  study;;  however,  duration  was  less  than  30  minutes  for  each  of  these  bouts.  
This  has  resonance  because  Kanaley  et  al.  (2001)  found  that  a  lipid-­use  increment  in  exercise  lipid  use  
was  identifiable  after  30,  but  not  15  minutes  of  exercise  for  obese  compared  to  normal-­weight  subjects.  
Hence,  longer  constant-­work-­rate  exercise  bouts  appear  to  be  required  to  adequately  test  lipid-­oxidizing  
capacity  across  different  types  of  subjects.  Finally,  the  obesity-­related  decrement  reported  by  Hickner  et  
al.  (2001)  during  the  10-­minute  constant-­work-­rate  cycling  bouts  they  employed  was  only  present  when  
obese  subjects  were  compared  to  Caucasian  normal-­weight  controls.  Conversely,  when  compared  with  
normal-­weight  African  American  controls,  no  decrement  was  observed.  Considering  what  was  discovered  
from  the  present  research  in  concert  with  the  fact  that  African  Americans  typically  demonstrate  lower  
insulin  sensitivity  compared  to  Caucasians,  it  is  possible  that  Hickner  et  al.’s  findings  represented  the  
deleterious  effect  of  metabolic  health  on  exercise  lipid  use  as  opposed  to  overweight/obesity  per  se.    
The  link  between  a  reduced  capacity  to  oxidize  lipid  as  fuel  and  loss  of  insulin  sensitivity  that  we  
observed  could  be  rooted  in  an  increased  accumulation  of  lipid  in  skeletal  muscle,  which  has  the  potential  
to  create  “lipotoxic”  repercussion  (Moro  et  al.,  2008).  Indeed,  it  is  attractive  to  speculate  an  inherent  
defect  in  mitochondrial  lipid  oxidation  that  results  in  lipid  accumulation  exceeding  use,  which  could  also  
predispose  the  overweight/obese  condition  (Kelley  et  al.,  1999).  However,  the  preponderance  of  evidence  
in  support  of  this  notion  has  been  derived  from  studies  that  have  assessed  lipid  use  during  basal  
conditions  when  lipid  use  should  predominate  (Kelley  et  al.,  1999)  and  the  degree  to  which  a  
mitochondrial  defect  during  a  condition  with  such  a  low  metabolic  demand  could  mediate  insulin  
sensitivity  has  been  questioned  (Holloszy,  2008).  It  is  also  important  to  note  that  a  reduced  capacity  for  
lipid  use  during  the  basal  condition  is  not  a  universal  finding.  Although  not  the  primary  purpose  of  the  
present  investigation,  we  also  assessed  lipid  use  during  fasting  for  our  four  groups  of  subjects  and  found  
no  deficit  associated  with  either  metabolic  compromise  or  the  overweight/obese  state.  Importantly,  prior  to  
this  measurement,  we  imposed  an  8-­day  controlled-­feeding  period  with  fixed  macronutrient  proportions  
and  weight  stability.  In  this  regard,  Galgani  et  al.  (2008)  emphasize  the  importance  of  this  dietary  control  
when  assessing  fuel  proportionality  because  of  the  profound  effect  of  acute  energy  balance  and  dietary  





With  respect  to  determining  the  influence  of  overweight/obesity  on  exercise  lipid  use,  a  number  of  
methodological  aspects  of  the  present  study  deserve  mention.  In  the  preponderance  of  previous  
research,  exercise  intensity  was  assigned  relative  to  the  peak  work  rate  achieved  on  a  maximal  
incremental  test  (i.e.,  “V̇O2max”).  This  method  of  normalizing  exercise  work  rate  would  not  be  expected  to  
provide  for  a  consistent  comparison  across  subjects  because  Venables  et  al.  (2005)  observed  that  the  
maximal  rate  of  lipid  use  occurred  anywhere  between  21  and  77%  of  V̇O2max  in  their  cohort  of  healthy  
individuals.  Conversely,  as  previously  mentioned,  the  maximal  rate  of  lipid  oxidation  is  correlated  with  LT;;  
hence,  assigning  work  rate  relative  to  that  parameter  appears  to  be  a  superior  alternative.  We  also  
modeled  the  V̇O2  response  to  the  exercise  transition  to  estimate  the  point  at  which  a  “steady  state”  level  
of  energy  expenditure  occurred  because  prior  to  this  point,  gas-­exchange  values  do  not  faithfully  indicate  
metabolism  and  fuel  proportionality.  Consequently,  regardless  of  the  rapidity  with  which  they  made  the  
transition  to  the  higher  work  rate  (i.e.,  V̇O2  kinetics),  subjects  were  compared  for  the  same  duration  of  
exercise  (i.e.,  the  initial  45  minutes  after  attainment  of  steady  state).  Finally,  we  assessed  fuel  use  for  45  
minutes  of  exercise  to  ensure  that  the  greater  temporal  increase  in  lipid  use  during  exercise  that  has  been  
reported  for  overweight/obese  subjects  by  Kanaley  et  al.  (see  above)  would  be  accounted  for  in  our  
comparison.    
A  few  limitations  to  our  study  need  to  be  discussed.  As  previously  mentioned,  a  potential  
interpretation  of  our  findings  is  that  the  condition  we  defined  for  our  two  groups  of  metabolically-­unhealthy  
subjects  could  be  rooted  in  a  mitochondrial  defect  that  restricts  oxidation  of  available  lipids.  Indeed,  
independent  of  adiposity,  individuals  with  type  2  diabetes,  a  disease  of  insulin  resistance,  have  been  
shown  to  demonstrate  a  decrease  in  mitochondrial  biogenesis,  reduce  mitochondrial  content,  and  lower  
concentration  of  oxidative  enzymes  compared  with  individuals  without  the  disease  (DeLany  et  al.,  2014).  
However,  a  potential  problem  with  this  interpretation  is  that  in  our  study,  we  did  not  assess  mitochondrial  
activity  and/or  function  directly,  but  instead,  lipid  oxidation  was  used  as  a  proxy.  Nevertheless,  it  has  been  
proposed  that  a  reduced  mitochondrial  oxidative  capacity  can  lead  to  impaired  lipid  oxidation  (Morino,  
Petersen,  &  Shulman,  2006)  and  therefore,  the  ability,  or  lack  thereof,  to  increase  lipid  oxidation  in  
response  to  an  increase  in  energy  needs  and/or  lipid  flux  might  represent  an  early  biomarker  of  metabolic  





Our  participants  underwent  body-­composition  analysis  using  the  Bod  Pod  to  quantify  fat  and  fat-­
free  components  of  their  body.  This  is  important  because  a  greater  fat-­free  mass  might  translate  to  a  
greater  metabolic  and  fat-­burning  capacity,  independent  of  fat  mass  (Goodpaster,  Wolfe,  &  Kelley,  2002).  
Consequently,  measurements  of  lipid  oxidation  expressed  in  absolute  terms  (e.g.,  as  mg∙min)  should  be  
normalized  to  fat-­free  mass  to  control  for  this  factor.  Given  that  individuals  with  excess  lipid  storage  
typically  possess  greater  fat-­free  mass  compared  with  normal-­weight  counterparts,  failure  to  express  an  
absolute  measurement  of  lipid  oxidation  relative  to  fat-­free  mass  could  lead  to  a  type  II  error  by  masking  
an  obesity-­  and/or  insulin-­resistance-­related  decrement  that  might  be  present.  Indeed,  most  studies  that  
have  failed  to  normalize  exercise  lipid  oxidation  to  fat-­free  mass  have  found  no  difference  in  exercise  lipid  
oxidation  between  normal-­weight  and  overweight/obese  individuals  (Balcı,  2012;;  Colberg  et  al.,  1996;;  
Kanaley  et  al.,  1993;;  Larsen  et  al.,  2009;;  Santiworakul  et  al.,  2014,  Slusher  et  al.,  2015;;  Thyfault  et  al.,  
2004).  Normalizing  lipid  oxidation  rate  for  fat-­free  mass  might  explain  the  reason  for  the  discrepancy,  and  
our  findings  are  consistent  with  previous  studies  that  have  measured  and  normalized  rates  of  lipid  
oxidation  to  fat-­free  mass  (Hickner  et  al.,  2001;;  Keim  et  al.,  1996;;  Lanzi  et  al.,  2014,  Mohebbi  &  Azizi,  
2011;;  Perez-­Martin  et  al.,  2001).  However,  there  is  a  growing  appreciation  that  in  many  cases,  fat  
deposition  pattern  (e.g.,  subcutaneous  vs.  muscle)  can  also  influence  the  insulin-­resistant  state  and/or  
patterns  of  fuel  selection  and  metabolism  independent  of  body  weight  (Fried,  Lee,  &  Karastergiou,  2015;;  
Patel  &  Abate,  2013;;  Stefan,  Schick,  &  Häring,  2017).  For  example,  lower  rates  of  lipid  oxidation  have  
been  observed  in  normal-­weight  women  with  a  higher  abdominal-­to-­lower-­body  fat  mass  ratio  compared  
with  women  with  a  lower  abdominal-­to-­body  fat  mass  ratio  during  45  minutes  of  steady-­state  exercise  at  
65%  V̇O2max.  Based  on  this  observation,  patterns  of  fat-­deposition  might  be  an  important  factor  to  
consider  when  a  comparison  of  exercise  lipid  use  is  made  between  overweight/obese  and  normal-­weight  
individuals.  Interestingly,  in  our  study,  the  normal-­weight  and  overweight/obese  unhealthy  subjects  
demonstrated  a  higher  waist-­to-­hip  ratio,  which  may,  in  part,  explain  our  observation.  Furthermore,  the  
normal-­weight  unhealthy  subjects  in  our  study  had,  on  average,  a  higher  body-­fat  percentage  compared  
with  their  normal-­weight  healthy  counterparts  (e.g.  ~28  vs.  21%;;  p  >  .05).  However,  we  did  not  assess  
patterns  of  fuel  storage  and/or  fat  deposition  in  discrete  compartments  (e.g.,  abdominal,  gluteal,  muscle,  





Previous  research  suggests  that  a  racial  difference  might  exist  in  the  capacity  for,  and  oxidation  
of,  lipids  during  basal  (DeLany  et  al.,  2014;;  Chitwood,  Brown,  Lundy,  &  Dupper,  1996;;  Weyer,  Snitker,  
Bogardus,  &  Ravussin,  1999)  and  exercise  (Chitwood  et  al.,  1996)  conditions.  For  example,  Chitwood  et  
al.  (1996)  reported  higher  metabolic  reliance  on  carbohydrate  during  rest  and  exercise  in  normal-­weight  
Black  women  compared  with  their  White  counterparts.  In  this  study,  Blacks  exhibited  higher  fasting  
plasma  insulin  levels  that  may,  in  part,  explain  their  findings.  As  previously  mentioned,  in  concert  with  
these  observation,  our  findings  help  to  inform  those  of  Hickner  et  al.  (2001)  by  implying  that  differences  in  
lipid-­oxidizing  capacity  that  were  observed  might  simply  reflect  the  metabolic-­health  differences  of  the  
races  as  oppose  to  race  per  say.  In  our  study,  we  did  not  control  for  race,  but  we  did  control  for  factors  
that  might  predispose  and/or  be  strongly  associated  with  poor  metabolic  health.  Overall,  we  observed  
significantly  lower  rates  of  lipid  oxidation  in  the  metabolically-­unhealthy  compared  with  metabolically-­
healthy  groups  with  all  of  our  participants  who  self-­identified  as  Black  (n  =  5)  falling  in  the  latter  category  
(normal-­weight,  n  =  1;;  overweight/obese,  n  =  4).  Based  on  this  observation,  it  is  attractive  to  speculate  
that  racial  differences  observed  in  previous  studies  have  little  to  do  with  race  per  se,  but  much  to  do  with  
related  metabolic-­health  differences.  With  that  said,  our  study  was  not  designed  to  assess  racial  
differences  and  future  studies  should  evaluate  whole-­body  exercise  lipid  oxidation  in  various  races  with  
factors  that  might  influence  the  comparisons  rigidly  controlled  (e.g.,  metabolically-­unhealthy  and  healthy  
Black  and  White  classifications).    
Another  potential  limitation  of  the  present  research  is  the  observed  differences  in  age  between  
the  metabolically-­healthy  normal-­weight  (~26  yrs)  and  metabolically-­unhealthy  overweight/obese    
(~35  yrs)  groups.  When  adjusted  for  metabolic  rate,  exercise  lipid  oxidation  expressed  as  RER  and  as  a  
rate  relative  to  FFM  (i.e.,  mg∙min-­1∙kg-­1FFM),  was  significantly  lower  in  the  metabolically-­unhealthy  obese  
compared  with  the  metabolically-­healthy  normal-­weight  group.  Consequently,  one  might  speculate  that  
advancing  age  (or  possibly  the  associated  change  in  muscle  phenotype  brought  on  by  passage  of  years  
with  insufficient  exercise)  influenced  our  results.  However,  in  a  study  of  32  women  aged  18–73  yrs,  
Calles-­Escandon,  Arciero,  Gardner,  Bauman,  and  Poehlman  (1995)  observed  no  association  between  
age  and  lipid  oxidation  when  the  effect  of  fat-­free  mass  was  statistically  removed.  Furthermore,  other  





used  age  gaps  that  were  three  (Solomon  et  al.,  2008),  four  (Levadoux  et  al.,  2001)  and  five  (Melanson  et  
al.,  1997)  times  the  one  that  was  present  in  our  study.  It  is  also  important  to  note  that  lipid  oxidation  was  
also  significantly  lower  in  the  metabolically-­unhealthy  normal-­weight  group  compared  with  both  the  
metabolically  healthy  normal-­weight  and  obese  groups  despite  no  statistically  significant  difference  in  age  
across  these  groups.  Finally,  while  mean  age  was  lower  in  the  metabolically-­unhealthy  normal-­weight  
compared  with  metabolically-­unhealthy  obese  group,  RER  and  rates  of  lipid  oxidation  were  similar,  which  
support  the  contentions  that  decrements  in  the  capacity  to  rely  on  lipid  during  exercise  found  for  the  
former  group  in  our  study  are  related  to  the  influence  of  metabolic  health  as  opposed  to  that  of  aging  per  
se.  In  closing,  with  regard  to  these  limitations,  future  research  should  be  designed  to  confirm  our  
contentions  regarding  the  relative  contribution  of  age  and  these  other  variables  to  exercise  lipid  use  being  
that  answering  these  questions  was  outside  the  scope  of  the  present  research.    
In  summary,  we  have  confirmed  that  when  important  pre-­test  diet  and  exercise  aspects  of  control  
are  present,  overweight/obese  subjects  do  not  demonstrate  a  reduced  capacity  for  exercise  lipid  use  
compared  to  their  normal-­weight  counterparts.  However,  when  metabolic  health  is  compromised,  an  
exercise  lipid-­use  decrement  is,  indeed,  present  and  of  similar  magnitude  regardless  of  whether  
overweight/obesity  accompanies  the  metabolic  demise.  Although  the  cross-­sectional  nature  of  this  study  
precludes  determination  of  a  cause/effect  relationship,  these  findings  are  consistent  with  the  contention  
that  a  sluggish  capacity  for  lipid  use  is  extant  early  in  the  progression  to  insulin  desensitization  regardless  
of  whether  overweight/obesity  is  present.      





Chapter  5  –  Discussion  
The  overarching  objective  of  this  dissertational  work  was  to  evaluate  a  9-­day  protocol  designed  to  
assess  metabolic  function  in  individuals  at  risk  for  developing  type  2  diabetes  by  measuring  whole-­body  
substrate  selectivity  during  exercise  with  various  factors  that  can  affect  exercise  lipid  use  rigidly  
controlled.  Specifically,  in  Chapter  4,  we  demonstrated  how  our  assessment  protocol  was  effective  for  
clarifying  lingering  ambiguity  in  the  research  regarding  the  influence  of  overweight/obesity  on  the  capacity  
for  lipid  oxidation  during  exercise  that  we  documented  in  Chapter  3.  We,  therefore,  contend  that  this  
protocol  can  be  advanced  as  a  standardized  one  designed  to  assess  exercise  lipid  use  as  a  proxy  for  
metabolic  health  to  establish  prognosis  and  potential  exercise-­related  treatment  options  early  in  the  
progression  of  insulin  desensitization  in  a  variety  of  at-­risk  subjects.      
The  etiology  of  type  2  diabetes  is  complex  and  the  causes  have  been  debated.  One  theory  that  
has  gained  traction  in  recent  years  suggests  that  type  2  diabetes,  and  the  insulin-­resistant  state  that  
predates  it,  are  rooted  in  dysfunctional  lipid  metabolism  (i.e.,  a  reduced  capacity  to  use  lipid  for  energy  
production  in  circumstances  where  lipid  would  be  preferred;;  e.g.,  the  fasting  state).  Within  this  schema,  
intramyocellular  lipids  that  would  serve  to  supply  a  readily  available  source  of  energy  is  instead  
accumulate  in  muscle  resulting  in  weight  gain,  insulin  resistance  and,  eventually,  type  2  diabetes  
(McGarry,  1992).  Indeed,  reports  from  biochemical  analysis  demonstrated  a  six-­fold  increase  in  
intramyocellular  lipid  content  in  subjects  with  type  2  diabetes  compared  with  sex-­  and  age-­matched  non-­
diabetic  controls  independent  of  body  weight  (Jansson  &  Kaijser,  1987;;  Perseghin  et  al.,  2002).  
Moreover,  an  inverse  relationship  between  insulin  sensitivity  and  intramyocellular  lipid  content  was  
reported  in  unaffected  normal-­weight  adults  (Krssak  et  al.,  1999),  and  a  similar  relationship  was  also  
found  in  obese  (Kelley  et  al.,  1999;;  Weyer  et  al.,  2001)  and  normal-­weight  offspring  of  subjects  with  type  
2  diabetes  (Jacob  et  al.,  1999).  Collectively,  these  observations  suggest  that  dysfunctional  lipid  
metabolism  might  be  responsible,  in  part,  for  the  metabolic  decline  associated  with  the  progression  to  
type  2  diabetes.    
Elevated  intramyocellular  lipid  content  can  be  the  result  of  excess  free-­fatty  acid  uptake,  
inadequate  lipid  use,  or  both.  However,  evidence  suggests  that  free-­fatty  acid  uptake  by  skeletal  muscle  





2000;;  Kanaley  et  al.,  2001;;  Kelley  et  al.,  1999).  This  implies  that  pathological  lipid  accumulation  in  muscle  
is  related  to  an  inability  to  use  it.  Early  evidence  in  the  support  of  this  notion  comes  from  studies  that  
assessed  lipid  oxidation  during  fasting  conditions  when  lipid  should  predominate  (Filozof  et  al.,  2000;;  
Kelley  et  al.,  1999;;  Kim  et  al.,  2000;;  Ukropcova  et  al.,  2007).  However,  reduced  lipid  use  in  the  fasting  
state  for  individuals  with  or  at  risk  for  type  2  diabetes  is  not  a  universal  finding.  Indeed,  evidence  exists  to  
show  that  the  capacity  to  use  lipid  in  the  basal  state;;  e.g.,  after  an  overnight  fast  of  12  hours,  is  not  limited  
in  individuals  with  insulin-­resistance  and/or  obesity  (Colberg  et  al.,  1996;;  Ekelund  et  al.,  2007;;  Galgani,  
Moro,  &  Ravussin,  2008;;  Goodpaster  et  al.,  2002;;  Kaneley  et  al.,  2001;;  Perez-­Martin  et  al.,  2001;;  Steffan  
et  al.,  1999;;  Weyer  et  al.,  2001).  Moreover,  in  some  studies,  fasting  lipid  oxidation  was  enhanced  for  
these  types  of  subjects  (Blaak  et  al.,  2006;;  Felber  et  al.,  1987;;  Schutz  et  al.,  1992).  The  reason(s)  for  this  
ambiguity  is/are  not  clear  but  might  be  related  to  a  number  of  factors  that  were  not  adequate  controlled  
when  fasting  lipid  oxidation  was  measured.  For  example,  weight  stability  and  energy  balance  in  the  days  
prior  to  measurement  have  been  shown  to  be  important  factors  influencing  post-­absorptive  substrate  
selectivity  and  oxidation  (Goris  &  Westerterp,  2000).  Moreover,  day-­to-­day  variations  in  energy  balance  
and  macronutrient  intake  can  profoundly  affect  the  type  of  fuel  used  by  skeletal  muscle  (Schutz  et  al.,  
1992;;  Weyer  et  al.,  2001).  For  example,  Schutz  et  al.  (1992)  demonstrated  that  one-­day  increases  in  
energy  intake  followed  by  one-­day  decreases  produce  significantly  different  RQ  values.  Collectively,  
these  findings  mean  that  energy  balance  (and,  by  extension,  body  weight)  and  macronutrient  composition  
of  the  diet  should  be  tightly  controlled  in  the  days  prior  to  an  assessment  of  substrate  selectivity.  
Interestingly,  these  factors  were  not  adequately  controlled  in  many  of  the  studies  mentioned  above  and,  
therefore,  the  interpretation  of  the  results  might  be  limited.  Conversely,  our  protocol  requires  that  subject  
follow  a  9-­day  controlled  dietary  protocol  specifically  designed  to  keep  their  weight,  energy  intake  and  
macronutrient  proportions  constant.  Moreover,  each  participant  receives  specific  instructions  about  the  
meal  plan  and  portion  sizing  and  was  asked  to  complete  a  diet  adherence  sheet  that  indicates  how  
closely  they  follow  the  diet.  Using  this  protocol,  we  found  that  body  weight  did,  indeed,  remain  constant  
while  fasting  lipid  oxidation  was  similar  between  metabolically-­healthy  and  metabolically-­unhealthy  





for  these  types  of  subjects.  We  also  used  our  assessment  protocol  to  show  that  that  overall  adherence  to  
the  type  of  diet  we  employed  is  very  high  (~90%).    
The  degree  of  consistency  we  observed  for  our  basal  measurements  supports  our  contention  that  
our  assessment  protocol  can  be  effective  for  assessing  lipid  use  during  circumstances  where  a  greater  
metabolic  challenge  to  lipid  use  (and,  therefore,  greater  potential  to  unveil  a  possible  early  defect)  is  
present.  One  such  condition  is  moderate-­intensity  exercise  because  metabolic  demand  is  higher  yet  lipid  
can  still  contribute  significantly  as  fuel  (Galgani,  Heilbronn,  et  al.,  2008).  For  example,  in  the  clinical  trial  
we  used  to  apply  our  assessment  protocol  in  the  exercise  setting,  we  observed  an  ~6-­fold  increase  in  
energy  use  along  with  an  ~3-­fold  increase  in  lipid  oxidation  during  the  moderate-­intensity  exercise  test  we  
had  subjects  perform.  Consequent  to  these  characteristics  of  energetic  demand,  we  did,  indeed,  
observed  differences  consistent  with  defective  lipid  oxidation  in  some  types  of  subjects.  Specifically,  lipid  
oxidation  was  significantly  lower  in  metabolically-­unhealthy  normal-­weight  and  overweight/obese  subjects  
compared  with  metabolically-­healthy  subjects  regardless  of  body  composition.  Consequently,  our  
assessment  protocol  provided  data  that  allow  us  to  conclude  that  an  impairment  in  lipid  use  for  
metabolically-­unhealthy  subject  that  was  not  apparent  during  basal  condition  does,  indeed,  become  
evident  when  a  comparison  is  made  using  the  exercise  condition.    
It  stands  to  reason  that  the  exercise  condition  would  provide  a  particularly  appropriate  one  during  
which  to  assess  the  capacity  for  lipid  use.  Skeletal  muscle  is  the  major  site  for  fuel  metabolism  and  
energy  production  and  the  amount  of  skeletal  muscle  one  has  influences  the  capacity  to  oxidize  lipid  
(Storlien  et  al.,  2004;;  Venables  et  al.,  2005),  especially  during  exercise.  Furthermore,  both  cross-­sectional  
and  longitudinal  analyses  confirm  that  endurance-­trained  individuals  demonstrate  a  greater  capacity  for  
lipid  use  during  exercise.  Specifically,  endurance-­training-­related  adaptations  include  increased  muscle  
size  and  content  of  type  I  muscle  fibers,  increased  capillary  density  and  blood  flow  to  the  working  
muscles,  increased  hemoglobin  and  myoglobin  concentrations,  increased  mitochondrial  content  and  
function  and  increased  content  of  oxidative  enzymes  (Cox,  1991;;  Hellsten  &  Nyberg,  2015;;  Jones  &  
Carter,  2000;;  Lundby  &  Jacobs,  2016;;  Neufer,  1989).  Each  of  these  factors  can  account  for  a  propensity  
for  greater  lipid  oxidation  during  exercise  (Costill  et  al.,  1979;;  Jansson  &  Kaijser,  1987).  However,  there  is  





(Timmons,  2010).  Therefore,  when  assessing  impairments  in  lipid  use  in  association  with  factors  that  
might  predispose  and/or  lead  to  type  2  diabetes,  it  is  vital  to  control  for  physical  activity  level  and  aerobic  
fitness  (Goodpaster  et  al.,  2002).  When  testing  our  assessment  protocol,  we  accounted  for  this  factor  by  
only  recruiting  sedentary  subjects  who  self-­reported  exercising  two  or  fewer  times  per  week.  Furthermore,  
each  subject  underwent  a  maximal  incremental  exercise  test  to  determine  their  cardiorespiratory  fitness  
(i.e.,  V̇O2max)  prior  to  enrollment  and  those  demonstrating  an  age  and  gender-­specific  classification  as  
“better  than  average”  according  to  American  College  of  Sports  Medicine  criteria  were  excluded.    
Another  key  factor  to  consider  when  a  comparison  of  exercise  lipid  oxidation  is  made  between  
groups  is  the  intensity  of  the  exercise  bout.  The  capacity  to  rely  on  lipid  during  exercise  decreases  when  
exercise  work  rate  surpasses  that  which  is  aligned  with  the  lactate  threshold  (Venables  et  al.,  2005)  and  
the  point  at  which  that  occurs  is  vastly  different  based  on  fitness  level  and  other  factors  (e.g.,  muscle  
phenotype)  (Achten  &  Jeukendrup,  2004).  Previous  research  found  that  in  sedentary  individuals,  the  
highest  rate  of  lipid  oxidation  during  exercise  occurs  at  approximately  ~50%  V̇O2max,  which  formed  the  
basis  for  using  the  highest  work  rate  achieved  on  an  incremental  test  as  a  point  of  reference  to  prescribe  
exercise  at  the  same  relative  intensity  for  different  subjects  or  the  same  subject  under  different  
circumstances.  However,  Venables  et  al.  (2005)  reported  large  intersubject  variability  with  the  maximal  
rate  of  lipid  oxidation  occurring  anywhere  between  25  and  77%  of  V̇O2max  in  the  cohort  they  recruited.  
Using  GET  as  a  non-­invasive  proxy  for  lactate  threshold  in  our  study,  we  found  that  as  a  percentage  of  
V̇O2max,  GET  occurred  on  average  at  53%  with  values  ranging  from  45  to  67%.  Being  that  we  only  
included  subjects  who  were  sedentary  and  unfit,  this  relatively  large  interpersonal  variability  supports  our  
contention  that  normalizing  exercise  intensity  relative  to  V̇O2max  is  not  sufficient  for  ensuring  that  all  
subjects  are  exercising  at  the  same  relative  challenge.  
As  discussed  above,  one  of  the  main  objectives  of  this  work  was  to  resolve  the  ambiguity  
regarding  the  capacity  for  lipid  oxidation  in  individuals  with  the  overweight/obese  state,  a  condition  
strongly  associated  with  diabetes  and  other  metabolic  disorders.  This  has  clinical  and  practical  
significance  because  the  degree  to  which  the  overweight/obese  condition  is  associated  with  a  
dysfunctional  lipid  metabolism  is  an  important  factor  to  consider  when  designing  an  exercise  intervention  





condition,  it  supports  the  contention  that  a  mitochondrial  defect  exists;;  hence,  exercise  that  is  specific  for  
improving  mitochondrial  capacity  (e.g.,  high-­intensity  interval  training)  would  be  warranted.  Conversely,  if  
the  capacity  for  lipid  use  is  similar,  or  enhanced,  with  the  overweight/obese  condition,  mitochondrial  
function  would,  apparently,  be  sufficient;;  hence,  a  training  work  rate  situated  closer  to  the  one  at  which  
lipid  use  is  maximized  might  be  preferred  as  a  way  to  perturb  the  intramyocellular  lipid  pool  and  reduce  its  
pathogenic  influence.  Our  findings  supports  our  experimental  hypotheses  and  suggest  that  the  lower  rate  
of  lipid  use  that  has  been  reported  for  the  overweight/obese  subjects  in  some  previous  studies  reflect  the  
loss  of  metabolic  health  often  associated  with  excessive  fat  deposition  as  opposed  to  the  
overweight/obese  conditions.  Therefore,  individuals  with  markers  of  metabolic  derangements,  such  as  
those  associated  with  the  metabolic  syndrome,  may  benefit  more  from  an  exercise  program  that  focuses  
specifically  on  improving  mitochondrial  function.  Conversely,  in  the  absence  of  metabolic  derangements,  
e.g.  metabolically-­healthy  obese,  mitochondrial  function  and  the  capacity  for  lipid  oxidation  is  likely  
preserved  and  therefore,  an  exercise  intensity  situated  closer  to  the  one  at  which  lipid  use  is  maximized  
(e.g.  endurance  training)  might  be  preferred  as  a  way  to  reduce  muscle  fat.  It  is  important  to  keep  in  mind  
however  that  a  large  intra-­subject  variability  exists  with  regard  to  the  work-­rate  at  which  maximal  fat  
oxidation  occurs  (Venables,  Achten,  &  Jeukendrup,  2005)  and  therefore,  the  tradition  way  to  normalize  
endurance-­exercsie  intensity  by  quantifying  work-­rate  relative  to  the  individual  V̇O2max  may  not  be  
sufficient.  Instead,  normalizing  endurance-­exercise  intensity  relative  to  lactate  threshold,  or  GET  (non-­
invasive  proxy  for  lactic  threshold),  as  a  way  to  ensure  that  work-­rate  is  carried  at,  or  close  to,  the  
individuals  maximal  fat  oxidation  capacity,  might  be  preferred  for  clinical  and  practical  applications.  
In  our  study,  lipid  use  was  not  different  between  metabolically-­healthy  and  -­unhealthy  individuals  
despite  a  statistical  and  clinical  difference  between  the  groups  observed  in  the  exercise  condition.  This  
suggests  that  dysfunctional  lipid  metabolism  may  not  be  reliably  identified  during  the  basal  state  for  these  
types  of  subjects  and  future  studies  should  consider  assessing  dysfunctional  lipid  metabolism  in  one  or  
more  at-­risk  phenotypes  using  the  exercise  condition  (e.g.  white  vs.  blacks,  lower-­body  obese  vs.  upper-­
body  obese,  men  vs.  women).  In  addition,  our  novel  and  robust  protocol  can  be  advanced  as  a  
standardized  one  designed  to  assess  exercise  lipid  use  as  a  proxy  for  metabolic  health  to  establish  





desensitization  in  a  variety  of  at-­risk  subjects.  For  example,  lingering  question  with  regard  to  metabolic  
risk  associated  with  patterns  of  fat  storage  (e.g.  lower-­body  obese  vs.  upper-­body  obese,  muscle  vs.  
abdominal  vs.  subcutaneous),  gender  (e.g.  female  vs.  male),  race/ethnicity  (e.g.  white  vs.  black),  genetics  
(nature  vs.  nurture),  and  more.    
In  closing,  with  respect  to  the  exercise  challenge  we  employed,  control  of  numerous  factors  that  
are  present  with  our  assessment  protocol  allowed  us  to  confidently  clarify  ambiguity  regarding  the  
influence  of  overweight/obesity  on  exercise  lipid  use.  Specifically,  in  previous  studies  that  have  addressed  
this  topic,  exercise  intensity  was  prescribed  relative  to  V̇O2peak  (Ara  et  al.,  2011;;  Colberg  et  al.,  1996;;  
Croci  et  al.,  2014;;  Devries  et  al.,  2013;;  Ezell  et  al.,  1999;;  Geerling  et  al.,  1994;;  Goodpaster  et  al.,  2002;;  
Guesbeck  et  al.,  2001;;  Helge  et  al.,  1999;;  Horowitz  &  Klein,  2000;;  Kanaley  et  al.,  1993;;  Lanzi  et  al.,  2014;;  
Larsen  et  al.,  2009;;  Mittendorfer  et  al.,  2004;;  Perez-­Martin  et  al.,  2001;;  Steffan  et  al.,  1999;;  Zunquin  et  al.,  
2009;;  Thyfault  et  al.,  2004),  which  means  that  subjects  were  likely  working  at  different  intensities  relative  
to  their  maximal  capacity  for  lipid  oxidation  (Meyer,  Gabriel,  &  Kindermann,  1999;;  Weltman  et  al.,  1990).  
Furthermore,  in  some  studies,  fitness  level  was  not  measured  or  controlled.  In  association  with  the  
aspects  of  control  we  applied  for  pre-­test  feeding  (see  above),  we  believe  our  exercise  assessment  
protocol  can  be  useful  as  a  standardized  method  for  assessing  whole-­body  substrate  selectivity  and,  by  
extension,  metabolic  function  in  individuals  at  risk  for  developing  type  2  diabetes.  
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